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PART I 
General Introduction and Aims of the Thesis 

Chapter I 
General Introduction 
Adhesions 
Definition, incidence and complications 
Intra-abdominal adhesions are abnormal unions between different peritoneal surfaces. The 
most common cause of intra-abdominal adhesion formation is prior abdominal surgery which 
accounts for 70-90% of all adhesions. 1-3 Remaining adhesions are due to inflammation or 
endometriosis or are congenital (18% and 2.8-6% respectively). 1• 3 Postoperative intra-
abdominal adhesion formation is a major, up till now unavoidable complication of any kind of 
abdominal surgery. Postoperative adhesions occur in 55-100% of patients undergoing 
abdominal surgery, with an average of approximately 85%.2· 3· s-? These adhesions can 
eventuate in bowel, fertility and abdominal syndromes which frequently require further 
surgery. Adhesion formation is the cause of 30% of all bowel obstructions,8-10 of 15-20% of 
infertility in women 11 "15 and of 13-26% of chronic pelvic pain in women.16' 17 The cumulative 
risk of adhesive small-bowel obstruction after (sub)total colectomy is 11% within 1 year, 
increasing to 30% at 10 years.18 After open abdominal or pelvic surgery in 29,790 patients 
studied by Ellis et al, 34.6% were readmitted a mean of 2.1 times in the subsequent 1 0 
years for a disorder directly or possibly related to adhesions. Of these readmissions 22.1% 
occurred in the first year after initial surgery, but readmissions continued steadily throughout 
the 10 year study period.19 About 1% of all surgical admissions and 3% of all laparotomies 
take place for intestinal obstruction due to adhesions? The mortality rate from intestinal 
obstruction as a result of adhesions is 6-13%. 1· 4· 20 Adhesions also increase the technical 
difficulty and the risk of intraoperative complications at subsequent surgery depending on the 
organs involved and severity of adhesions. One of five patients undergoing adhesiotomy 
during reoperation suffers an inadvertent enterotomy, possibly resulting in extensive 
postoperative morbidity and mortality. Morbidity involves bowel obstruction, anastomotic 
leak, wound dehiscence, sepsis and pneumonia.21 Clearly in addition to the obvious 
morbidity and mortality due to postoperative adhesion formation the costs of adhesion 
related health care are significant.19' 20" 22"24 Until now there is no clinically relevant cost 
effective method available to reduce or prevent postoperative intra-abdominal adhesion 
formation. 
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Clinical diagnosis 
Intra-abdominal adhesions cannot be shown by non-invasive modalities. The combination of 
medical history and physical examination fail to adequately predict adhesion formation and 
invasive as well as non-invasive imaging studies have poor sensitivity for detecting 
adhesions. 25-27 In general, the presence of adhesions can only be confirmed by either 
laparoscopy or laparotomy. 
Aetiology and patholophysiology 
Adhesion formation is a physiological consequence of peritoneal tissue repair. Surgical 
trauma of the peritoneal surfaces induces a sequence of events which effectuates wound 
healing but which can also ultimately lead to fibrous adhesions between different peritoneal 
surfaces. Damage to the peritoneum causes desquamation of injured mesothelial cells leaving 
a denuded area, and a local inflammatory reaction which leads to the formation of a 
serosanguineous exudate.2e-31 The primary inflammatory response, the acute phase response, 
is characterised by an increased vascular permeability and the migration of neutrophils (PMNs) 
and subsequently macrophages and leucocytes to the site of the inflammation during the first 
48 to 72 hours after trauma.32-34 Chemoattractants (IL-8, MCP-1), cytokines (TN F-a, IL-1~ and 
IL-6) and growth factors (TGF-~, IGF-1, PDGF), produced and released by damaged 
mesothelial cells and resident and invading inflammatory cells are the key mediators of this 
inflammatory reaction. 35-39 In the resulting serosanguineous exudate fibrin deposition will take 
place through the activated complement- and coagulation systems and when two surfaces 
contact each other during this process a fibrinous adhesion will appear between day 2 and 4. 30· 
31
· 
40 Whether these adhesions are permanent of character or will eventually be lysed depends 
upon the fibrinolytic capacity of the peritoneum. 30· 4144 1ntra-abdominally deposited fibrin has to 
be lysed to free attached structures, restore the patency of the peritoneal cavity and open up 
the way to adhesion free healing. When the peritoneum is slightly damaged and mesothelial 
cells are mostly intact, there will be a dynamic balance between fibrinogenesis and fibrinolysis, 
between tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitors (PAls). 
41
· 
42
· 
45
· 
46 Adhesion-free healing may then take place by conversion of plasminogen into 
plasmin effectuating the sufficient break-down of fibrin by day 4 to 5 followed by proliferation 
and centripetal migration of residual mesothelial cells and proliferation and differentiation of 
interspersing mesothelial stem cells.28· 32· 4749 Reepithelialisation occurs through continuous 
simultaneous dividing of adjacent mesothelial cells and "islands" of multipotentia! sub-
mesothelial cells until the surface of the entire site of injury is covered by new mesothelium 5 to 
8 days after the initial peritoneal trauma.28· 32' 48 The remesothelialisation process appears to be 
mostly the result of mediators released by the mesothelial cells themselves. 50 
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Loss of mesothelial integrity due to the initial peritoneal trauma and invading leucocytes, which 
have been shown to enhance peritoneal injury by adhering to and damaging mesothelial cells 
through the release of active oxygen species, 51-54 will expose the underlying connective tissue 
(ECM) and normal mesothelial fibrinolytic activity will be lost for at least 48 hours post 
trauma.43' 55' 56 Exposed endothelial cells, damaged mesothelial cells, as well as resident and 
invading inflammatory cells, produce plasminogen activator inhibitor 1 and 2 (PAl 1 and 2), 
factors mediating a reduced functional fibrinolytic activity by down-regulating t-PA activity and 
thus plasminogen-plasmin conversion and fibrin demolishment.42· 57 Cytokines and growth 
factors, also produced by damaged mesothelial cells and inflammatory cells, decrease t-PA 
and increase PAl concentrations intra-peritoneally diminishing fibrinolytic activity of the 
mesothelium likewise.58• 59 The autonomous plasminogen activator activity (PAA) of the 
peritoneal exudates itself (result of local t-PA release and clearance) is also reduced during 
several hours postoperatively which contributes even more to the disbalance between t-PA 
and PAls and thus to decreased fibrinolytic activity.60• 61 Reduced plasminogen-plasmin 
conversion i.e. low fibrinolytic activity declines fibrin degradation and allows the fibrinous 
adhesion to organise to a fibrous permanent adhesion through invasion, proliferation and 
differentiation of fibroblasts and endothelial cells. This is followed by capillary formation and 
incorporation of collagen, all stimulated by cytokines, and growth factors (day 4 to 10).29. 62-67 
Cytokines increase expression of integrins, cell surface receptors mediating fibroblast and 
mesothelial cell adhesion to ECM.68 The mesothelial cells recover the exterior aspects of the 
adhesion, isolating the ECM from the peritoneal cavity and reconstituting an intact peritoneal 
mesothelial surface.69 
The results of the inflammatory and fibrinogenetic response to peritoneal trauma eventuate in 
ultimate resolution of the process, by triggering events that lead to cell regeneration and wound 
healing. Normal intra-abdominal inflammatory and fibrinogenetic defences become detrimental 
to the host if the balance between mediators of the inflammatory response and the balance 
between fibrinogenesis and fibrinolysis is lost and two peritoneal surfaces are apposed (Figure 
1.1 ). 
Treatment 
Relaparotomy or laparoscopy for adhesiolysis can be a technical challenge with elevated 
peroperative complication risks and significant postoperative morbidity and even mortality. 
Clinical studies involving second look operations show that operative adhesiolysis is also 
complicated by a high recurrence rate of adhesions at the operated site (adhesion 
reformation) or at other sites (de novo adhesions). 70-73 Laparoscopy does appear to be 
associated with equal adhesion reformation as laparotomy, between 38 and 97%, whereas 
de novo adhesions seem to be significantly less common after laparoscopy (12%) than 
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laparotomy (51%)?0-74 Recurrence rate of adhesions possibly depends on technique of 
adhesiolysis and time between initial surgery and evaluation of reformation.72. 73 Furthermore 
the degree of reformed adhesions is often more severe than that of the primary adhesions. 75 
Adhesive bowel obstructions can be treated conservatively, by intravenous drip and 
nasogastric suction, or by operation. The danger of conservative measures is of course that 
a loop of obstructed bowel is strangulated and is going to progress to gangrene with eventual 
perforation and subsequent increased mortality rate. Even for experienced surgeons the 
distinction between simple and strangulated obstruction is extremely difficult since there are 
no clinical signs, diagnostic laboratory tests or radiological features that will accurately 
confirm or refute the diagnosis of bowel ischemia. There are no fixed rules regard'1ng 
indications for or timing of operation and the decision is ultimately at the discretion of the 
individual surgeon. Conservative management is attempted in 27 to 83% of the patients 
while surgery rates also vary widely, from 22 to 54%. 4' 76-78 Non-operative treatment results in 
a shorter hospital stay and similar recurrence and reoperation quantities, but a reduced 
interval to reobstruction when compared with operative treatment 78 During adhesiolysis the 
bowel resection rate ranges from 5 to 20% and mortality following resection varies from 15 to 
20%.77 After an operation for an episode of adhesive bowel obstruction the risk of further 
episodes of obstruction ranges from 11-21%.79· 80 The likelihood of reobstruction increases 
and the time to reobstruction decreases with an increasing number of previous episodes of 
obstruction. 78• 81 Patients with multiple dispersed adhesions have a greater recurrence rate 
than those with band adhesions but strangulation occurs more frequently in patients with a 
single obstructive band. 78' 82 
Prevention of adhesion formation 
Many chemical agents and procedures to prevent or reduce the formation of postoperative 
adhesions have been studied. The purpose of all studies has been to interfere with one or 
several of the pathogenetic steps in the dynamic process of peritoneal healing and adhesion 
formation (Figure 1.2). 
Reduction of the inflammatory reaction 
The use of anti-inflammatory drugs like corticosteroids, nonsteroidal anti-inflammatory drugs 
(NSAID's) and antihistamines can lead to a decreased permeability of vessels and to 
reduced posttraumatic intra-peritoneal influx of inflammatory cells. Experimental nor clinical 
studies could show significant adhesion reducing effects of these agents and various side 
effects like impaired wound healing, immunosuppression, gastrointestinal bleeding and even 
the occurrence of psychoses eliminated this treatment modality.83-86 The efficacy of antibiotic 
peritoneal lavage (also quite an a-specific anti-inflammatory method) in the prevention of 
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adhesion formation has long been controversial and recent experimental studies even 
revealed adhesion promoting qualities of lavage fluids and antibiotics.87· 88 
Attempts at decreasing adhesion formation by specifically altering macrophage function have 
also been considered. Results of experiments using calcium channel blockers have not 
yielded benefit of sufficient magnitude in animal models to implement these in large scale 
human trials.89• 90 "Simply" reducing the number of macrophages infiltrating the traumatised 
peritoneal surface by using neutralising antibodies to monocyte chemotactic protein-1 (MCP-
1) diminished adhesion formation in an animal study. 91 It is too early to know whether these 
experiments will lead to a treatment option in humans, but to focus on the cellular 
constituents of the inflammatory reaction during wound healing appears to be a worthwhile 
avenue of investigation. 
Efforts to attenuate the inflammatory reaction by mastering the mediators of this process 
have also been suggested as an adhesion abating alternative. An experimental study 
showed a decrease of adhesion formation after the administration of antibodies against the 
cytokines TNF-a and IL-1.92 Again, it is not certain that these results can be repeated in clinical 
studies, but selective immunosuppression, at a molecular level, might be part of future 
solutions to the problem of postoperative adhesion formation. 
Prevention of fibrin deposition 
In the absence of a coagulated serosanguineous exudate or a fibrinous adhesion, 
organisation of adhesions may not occur. To prevent coagulation of the inflammatory 
exudates, dilution and neutralisation of the coagulation factors (comprising prothombin, 
calcium, trombokinase, fibrinogen and trombin) has been effectuated by sodium citrate, 
heparin, dicoumarol and dextran. Experimental as well as clinical trials demonstrated that 
these agents also had inconclusive effects on postoperative adhesion formation while side 
effects like intra-abdominal haemorrhage were imposing.93. 94 This treatment modality was 
abandoned because it simply had too many side effects without a clear demonstration of a 
sufficient efficacy. 
Removal of fibrinous exudates 
Fibrin is a prerequisite for normal tissue repair; on the other hand the removal of fibrin is 
needed to restore preoperative conditions and guarantee adhesion free peritoneal healing. 
The earliest methods to forestall adhesion formation were methods removing fibrin 
depositions. Removal of fibrinous exudates by peritoneal lavages theoretically erases the 
source of fibrous adhesions but experimental results showed no adhesion reducing effect, on 
the contrary, peritoneal lavage even seemed to induce adhesion formation in some studies. 95· 
96 
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Stimulation of fibrinolysis 
The disturbed dynamic balance between fibrinogenesis and fibrinolysis to the detriment of 
fibrinolysis prohibits adhesion free healing. The actual cause of adhesions is the excess of 
f1brin that is not broken down fast enough as result of an insufficient fibrinolytic capacity. 
Experimental and clinical reports on the intra-peritoneal use of digestive ferments with 
supposed natural fibrinolytic activity like pepsin, trypsin and papain did not offer any 
acceptable evidence for its effectiveness in adhesion prevention. The instability of the 
preparation, the neutralisation of the solutions by the peritoneal fluid and the occurrence of 
peritonitis did not support the usage of these materials. 97~100 Animal studies in which the 
fibrinolytic activity was enhanced by streptok'1nase and urokinase did also show conflicting 
results while carrying the risk of bleeding. 101 · 102 The rate-limiting factor of the fibrinolysis is t-
PA which converts plasminogen into plasmin that in turn will stimulate demolishment of fibrin. 
Eliminating the intra-abdominal posttraumatic t-PA deficiency by adding recombinant tissue-
plasminogen activator (rt-PA) might increase the fibrinolytic activity and reduce adhesion 
formation. Experimental studies demonstrated that rt-PA decreased postoperative 
adhesions 103.105 but that the levels of rt-PA required to prevent adhesion formation also 
produced a significant impairment of the early phase of wound healing, as measured by the 
wound content of hydroxyproline and bursting strength of the wound. 106 
Inhibition of fibroblast proliferation and organisation of fibrinous adhesion 
Through blocking of integrins, and thus binding of fibroblasts to the fibrinous adhesion/ECM 
components, fibroblast invasion and reorganisation of fibrinous into fibrous adhesions may 
be prohibited and adhesion formation decreased. Administration of viscous agents containing 
arginine-glycine-aspartic acid (RGD) peptides (blockers of integrin-ligand interactions) at the 
end of surgery significantly reduced adhesion formation in animals.107 Whether this treatment 
modality will proof to be effective in humans remains to be investigated, but given the 
complexity of the cell adhesion apparatus, blocking of one single receptor is not likely to 
prohibit adhesion through another and therefore this pathway may prove difficult for the 
clinical situation. 
Inhibition of fibroblast proliferation by the use of steroids and 5-fluorouracil was not effective in 
adhesion prevention and these chemotherapeutics had side-effects that made them 
inappropriate as anti-adhesive treatment modality.108• 109 
Averting the production of procollagen by invading fibroblasts might forestall the formation of 
collagenous fibers and thereby prohibit transformation of fibrinous into fibrous adhesions. An 
in vitro inhibitor of procollagen (cianidanol) substantially inhibited adhesion formation but was 
toxic in low concentrations to animals and consequently not suitable for further therapeutic 
research in humans.110 
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Mesenchymal stem cell seeding 
Mesothelial damage is the primary event in adhesion formation. Mesothelial stem cells 
differentiate into mesothelial cells and hypothetically, adhesiogenesis could be reduced by 
seeding mesothelial stem cells onto peritoneal defects. One experimental study 
demonstrated this effect in a dose-dependent manner in rats but clinical trials have yet to be 
carried out.111 
Adhesion prevention barriers 
Theoretically with the barrier technique two, damaged peritoneal surfaces are mechanically 
separated during mesothelial regeneration, thereby preventing adhesion formation. Different 
animal and clinical studies have indicated that placement of an absorbable barrier like 
expanded polytetraflouroethylene (Preclude® Surgical Membrane), polaxamer 407, oxidised 
regenerated cellulose (INTERCEED•), or hyaluronic acid/carboxymethylcellulose 
(Seprafilm ™) between injured peritoneal sites or the peroperative intra-abdominal application 
of a viscous solution such as ionically cross-linked 0.5% hyaluronic acid (lntergel™l, 32% 
dextran 70 (Hyskon®) or low viscosity 0.04% hyaluronic acid (Sepracoat™) can reduce 
postoperative adhesion formation. 112-129 In our prospective clinical randomised multicenter 
trial performed by Vrijland et al, the effectiveness of bioresorbable Seprafilm TM membrane in 
the prevention of postoperative adhesion formation was assessed in patients requiring a 
Hartmann's procedure for either sigmoid diverticulitis or obstructing sigmoid carcinoma. The 
intra-abdominal placement of Seprafilm TM at the midline abdominal incision and in the pelvis 
was effective in significantly abating the severity of the formed adhesions, but did not 
diminish the incidence of adhesion formation. No results are available yet about the effect of 
this on the postoperative incidence of small bowel obstruction, infertility and chronic 
abdominal pain but it seemed to facilitate abdominal re-exploration. 130 Nevertheless major 
disadvantages of the site-specific adjuvants are that the surgeon must predict adhesion 
formation sites to determine barrier placement and that the materials in itself may be 
injurious to the peritoneum. 131 Non site-specific adjuvants show doubtful adhesion 
diminishing qualities and are associated with undesirable local and systemic side effects like 
oedema, an increase in body weight and central venous pressure, transient liver function 
disturbances and anaphylactic shock.132-135 Furthermore, most barrier materials are in 
practice difficult to handle and apply. 130 Despite the great variety of agents employed, there is 
no standard treatment for adhesions yet. The ideal anti-adhesive barrier would be composed 
of a material that (1) does not injure the peritoneum, (2) does not elicit or activate peritoneal 
neutrophils, macrophages or mesothelial cells, (3) does not impede the natural fibrinolytic 
activity of the peritoneal surface (4) is removed from the peritoneum by simple absorption 
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and not by degradation, (5) is not trombogenic, (6) covers all peritoneal surfaces, (7) remains 
intact and in situ for 5 to 7 days and (8) can be used at both laparotomy and laparoscopy. 
Other drugs 
Nitric oxide has been shown to modulate a number of inflammatory and vascular disease 
processes with effect on macrophages and endothelial cells. Its natural precursor, L-arginine, 
is used to increase levels of nitric oxide in tissues and turned out to diminish adhesions in 
rats after intra-peritoneal administration.136 
Because oxygen free radicals are believed to play a role in adhesion induction through 
damaging of the mesothelial cells, intra-abdominal adhesion formation may be reduced by 
limiting the intra-peritoneal levels of reactive oxygen. Drugs that can function as free radical 
scavengers indeed have been shown to decrease adhesion formation in animals. Further 
research has to be executed to estimate the clinical value of these kind of pharmaceutics. 137· 
138 
Minimalisation of peroperative peritoneal trauma 
The only consensus concerning the prevention of postoperative adhesions, that has 
remained valid over time, comprehends the avoidance of peroperative damage to the 
peritoneum through evading procedures with known adhesion-provoking consequences. 13s-
141 Forestalling of unnecessary drying, handling, clamping or suturing (ischaemia) of tissue 
and leaving behind as little foreign material as possible is the sole clinically available option 
to reduce postoperative adhesion formation. 142· 143 Universally accepted agreement also 
exists about the fact that closure of the peritoneum is superfluous, since the peritoneum 
regenerates rapidly without reapproximation. 28 • 32• 48· 56 Non-closure even reduced non 
adhesion related postoperative complications, 144-147 and is desired because of its adhesion 
preventing effect. 148-141 
Laparoscopic surgical procedures with their minimal access to the abdominal cavity, and 
thus minimal parietal peritoneal trauma, are likely to be associated with fewer postoperative 
adhesions compared to open surgery. 152· 153 
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Intra-Abdominal Tumour Recurrence 
Incidence and aetiology 
Peritoneal dissemination is a common cause for post-surgical tumour recurrence after 
potentially curative resection of gastro-intestinal adenocarcinomas and represents terminal 
stage of the disease.154"157 Loco-regional recurrence incidence may amount up to 45% for 
colorectal carcinoma 15a-161 and lies around 50% for gastric carcinoma.162 Distribution patterns of 
first peritoneal recurrence show that the resection site is preferential, and combined 
recurrence on peritoneal surfaces and resection site is common. 154· 159· 163· 164 
Early preoperative tumour cell seeding and peroperative intra-abdominal shedding of tumour 
cells, due to handling the tumour and leakage from dissected lymphatic channels, are the 
most likely causes of peritoneal carcinosis. 154' 155' 165.167 With current techniques, 
disseminated cancer cells are detectable in the peritoneal cavity in patients with colorectal, 
gastric and pancreatic cancer.147' 168· 169 Previous experimental data have demonstrated that 
the proliferative and metastatic potentials of these spilled tumour cells are very well 
preserved. 165· 17° Consequently exfoliated carcinoma cells may undergo further division and give 
rise to implantation of metastases. Furthermore, the peroperative occurrence of tumour cells in 
the peritoneal cavity has been shown to correlate with the postoperative survival rate. Positive 
peritoneal (tumour) cytology in abdominal washings of patients with colorectal, gastric and 
pancreatic cancer is associated with poor prognosis.157· 17H 73 The process of haematogenic or 
lymphogenic cancer metastasis consists of a series of sequential, interrelated steps including 
invasion, embolism and transport, arrest in organs, adherence and growth. 174 In case of 
peritoneal carcinosis due to pre- or peroperatively seeded tumour cells, the metastatic 
process only depends on adherence and subsequent growth of these cells on the peritoneal 
surfaces. Prevention of peritoneal tumour recurrence by impeding these steps offers a 
promising mode of improving disease free survival. 
Mechanism of action in peritoneal tumour recurrence 
Several theories speculate on the mechanisms of intra-peritoneal tumour recurrence as a 
consequence of peroperatively spilled intra-abdominal tumour cells. Presumed implantation 
strategies of tumour cells include the theory of metastatic efficiency and the tumour cell 
entrapment hypothesis.154 According to the theory of metastatic efficiency the implantation of 
spilled tumour cells on raw tissue surtaces is very efficient as opposed to the inefficient 
implantation on intact surtaces. The tumour cell entrapment hypothesis proposes that the 
fibrinous exudate, formed as an initial response to surgical trauma of the peritoneum, 
facilitates implantation of cancer cells onto raw tissue due to entrapment of the spilled tumour 
cells in the fibrin. This would secure tumour emboli at surgically injured peritoneal sites 
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particularly. These trapped tumour cells may also be protected from natural host defences 
and systemic chemotherapy by their coating of fibrin. During peritoneal wound healing after 
peritoneal trauma, exposed endothelial cells, damaged mesothelial cells, as well as resident 
and invading inflammatory cells produce an abundance of chemoattractants (11-8, MCP-1 ), 
cytokines (TNF-a, IL-1~ and IL-6) and growth factors (TGF-~, IGF-1, PDGF).35·39 The micro 
environment of the peritoneal wound hereby contains a plethora of factors creating a 
prerequisite area for cell proliferation and differentiation. Accordingly surgical peritoneal 
damage induces the release of substances that not only participate in the local healing 
process but that also, unfortunately, could be beneficial for proliferation and growth of spilled 
and trapped tumour cells. This should make the surgical wound in particular, a fertile soH for 
tumour growth and could result in augmented growth of an intra-abdominal tumour cell 
deposit at traumatised peritoneal sites. Indeed previously described clinical and experimental 
studies showed that surgical trauma may promote intra-abdominal tumour recurrence and in 
clinical situations, it appears that peritoneal tumour implants may recur within a fibrous adhesion 
resulting from surgical trauma. 175-179 Apart from stimulated growth, tumour cells may profit from 
the enriched wound micro-environment by enhancing the process of cell adhesion. 170-172 This 
would explain tumour recurrence at not specifically traumatised peritoneal surfaces. Most 
likely, metastatic cells respond to physiologic signals produced when homeostasis is 
disturbed. Tumour cells that either originate from or have an affinity for growth in a particular 
organ can also respond to these signals. 174 
Recapitulating, the dynamic cascade of peritoneal healing, induced by peritoneal damage, 
sometimes leading to adhesion formation also seems to be important in the process of intra-
peritoneal adhesion and growth of free intra-abdominal tumour cells. Consequently the 
trauma ensuing tissue regeneration may affect tumour recurrence in various ways (Figure 
1.1 ). 
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Chapter II 
Aims of the Thesis 
Surgical peritoneal trauma and adhesion formation 
Adhesions may be regarded as the most frequent complication of surgery, with a high impact 
on health-care. 19' 20· 22-24 Adhesion formation produces burden to the patient and a clinical 
challenge for general surgeons due to complications of adhesions, prolonged incision time 
and substantial time necessary for divisiort of adhesions at abdominal re-operations and 
inadvertent enterotomy during difficult re-interventions. 21 • 183 Adhesions were considered to 
be a natural occurring phenomenon by most surgeons. It is only recently that surgeons, 
realising that there might be precautions that may be useful at the time of surgery, are 
becoming interested in identifying the magnitude of adhesion-related problems. A wide 
variety of therapeutic modalities to reduce the incidence of postoperative adhesion formation 
have been evaluated in clinical and experimental work.83.139 The results achieved with the 
different treatment modalities are inconsistent and associated with many side effects. At the 
present time no agent seems to be overwhelmingly suitable for general use in humans. 
Accordingly, it is the surgeon herself who seems to play the most important role by operating 
in a non-traumatising fashion to prevent peritoneal injury. 139.151 Studies, in which peritoneal 
trauma was proven to be a cause of adhesion formation did not mention whether there was a 
connection between the degree of trauma, and the extent of formed adhesions.28· 29· 55 
Therefore one of the aims of this thesis was to analyse whether the extent and type of post-
surgical adhesion formation correlates with the degree of peritoneal damage. Furthermore we 
tried to identify whether agents like surgical gauze, lavage solutions and glove powder, not 
yet generally considered as traumatic for the peritoneum, and commonly used in general 
surgical practice, indeed were traumatic and could consequently cause adhesion formation. 
and whether there were less traumatic and feasible alternatives for these agents. In order to 
achieve these aims we first developed a reproducible rat adhesion model allowing 
semiquantitative and qualitative scoring of adhesions. 
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Surgical peritoneal trauma and intra-abdominal tumour recurrence 
Pre- and peroperative!y seeded tumour cells influence the prognosis of patients with gastro-
intestinal malignancies dramatica!ly.147· 161 -163 Tumour cells disseminated during surgical 
dissection will not be treated using the conventional therapeutic modalities. Peroperative 
lavage will remove some of the spilled cells, but sufficient irrigation of the peritoneal cavity is 
not possible. In addition several experimental approaches to control the local recurrence 
have been initiated. C1"1nical trials are investigating the possibility of intra-peritoneal 
chemotherapy. 184· 185 Lavaging the abdominal cavity with chemotherapeutic agents will 
deteriorate the micro milieu for residual tumour cells but may have adverse side~effects on 
wound healing and peritoneal adhesion formation. 186 · 187 Photodynamic therapy (PDT) may 
be another promising approach to attack manifest peritoneal tumour recurrence. PDT is a 
surface oriented, locally cytotoxic intervention. Defined tumour foci are specifically 
eradicated, hereby only traumatising restricted areas of the peritoneum.188-190 The above 
mentioned therapies are mainly aimed at annulling manifest peritoneal tumour foci but do not 
focus on prohibiting the postoperative arising of peritoneal tumour recurrence. A profound 
understanding of the pathophysiology of tumour recurrence may lead to more spec'lf1c tools 
to confront the initial process of tumour cell implantation. One hypothesis, trying to clarify the 
pattern of surgical treatment failure after potentially curative resection of gastro~intestinal 
adenocarcinoma, suggests the ·implantation of free tumour cells is most efficient on damaged 
tissue while the coating of these trapped cells with reactive fibrin protects them from natural 
host defences.154 The fact that the resection site and surgical wounds are predestined sites 
for recurrence, 191 indeed indicates there may be a mechanistic relation between surgical 
tissue trauma and tumour recurrence. The dynamic cascade of peritoneal healing, induced 
by peritoneal damage, sometimes leading to adhesion formation also seems to be important 
in the process of intra~peritoneal adhesion and growth of free intra-abdominal tumour cells. 
This thesis tries to demonstrate the similarities between the process of adhesion formation 
and tumour recurrence by evaluating whether there was a relationship between degree of 
peritoneal trauma and the extent of tumour cell adhesion and growth and if this presumed 
relationship was merely a local phenomenon or whether systemic effects might also be 
involved. Furthermore we tried to identify whether exposure of the peritoneum to surgical 
gauze and glove powder known to cause adhesion formation also could induce more tumour 
recurrence. Next we investigated whether the less traumatising alternatives were valid in 
reducing tumour recurrence as well. To fulfil these tasks we developed a reproducible rat 
tumour adhesion and growth model, analogous to the rat adhesion model, allowing 
semiquantitative scoring of tumour load. 
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Pathways of adhesion formation and intra-abdominal tumour recurrence 
Adjuncts to good surgical techniques are needed for adhesion and tumour recurrence 
prevention. Better understanding of the underlying pathogenesis of both processes is a 
prerequisite to rational prophylaxis and therapy of both surgical complications. Further 
experiments described in this thesis aim at unravelling pathways of enhanced tumour cell 
adhesion and growth after surgical peritoneal trauma. Soluble and cellular constituents of the 
peritoneal cavity are believed to both reflect the events occurring during peritoneal healing 
and the potential to modulate the outcome of tissue response to injury. We analysed the 
effect of cellular and non-cellular soluble inflammatory components using our in vivo and in 
vitro reproducible tumour adhesion and growth models. 
Results of the analysis of the inflammatory cells in these experiments demonstrated a 
trauma-related influx of neutrophils (PMN) in the abdominal cavity. We evaluated the role of 
these PMN in postoperative adhesion formation and peritoneal tumour recurrence by treating 
rats intra-peritoneally with anti-neutrophil serum (ANS}. 
Adjuvant measures to prevent adhesion formation and tumour recurrence 
Since peroperative peritoneal trauma cannot entirely be prevented in practice, the need for 
supplementary measures to reduce adhesions and tumour recurrence remains urgent. 
Accordingly, we performed experiments evaluating the capacity of a new glucose polymer 
solution, icodextrin®, to reduce adhesion formation and whether icodextrin® might reduce or 
possibly promote the adhesion and growth of intra-peritoneally injected tumour cells. 
The results obtained from these experiments will lead to feasible measures that may 
ultimately support the surgeon to prevent peritoneal injury and thereby reduce postoperative 
adhesion formation and intra-abdominal tumour recurrence. 
A more thorough understanding of the impact of neutrophils (PMN}, macrophages, cytokines 
and integrins on the wound healing process and its derangement will undoubtedly help in the 
development of more specific therapeutic strategies to reduce postoperative adhesion 
formation and local tumour recurrence without causing serious complications. 
25 
REFERENCES 
1. Perry JF, Smith GD, Yonehiro EG. Intestinal obstruction caused by adhesions; a review of 388 
cases. Ann Surg 1955; 142: 810-816. 
2. Weibel MA, Majno G. Peritoneal adhesions and thek relation to abdominal surgery. Am J Surg 
1973; 126: 345-353. 
3. Nemir P Jr. Intestinal obstruction: ten year survey at the Hospital of the University of 
Pennsylvania. Ann Surg 1952; 135: 367-375. 
4. Menzies D, Parker M, Hoare R, Knight A. Small bowel obstruction due to postoperative 
adhesions: treatment patterns and associated costs in 110 hospital admissions. Ann R Coli 
Surg Eng/2001; 83: 40-46. 
5. Ell'ls H. Internal overheating: The problem of intra-peritoneal adhesions. Wrfd J Surg 1980; 4: 
303-306. 
6. Diamond MP. Surgical aspects of infertil'lty. In Sciarra JJ, ed. Gynecology and Obstetrics, Vol 
5. Philadelphia: Harper & Row, 1995: 1-26. 
7. Menzies D, Ellis H. Intestinal obstruction from adhesions-how big is the problem? Ann R Coli 
Surg Eng/1990; 72: 60-63. 
8. Ellis H. The causes and prevention of intestinal adhesions. Br J Surg 1982; 69: 241-243. 
9. McEntee G, Pender D, Mulvin 0, McCullough M, Naeeder S, Farah S, Badurdeen MS, Ferraro 
V, Cham C, Gillham N. Current spectrum of intestinal obstruction. Br J Surg 1987; 74: 976-
980. 
10. Menzies D. Peritoneal adhesions. Incidence, cause and prevention. Surg Annu 1992; 24: 27-
45. 
11. Drake TS, Grunert GM. The unsuspected pelvic factor in the infertility investigation. Br J Surg 
1980; 50: 10-16. 
12. PfefferWH. Adjuvants in tubal surgery. Fertil Sterif 1980; 33:245-256. 
13. Gamel V. An odyssey through the evident. Fertil Steri/1983; 39: 144-156. 
14. Fayez JA. An assessment of the role of operative laparoscopy in tuboplasty. Fertil Steri/1983; 
39: 476-479. 
15. Hershlag A, Diamond MP, DeCherney AH. Adhesiolysis. Cfin Obstet Gyneco/1991; 34:395-
302. 
16. Goldstein DP, DeCholnoky C, Emans SJ, Leventhal JM. Laparoscopy in the diagnosis and 
management of pelvic pain in adolescents. J Reprod Med 1980; 24:251-256. 
17. Rapkin AJ. Adhesions and pelvic pain: a retrospective study. Obstet Gyneco/1986; 68: 13-15. 
18. Nieuwenhuijzen M, Reijnen MM, Kuijpers JH, Goor van H. Small bowel obstruction after total 
or subtotal colectomy: a 1 0-year retrospective review. Br J Surg 1998; 85: 1242-1245. 
19. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, McGuire A, Lower AM, 
Hawthorn RJ, 'OBrien F, Buchan S, Crowe AM. Adhesion-related hospital readmissions after 
abdominal and pelvic surgery: A retrospective cohort study. Lancet 1999; 353: 1476-1480. 
20. Jeekel J. Cost implication of adhesions as highlighted in a European study. Eur J Surg 1997; 
579 (suppl): 43-45. 
26 
21. Krabben van der AA, Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, Schaapveld M, Goor van 
H. Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg 2000; 87: 
467-471. 
22. Ray NF, Larsen JW, Stillman RJ. Economical impact of hospitalisations for lower abdominal 
adhesiolysis in the United States in 1988. Surg Gynecol Obstet 1993; 176: 271-276. 
23. Holmdahl L, Risberg B. Adhesions: prevention and complications in general surgery. Eur J 
Surg 1997; 163: 169-173. 
24. Beck DE, Opelka FG, Bailey HR, Rauch SM, Pashas CL. Incidence of small bowel obstruction 
and adhesiolysis after colorectal and general surgery. Dis. Colon Rectum 1999; 42: 241-248. 
25. Stovall TG, Elders RF, Ling FW. Predictors of pelvic adhesions. J Reprod Med 1989; 34: 345-
348. 
26. Swart P, Mol BW, Veen van der F, Beurden van M, Redekop WK, Bossuyt PM. The accuracy 
of hysterosalpingography in the diagnosis of tubal pathology: a meta-analysis. Fertil Steril 
1995; 64: 486-491. 
27. Ubaldi F, Wisanto A, Camus M, Tournaye H, Clasen K, Devroey P. The role of transvaginal 
ultrasonography in the detection of pelvic pathologies in the infertility workup. Human Reprod 
(Ox0 1998; 13: 330-333. 
28. Ellis H. The healing of peritoneum under normal and pathological conditions. Br J Surg 1965; 
52: 471-476. 
29. Milligan OW, Raftery AT. Observations on the pathogenesis of peritoneal adhesions: a light 
and electron microscopical study. Br J Surg 197 4; 61: 27 4-280. 
30. Thompson JN, Whawell SA. Pathogenesis and prevention of adhesion formation. Br J Surg 
1995; 82: 3-5. 
31. Monz FJ, Shimanuki T, diZerega GS. Post-surgical mesothelial reepithelia\isation. In: 
DeCherney AH, Polan ML eds. Reproductive Surgery, Year Book Medical Publishes. 1987: 
31-47. 
32. Raftery AT. Regeneration of parietal and visceral peritoneum. A light microscopical study. Br J 
Surg 1973; 60: 293-299. 
33. Nagy JA, Jackman R. Response of the peritoneal membrane to injury. Semin Dialysis 1998; 
11; 242-248. 
34. Ward PA, Lentsch AB. The acute inflammatory response and its regulation. Arch Surg 1999; 
134: 666-669. 
35. Lanfrancone L, Boraschi 0, Ghiara P, Falini B, Grignani F, Peri G, Mantovani A, Pelicci PG. 
Human peritoneal mesothelial cells produce many cytokines {granulocyte colony-stimulating 
factor {CSF), granulocyte-monocyte-CSF, Macrophage-CSF, interleukin-1 {11-1) and 11-6) and 
are activated and stimulated to grow by !1-1. Blood 1992; 80: 2835-2842. 
36. Tsudaka K, Katoh H, Shiojima M, Suzuki T, Takenoshita S, Nagamachi Y. Concentrations of 
cytokines in the peritoneal fluid after abdominal surgery. Eur J Surg 1993; 159: 475-479. 
37. Tapley N. The cytokine network controlling peritoneal inflammation. Peril Dial fnt 1995; 15: 
835-839. 
27 
38. Badia JM, Whawe!l SA, Scott-Coombes OM, Abel PO, Williamson RC, Thompson JN. 
Peritoneal and systemic cytokine response to laparotomy. Br J Surg 1996; 83: 347-348. 
39. Tapley N, Liberek T, Davenpot A, Li FK, Fear H, Wiliams JD. Activation of inflammation and 
leukocyte recruitment into the peritoneal cavity. Kidney lnt Supp/1996·, 56·. S17-S21. 
40. Holz G. Prevention and management of peritoneal adhesions. Fertil Steril1984; 41:497-507. 
41. Buckman RF, Woods M, Sargent L, Gervin AS. A unifying pathogenetic mechanism in the 
aetiology of intra-peritoneal adhesions. J Surg Res 1976; 20: 1-5. 
42. Vipond MN, Whawell SA, Thompson JN, Dudley HA. Peritoneal fibrinolytic activity and intra-
abdominal adhesions. Lancet 1990; 335: 1120-1122. 
43. Raftery AT. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intra-peritoneal 
adhesion formation. EurJ Res 1981; 13:397-401. 
44. Goor van H, Graaf FJ, Grand J, Sluiter WJ, Meer J, Born VJJ, BJeichrodt RP. Fibrinlytic activity 
in the abdominal cavity of rats with faecal peritonitis. Br J Surg 1994; 81: 1046-1049. 
45. Myrhe-Jensen 0, Larsen SB, Astrup T. Fibrinolytic activity in serosal and synovial 
membranes. Arch Patho/1969; 88: 623-630. 
46. D'Angelo A, Kluft C, Verheijen JH, Rijken DC, Mozzi E. Fibrinolytic shutdown after surgery: 
impairment of the balance between tissue type plasminogen activator and its specific 
inhibitors. Eur J C/in Invest 1985; 15: 308-312. 
47. Sherry S. The fibrinolytic system and its pharmacologic activation for trombolysis. Cardia! Clin 
1987; 5:1-11. 
48. Watters WB, Buck RC. Scanning electron microscopy of mesothelial regeneration in the rat. 
Lab Invest 1972; 13: 48-54. 
49. Bolen JW, Hammer SP, McNutt MA. Serosal tissue: reactive tissue as a model for 
understanding mesotheliomas. Ultrastruct Patho/1987; 11: 251-262. 
50. Yung S, Davies M. Response of the human peritoneal mesothelial cell to injury: an in vitro 
model of peritoneal wound healing. Kidney Jnt 1998; 54:2160-2169. 
51. Weiss SJ, Young J, LoBuglio AF, Slivka A, Nimeh NF. Role of hydrogen peroxide in neutrophil 
mediated destruction of cultured mesothelial cells. J C/in Invest 1981; 68: 714-721. 
52. Weiss SJ. Tissue destruction by neutrophils. N Eng! J Med 1989; 320:365-376. 
53. Anderson 80, Brown JM, Harken AH. Mechanism of neutrophil-mediated tissue injury. J Surg 
Res 1991; 51:170-179. 
54. Adreoll SP, Mallett C, Williams K, McAteer JA, Rothlein R, Doerschuk CM. Mechanisms of 
polymorphoneclear leukocyte mediated peritoneal mesothelial cell injury. Kidney tnt 1994; 46: 
1100-1109. 
55. Graeme BR, Grobety J, Majno G. Mesothelial injury and recovery. Am J Pathol 1973; 71:93-
102. 
56. Raftery AT. Regeneration of peritoneum: a fibrinolytic study. J Anat 1979; 129: 659-664. 
57. Whawell SA, Wang Y, Fleming KA, Thompson EM, Thompson JN. Localisation of 
plasminogen activator inhibitor-1 production in inflamed appendix by in situ mRNA 
hybridisation. J Patho/1993; 169:67-71. 
28 
58. Holmdahl L, lvarsson ML. The role of cytokines, coagulation, and fibrinolysis in peritoneal 
tissue repair. EurJ Surg 1999; 165:1012-1019. 
59. Tietze L, Elbrecht A, Schauerte C, Klosterhalfen B, Amo Takyi B, Gehlen J, Winkeltau G, 
Mittermayer C, Handt S. Modulation of pro- and anti-fibrinolytic properties of human peritoneal 
mesothelial cells by transforming growth factor beta (TGF-beta), tumour necrosis factor alpha 
(TNF-alpha) and interleukin 1 beta (11-1 beta). Tromb Haemostasis 1998; 79: 362-370. 
60. Scott-Coombes ON, Whawell SA, Vipond MN, Thompson JN. The human intra-peritoneal 
fibrinolytic response to elective surgery. Br J Surg 1995; 82: 414-417. 
61. Holmdahl L, Eriksson E, Eriksson B, Risberg B. Depression of peritoneal fibrinolysis during 
operation is a local response to trauma. Surgery 1998; 123:539-544. 
62. Schade OS, Williamson JR. The pathogenesis of peritoneal adhesions; an ultrastructural 
study. Ann Surg 1968; 167: 500. 
63. Seppa H, Grotendorst G, Seppae S, Schiffmann E, Martin GR. Platelet derived growth factor 
is chemotactic for fibroblasts. J Cell Bio/1982; 92 ; 584-588. 
64. Postlethwaite AE, Lachman LB, Mainadri CL, Kang AH. lnterleukin-1 stimulation of 
collagenase production by cultured fibroblasts. J Exp Med 1983; 157: 801-806. 
65. Ignatz RA, Massaque J. Transforming growth factor [3 stimulates the expression of fibronectin 
and collagen and their incorporation into the extra cellular matrix. J Bioi Chern 1986; 261: 
4337-4345. 
66. Pledgers WJ, Stiles CD, Antiniades HN. An ordered sequence of events is required before 
BALB/c-3T3 cells have become committed to DNA synthesis. Proc Nat! Acad Sci USA 1987; 
74: 2839-2848. 
67. Varga J, Jimenez SA. Stimulation of normal human fibroblast collagen production and 
processing by transforming growth factor-[3 and 12-0-tetradecanoyl phorbol-1 3-acetate. J Bioi 
Chern 1987; 262:2283-2287. 
68. Hynes RO. lntegrins: a family of cell surface receptors. Cel/1987; 48: 549-554. 
69. Haney AF, Doty E. The formation of coalescing peritoneal adhesions requires injury to both 
contacting peritoneal surfaces. Fertil Steri/1994; 61: 767-775. 
70. Diamond MP, Daniell JF, Feste J, Surrey MW, Mclaughlin OS, Friedman S, Vaughn WK, 
Martin DC. Adhesion reformation and de novo adhesion formation after reproductive pelvic 
surgery. Fertil Steri/1987; 47: 864-866. 
71. Nezhat CR, Nezhat FR, Mezger OA, Luciano AA. Adhesion reformation after reproductive 
surgery by videolaparoscopy. Fertil Steri/1990; 53: 1008-1011. 
72. Operative Laparoscopy Study Group. Postoperative adhesion development after operative 
laparoscopy: evaluation at early second look procedures. Fertil Steri/1991; 55: 700-704. 
73. Trimbos-Kemper TCM, Trimbos JB, Hall van EV. Adhesion formation after tubal surgery: 
results of the eight-day laparoscopy in 188 patients. Fertil Steri/1985; 43: 395-400. 
74. Tittel A, Schippers E, Treutner KH, Anuroff M, Polivoda M, Ottinger A, Schumpelick V. 
Laparoscopy versus laparotomy comparing adhesion formation in the dog. Langebecks Arch 
Chir 1994; 379: 95-98. 
29 
75. Diamond MP, Seprafilm Adhesion Group. Reduction of adhesion formation after uterine 
myomectomy by Sepreafilm™ membrane (HAL-F™): a blinded, prospective, randomised, 
multicenter clinical study. Fertil Sterif 1996; 66: 904-910. 
76. Seror D, Feigin E, Szold A, A!lweis TM, Carmon M, Nissan S, Freund HR. How conservatively 
can postoperative small bowel obstruction be treated? Am J Surg 1993; 165: 121-125. 
77. Meagher AP, Moiler C, Hoffmann DC. Non-operative treatment of small bowel obstruction 
following appendicectomy or operation on the ovary or tube. Br J Surg 1993; 80 1310-1311. 
78. Miller G, Boman J, Shrier I, Gordon PH. Natural history of patients with adhesive small bowel 
obstruction. Br J Surg 2000; 87: 1240-1247. 
79. Close MB, Christensen NM. Transmesenteric small bowel plication or intraluminal stenting. 
Am J Surg 1979; 138: 89-96. 
80. Sizer LS, Delaney HM, Gerut Z. Observations on recurrent intestinal obstruction and modern 
non-operative management. Dig Surg 1986; 3: 229-231. 
81. Barkan H, Webster S, Ozaran S. Factors predicting the recurrence of adhesive small bowel 
obstruction. Am J Surg 1995; 170: 361-365. 
82. Cox MR, Gunn IF, Eastman MC, Hunt RF, Heinz AW. The operative aetiology and types of 
adhesions causing small bowel obstruction. Aust N Z J Surg 1993; 63: 848-852. 
83. Horne RW Jr., Clyman M, Debrovner C, Griggs G, Kistner R, Kosasa T, Stevenson CS, 
Taymor M. The prevention of postoperative adhesions following conservative operative 
treatment for human infertility. lnt J Fert 1973; 18: 109-115. 
84. Hackel M, Ott S, Siemann U, Kissell T. Prevention of peritoneal adhesions in the rat with 
sustained intra-peritoneal dexamethason delivered by a novel therapeutic system. Ann Chir 
Gyneco/1987; 76: 306-313. 
85. Siegler AM, Kontopoulos V, Wang CE. Prevention of postoperative adhesions in rabbits with 
Ibuprofen, a non-steroidal anti-inflammatory agent. Fertil Steri11980; 34: 46-49. 
86. Rodgers KE. Non-steroidal anti-inflammatory drugs (NSAID's) in the treatment of post-
surgical adhesion. In: Treatment of Postsurg Adh.Eds.: diZeraga GS, Russell Malinak L, 
Diamond MP, Linsky CB, Willy-Liss, New York 1990; 35-44: 119-130. 
87. Philips RK, Dudley HA. The effect of tetracycline lavage and trauma on visceral and parietal 
ultrastructure and adhesion formation. Br J Surg 1984; 71: 537-539. 
88. Rappaport WD, Holcomb M, Valente J, Chvapil M. Antibiotic irrigation and the formation of 
intra-abdominal adhesions. Am J Surg 1989; 158: 435-437. 
89. Steinleitner A, Lambert H, Kazensky C, Sanchez I, Sueldo C. Reduction of primary 
postoperative adhesion formation under calcium channel blockade in the rabbit. J Surg Res 
1990; 48: 42-54. 
90. Dunn RC, Steinleitner AJ, Lambert H. Synergystic effect of intra-peritoneally administered 
calcium channel blockers and recombinant tissue plasminogen activator to prevent adhesion 
formation in an animal model. Am J Obstet Gynecol1991; 164: 1327-1330. 
30 
91. Zeyne!og!u HB, Se!i E, Senturk LM, Gutierrez LS, Olive DL, Arici A. The effect of monocyte 
chemotactic protein-1 in intra-peritonea! adhesion formation in a mouse mode!. Am J Obstet 
Gyneco/1998; 179:438-443. 
92. Kaidi AA, Nazza! M, Gurchumelidze T, AliMA, Dawe EJ, Silva YJ. Preoperative administration 
of antibodies against tumour necrosis factor-alpha (TNF-a!pha) and inter!eukin-1 (1!-1) and 
their impact on peritonea! adhesion formation. Am Surg 1995; 61: 569-572. 
93. Davidson MN. Systemic administration of heparin and dicoumaro! for postoperative 
adhesions: an experimental study. Arch Surg 1949; 59: 300-325. 
94. Janseno RPS. Failure of intra-peritoneal adjuncts to improve the outcome of pelvic operations 
in young women. Am J Obstet Gyneco/1985; 153: 363-371. 
95. Kappas AM, Fatouros M, Papadimitriou K, Katsouyannopoulos V, Cassioumis D. Effect of 
intra-peritoneal saline at different temperatures on adhesion formation. Br J Surg 1988; 75: 
854-856. 
96. Treutner KH, Winkeltau G, Lerch MM, Stadel R, Schumpe!ick V. Prevention of postoperative 
intra-peritoneal adhesions. A new study standardised in rats. Research in Surgery 1992; 4: 
50-54. 
97. Johnson HL Observations in the prevention of postoperative peritonitis and abdominal 
adhesions. Surg Gyn Obst 1927; 45:612-619. 
98. Kubota T. Peritoneal adhesions. Japan Med World 1922; 11: 226-229. 
99. Donaldson JK. Abdominal adhesions and the use of papain. Arch Surg Chicago 1938; 36: 20-
27. 
100. Ochnser A, Manson F. Prevention of peritoneal adhesions by use of vegetable ferments. Proc 
Soc Exp Bioi Med 1928; 25: 524-525. 
101. James DCO, E!!is H, Hugh TB. The effect of streptokinase on experimental adhesion 
formation. J Pathol Bacterio/1965; 90:279-287. 
102. Rivkind AI, Lieberman N, Durst AL. Urokinase does not prevent adhesion formation in rats. 
EurJ Surg 1985; 17:254-258. 
103. Doody KJ, Dunn RC, Buttram VC. Recombinant tissue plasminogen activator reduces 
adhesion formation in a rabbit uterine horn model. Fertil Steri/1989; 51: 509-512. 
104. Menzies D, Ellis H. Adhesion formation: the role of plasminogen activator. Surg Gyneco/1991; 
172: 362-366. 
105. Vipond MN, Whawe!! SA, Scott-Coombed OM, Thompson JN, Dudley HA. Experimental 
adhesion prophylaxis with recombinant tissue plasminogen activator. Ann R Coli Surg Eng/ 
1994; 76:412-415. 
106. Evans OM, McAree K, Guyton DP, Hawkins N, Stakleff K. Dose dependency and wound 
healing aspects of tissue plasminogen activator on the prevention of intra-abdominal 
adhesions. Am J Surg 1993; 165: 229-232. 
107. Rodgers KE, Girgis W, Campeau J, diZerega GS. Reduction of adhesion formation by intra-
peritoneal administration of Arg-Giy-Asp-containing peptides. Fertil Steril 1998; 70: 1131-
1138. 
31 
108. Holden M, Adams LB. lnh'1bitory effect of cortisone acetate and hydrocortisone on growth of 
fibroblasts. Proc Soc Exp Bioi Med 1957; 96: 64. 
109. Goldman U, Rosemond GP. 5-Fiuorouracil inhibition of experimental peritoneal adhesions. 
Am J Surg 1967; 113: 491-493. 
110. Rivkind AI, Marshood M, Durst AL, Becker Y. Cianidanol (+-cyanidanol-3) prevents the 
development of abdominal adhesions in rats. Arch Surg 1983; 118: 1431-1433. 
111. Lucas PA, Waejcka OJ, Zang LM, Newman WH, Young HE. Effect of rat mesenchymal stem 
cells on development of abdominal adhesions after surgery. J Surg Res 1996; 62:229-232. 
112. Boyers SP, Diamond MP, DeCheney AH. Reduction of postoperative pelvic adhesions in the 
rabbit with Gore-Tex surgical membrane. Fertil Steri/1988; 49: 1066-1070. 
113. Magro B, Mita P, Bracco GL, Coccia E, Scarselli G. Expanded polytetraethylene surgical 
membrane in ovarian surgery on the rabbit. Biocompatibility, adhesion prevention properties 
and ability to preserve reproductive capacity. J Reprod Med 1996; 41: 73-78. 
114. Hellebrekers BW, Trimbos-Kemper GC, Blitterswijk van CA, Bakkum EA, Trimbos JB. Effects 
of five different barrier materials on post-surgical adhesion formation in the rat. Hum Reprod 
2000; 15: 1358-1363. 
115. Leach RE, Henry RL. Reduction of postoperative adhesions in the rat uterine horn model with 
poloxamar 407. Am J Obstet Gyneco/1990; 162: 1317-1319. 
116. Stein Ieitner A, Lambert H, Kazensky C, Cantor B. Polaxamer 407 as an intra-peritoneal barrier 
material for the prevention of post-surgical adhesion formation and reformation in rodent 
models for reproductive surgery. Obstet Gyneco/1991; 77:48-52. 
117. Adhesion Barrier Study Group (lnterceed, TC7). Prevention of post-surgical adhesions by 
lnterceed (TC7), an absorbable adhesion barrier: a prospective randomised multicenter 
clinical study. Fertil Steri/1989; 51: 933-938. 
118. Franklin RR, Ovarian Adhesion Group. Reduction of ovarian adhesions by the use of 
lnterceed. Obstet Gyneco/1995; 86: 335-340. 
119. Becker JM, Dayton MT, Fazio V, Beck DE, Stryker SJ, Wexner SO, Wolff BG, Roberts PL, 
Smith LE, Sweeney SA, Moore M. Prevention of postoperative abdominal adhesions by a 
sodium hyaluronate-based bioresorbable membrane: a prospective, randomised, double blind 
multicenter study. JAm Coli Surg 1996; 183: 297-306. 
120. Burns JW, Colt MJ, Burgess LS, RoseR, Skinner KC. Preclinical evaluation of SeprafilmTM 
bioresorbable membrane. Eur J Surg 1997; 163 (suppl 557): 40-48. 
121. Beck DE. The role of Seprafilm ™ bioresorbable membrane in adhesion prevention. Eur J Surg 
1997; 163 (suppl 557): 49-55. 
122. Burns JW, Skinner K, Colt MJ, Burgess L, Rose R, Diamond MP. A hyaluronate based gel for 
the prevention of post-surgical adhesions: evaluation in two animal species. Fertil Steri/1996; 
55: 814-820. 
123. Johns DB, Rodgers KE, Donahue WD, Kiorpes TC, diZerega GS. Reduction of adhesion 
formation by postoperative administration of ionically cross-linked hyaluronic acid. Fertil Steril 
1997; 68:37-42. 
32 
124. Thornton MH, Johns DB, Campeau JD, Hoehler F, diZerega GS. Clinical evaluation of 0.5% 
ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal 
cavity surgery: open-label pilot study. Hum Reprod 1998; 13: 1480-1485. 
125. diZerega GS, Hodger GO. Prevention of postoperative tubal adhesions. Comparative study of 
commonly used agents. Am J Obstet Gyneco/1980; 136: 173-178. 
126. Heidrick GW, Pippitt CH Jr, Morgan MA, Thurnau GR. Efficacy of intra-peritoneal sodium 
carboxymethylcellulose in preventing postoperative adhesion formation. J Reprod Med 1994; 
39: 575-580. 
127. Urman B, Gamel V, Jetha N. Effect of hyaluronic acid on postoperative intra-peritoneal 
adhesion formation in the rat model. Fertil Steri/1991; 56: 563-367. 
128. Goldberg EP, Burns JW, Yaacobi Y. Prevention of postoperative adhesions by precoating 
tissues with dilute sodium hyaluronic solutions. Prog Clin Bioi Res 1993; 381: 191-204. 
129. Burns JW, Skinner K, Colt J, Sheidlin A, Bronson R, Yaacobi Y, Goldberg EP. Prevention of 
tissue injury and post-surgical adhesions by precoating tissues with hyaluronic acid solutions. 
J Surg Res 1995; 59: 644-652. 
130. Vrijland WW, Tseng LNL, Eijkman HJM, Hop WCJ, Jakimowicz JJ, Leguit P, Stassen LPS, 
Swank OJ, Haverlag R, Bonjer HJ, Jeekel J. Less intra-peritoneal adhesions due to hyaluronic 
acid/carboxymethylcellulose membrane: a randomised clinical trial. Ann Surg 2001 in press. 
131. Haney AF, Doty E. Comparison of the peritoneal cells elicited by oxidised regenerated 
cellulose (lnterceed®) and expanded-polytetrafluoroethylene (Gore-Tex® Surgical Membrane) 
in a murine model. Am J Obstet Gynecol1992; 166: 1137-1149. 
132. Diamond MP, Michael P and the Sepracoat Adhesion study group. Reduction of de novo post-
surgical adhesions by interoperative precoating with Sepracoat (HAL-C ™) solution: a 
prospective, randomised, blinded, placeb-o-controlled multicenter study. Fertil Steri/1998; 69: 
1067-1074. 
133. Trimbos-Kemper TC, Veering BT. Anaphylactic shock from intracavitary 32% dextran-70 
solution during hysteroscopy. Fertil Steri/1989; 51: 1053-1054. 
134. Wei mans MJ, Kauer FM, Klompmaker IJ, Wijma J. Transient liver function disturbances after 
intra-peritoneal use of 32% dextran 70 as adhesion prophylaxis in infertility surgery. Fertil 
Steri/ 1990; 53: 159-161. 
135. Gauwerky JF, Heinrich D, KubH F. Complications of intra-peritoneal dextran application for 
prevention of adhesions. Bioi Res Pregnancy Perinato/1996; 7: 93-96. 
136. Kaleli B, Ozden A, Aybek Z, Bostanci B. The effect of L-arginin and pentoxifylline on 
postoperative adhesion formation. Acta Obstet Gynecol Scand 1998; 77: 377-380. 
137. Portz OM, Elkins TE, WhiteR, Warren J, Adadevoh S, Randolph J. Oxygen free radicals and 
pelvic adhesion formation. I. Blocking oxygen free radical toxicity to prevent adhesion 
formation in an endometriosis model . lnt J Fertil1991; 36: 39-42. 
138. Rodgers KE, Girgis W, St Amand K, Campeau J, diZerega GS. Reduction of adhesion 
formation in rabbits by intra-peritoneal administration of lazaroid formulations. Hum Reprod 
(Ox~ 1998; 13: 2443-2451. 
33 
139. Siegler AM, Kontoupoulos V. An analysis of macrosurgica! and microsurgical techniques in the 
management of the tuboperitoneal factor in infertility. Fertil Steri/1 979; 32: 377-383. 
140. Thompson J. Pathogenesis and prevention of adhesion formation. Dig Surg 1998; 15:153-157. 
141. Holmdahl L, Risberg B, Beck DE, Burns JW, Chegini N, diZerega GS, Ellis H. Adhesions: 
pathogenesis and prevention-panel discussion and summary. Eur J Surg Supp/1997: 56-62. 
142. Elkins TE, Stovall TG, Warren J, Ling FW, Meyer NK. A histologic evaluation of peritoneal 
injury and repair: Implications for adhesion formation. Obstet Gyn 1987; 70: 377-383. 
143. luijendijk RW, Lange de DC, Wauters CCAP, Hop WC, Duron JJ, Pailler JC, Camprodon BR, 
Holmdahl LE, Geldrop van HJ, Jeekel J. Foreign material in postoperative adhesions. Ann 
Surg 1996; 223: 242-248. 
144. Ellis H, Heddle R. Does the peritoneum need to be closed at laparotomy? Br J Surg 1977; 64: 
733-736. 
145. Gilbert JM, Ellis H, Foweraker S. Peritoneal closure after lateral paramedian incision. Br J 
Surg 1987; 74: 113-115. 
146. Hugh TB, Nankivell C, Meagher AP, LiB. Is closure of the peritoneal layer necessary in the 
repair of the midline surgical abdominal wounds? World J Surg 1 990; 14: 231-234. 
147. Irion 0, Luzuy F, Seguin F. Non-closure of the visceral and parietal peritoneum at caesarean 
section: a randomised controlled trial. Br J Obstet Gynaeco/1 996; 103: 690-694. 
148. Kyzer S, Bayer I, Turani H, Chaimhoff C. The influence of peritoneal closure on formation of 
intra-peritoneal adhesions: an experimental study. lnt J Tissue React 1 986; 8: 355-359. 
149. Holmdahl L, AI-Jabreen M, Risberg B. Experimental models for quantitative studies on 
adhesion formation in rats and rabbits. Eur Surg Res 1 994; 26: 248-256. 
150. diZerega GS. Contemporary adhesion prevention. Fertil Steri/1 994; 61: 219-235. 
151. Duffy OM, diZerega GS. Is peritoneal closure necessary? Obstet Gynecol SuN 1994; 49:817-
822. 
152. Schafer M, Krahenb HL, Buchler MW. Comparison of adhesion formation in open and 
laparoscopic surgery. Dig Surg 1998; 15: 148-152. 
153. Duron JJ, Hay JM, Msika S, Gaschard D, Domergue J, Gainant A, Fingerhut A. Prevalence 
and mechanism of small intestinal obstruction following laparoscopic abdominal surgery: a 
retrospective multicenter study. French Association for Surgical Research. Arch Surg 2000; 
135: 208-212. 
154. Sugarbaker PH. A perspective on cllnical research strategies in carcinoma of the large bowel. 
World J Surg 1991; 15: 609-616. 
155. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, 
management and adjuvant therapy [see comments]. Br J Surg 1994; 81: 7-19. 
156. Delpero JR, Pol B, Le Treut P, Bardou VJ, Moutardier V, Hardwigsen J, Granger F, 
Houvenaeghel G. Surgical resection of locally recurrent colorectal adenocarcinoma. Br J Surg 
1998; 85: 372-379. 
34 
157. Schott A, Vogel I, Krueger U, Kalthoff A, Schreiber HW, Schmiegel W, Henne-Burns D, 
Kremer B, Juhl H. Isolated tumour cells are frequently detectable in the peritoneal cavity of 
gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998; 
227: 372-379. 
158. Rich T, Gunderson LL, Lew R, Ga!dibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of 
rectal cancer after potentially curative surgery. Cancer 1983; 52: 1317-1329. 
159. McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AS. Local recurrence after potentially 
curative resection for rectal cancer in a series of 1008 patients. Br J Surg 1985; 72: 34-37. 
160. Long RT, Edwards RH. Implantation metastasis as a cause of local recurrence of colorectal 
carcinoma. Am J Surg 1989; 157: 194-201. 
161. Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic 
carcinoma: Implications for adjuvant therapy. Dis Colon Rectum 1991; 34: 723-727. 
162. Sugarbaker PH, Cunliffe WJ, Belliveau J, Bruijn de EA, Graves T, Mullins RE, Schlag P. 
Rationale for integrating early postoperative intra-peritoneal chemotherapy into the surgical 
treatment of gastrointestinal cancer. Semin Oncol1989; 16: 83-97. 
163. Cunliffe WJ, Sugarbaker PH. Gastrointestinal malignancy: rationale for adjuvant therapy using 
early postoperative intra-peritoneal chemotherapy. Br J Surg 1989; 76: 1082-1090. 
164. Galandiuk S, Wienand HS, Moertel CG, Cha SS, Fitzgibbons RJ Jr, Pemberton JH, Wolff BG. 
Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg 
Gynecol Obstet 1992; 174:27-32. 
165. Umpleby HC, Fermor 8, Symes MO, Williamson RCN. Viability of exfoliated colorecta! carcinoma 
cells. Br J Surg 1984; 71: 659-663. 
166. Skipper D, Cooper AJ, Marston JE, Taylor !. Exfoliated cells and in vitro growth in colorectal 
carcinoma. Br J Surg 1987; 74: 1049-1052. 
167. Catterall JB, Gardner MJ, Jones LM, Thompson GA, Turner GA. A precise, rapid and sensitive in 
vitro assay to measure the adhesion of ovarian tumour cells to peritoneal mesothelial cells. 
Cancer Lett 1994; 87: 199-203. 
168. Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schmiegel W, Neumaier M, 
Wagener C, Schreiber HW, Kalthoff H. lmmunocytological detection of micrometastatic cells: 
comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, 
colorectal and pancreatic cancer patients. fnt J Cancer 1994; 57: 330-335. 
169. Leather AJ, Kocjan G, Savage F, Hu W, Yiu CY, Boulos PB, Northover JM, Phillips RK. 
Detection of free malignant cells in the peritoneal cavity before and after resection of 
colorectal cancer. Dis Colon Rectum 1994; 37: 814-819. 
170. Fermer B, Umpleby HC, Lever JV, Symes MO, Williamson RCN. Proliferative and metastatic 
potential of exfoliated colorectal cancer cells. J Nat! Cancer 1986; 76: 347-349. 
171. Bonenkamp JJ, Songun I, Hermans J, Velde van de CJ. Prognostic value of positive cytology 
findings from abdominal washings in patients with gastric cancer. Br J Surg 1996; 83: 672-
674. 
35 
172. Burke EC, Karpeh MSJ, Conlon KC, Brennan MF. Peritoneal lavage cytology in gastric 
cancer; an independent predictor of outcome. Ann Surg Onco/1998; 5:411-415. 
173. Eijck van CHJ, Muller SOL, Meyer DCM, Toorenbergen van AW, Hop WCJ, Dam van JH, 
Jeekel J. A prospective study on the prognostic value of cytology and tumour markers (CEA 
and CA 1 9-9) in peritoneal washings of patients with periampullary tumours. HPS 2000; 2: 75-
81. 
174. Gutman M, Fidler IJ. Biology of human colon cancer metastasis. World J Surg 1995; 19: 226-
234. 
175. Eggermont AMM, Steller EP, Sugarbaker PH. Laparotomy enhances intra-peritoneal tumour 
growth and abrogates the anti-tumour effects of interleukin-2 and lymphokine-activated killer cells. 
Surgel)'1987; 102:71-78. 
176. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusion 
and prognosis in colorectal cancer. N Eng/ J Med 1993; 328: 1372-1376. 
177. Lee YT. Local and regional recurrence of carcinoma of the colon and rectum: II. Factors relating 
to operative technique. Surg Onco/1996; 5: 1-13. 
178. Bouvy ND, Marquet RL, Hamming JF, Jeekel J, Bonjer HJ. Laparoscopic surgery in the rat: 
beneficial effect on body weight and tumour take. Surg Endosc 1996; 10: 490-494. 
179. Jacobi CA, Ordemann J, Zieren HU, Volk HD, Bauhofer A, Halle E, Muller JM. Increased 
systemic inflammation after laparotomy vs laparoscopy in an animal model of peritonitis. Arch 
Surg 1998; 133:258-262. 
180. Rice GE, Gimbrone MAJ, Bevilacqua MP. Tumour cell-endothelial interactions. Increased 
adhesion of human melanoma cells to activated vascular endothelium. Am J Pathol 1988; 
133:204-210. 
181. Menger MD, Vollmar B. Adhesion molecules as determinants of disease: from molecular 
biology to surgical research. Br J Surg 1996; 83: 588-601. 
182. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. 
Cytokine Growth Factor Rev 1999; 10: 27-39. 
183. Coleman MG, Mclain AO, Moran BJ. Impact of previous surgery on the time taken for incision 
and division of adhesions during laparotomy. Dis Colon Rectum 2000; 43: 1297-1299. 
184. Sugerbaker PH. Successful management of microscopic residual disease in large bowel 
cancer. Cancer Chemother Pharmaco/1999; 43 (suppl): S15-S25. 
185. Esquivel J, Vidal-Jove J, Steves MA, Sugarbaker PH. Morbidity and mortality of cytoreductive 
surgery and intra-peritoneal chemotherapy. Surgery 1993; 113: 631-636. 
186. Drake DB, Oishi SN. Wound healing considerations in chemotherapy and radiation therapy. 
Clin Plast Surg 1995; 22: 31-37. 
187. Jacquet P, Sugarbaker PH. Effects of postoperative intra-peritoneal chemotherapy on 
peritoneal wound healing and adhesion formation. Cancer Treat Res 1996; 82: 327-335. 
188. Pass HI, Donington JS. Use of photodynamic therapy for the management of pleural 
malignancies. Semin Surg Onco/1995; 11: 360-367. 
36 
189. Veenhuizen RB, Reuvekamp MC, Oppe!aar H, He!merhorst T J, Kenemans PJ, Stewart FA. 
Foscan-mediated photodynamic therapy for a peritoneal-cancer mode!: drug distribution and 
efficacy studies. tnt J Cancer 1 997; 73: 230-235. 
190. Gahlen J, Prosst RL, Pietschmann M, Rheinwald M, Haase T, Hertarth C. Spectometry 
supports fluorescence staging laparoscopy after intra-peritoneal aminoleavulinic acid lavage 
for gastro-intestinal tumours. J Photochem Photobiof 8 1999; 52: 131-135. 
191. Hofer SO, Molema G, Hermens RA, Wanebo HJ, Reichner JS, Hoekstra HJ. The effect of 
surgical wounding on tumour development. Eur J Surg Onco/1999; 25: 231-243. 
37 

PART II 
Surgical Peritoneal Trauma and Adhesion Formation 

Chapter Ill 
Reduction of Intra-Peritoneal Adhesion Formation by 
Use of Non-Abrasive Gauze 
Adapted from the original publication in the British Journal of Surgery 1997; 84: 1410-1415 
Adhesion formation is potentially harmful. Surgical swabs may contribute to adhesions by 
traumatising the peritoneum. The purpose of this study was to evaluate whether standard 
surgical gauze (Medipres) has an adhesion promoting effect, and to determine whether a soft 
textile (Fastsorb), used in the electronics industry, might be less traumatic and therefore lead 
to less adhesion formation. 
A reproducible rat model allowing semiquantitative scoring of adhesion formation was used. 
Three different adhesion models representing increasing degrees of peritoneal trauma 
(minimal, moderate and severe) were employed. The model inflicting minimal peritoneal 
trauma was combined with standardised rubbing of the peritoneum with surgical gauze or 
non-surgical textile. 
Minimal peritoneal trauma resulted in a significantly lower adhesion percentage (21%) than 
moderate (44%) or severe (60%) peritoneal trauma (p s 0.005). Rubbing of the peritoneum 
with surgical gauze after infliction of minimal peritoneal trauma did induce significantly extra 
adhesion formation (58% versus 23%, p < 0.0001). After inflicUon of minimal peritoneal 
trauma, rubbing with surgical gauze did produce significantly more adhesions than rubbing 
with non-surgical textile (63% versus 19%, p < 0.0001). Moreover, rubbing the peritoneum 
with non-surgical textile after infliction of minimal peritoneal trauma did not induce additional 
adhesion formation at all (35% versus 24%, p = 0. 23). 
The extent of adhesion formation correlates significantly with the inflicted degree of 
peritoneal damage. Standard surgical gauze is traumatising to the peritoneum and promotes 
adhesion formation whereas a less abrasive non-surgical textile does not. 
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INTRODUCTION 
Postoperative adhesions are abnormal unions between tissue surfaces which occur after 
almost every intra-abdominal surgical intervention and can lead to a number of 
complications. Adhesion formation after intra-abdominal surgery accounts for 70-90% of all 
adhesions, 1•3 the rest being caused by inflammation of the peritoneum, endometriosis (18%) 
and congenital adhesions (2.8-6%). 4 Abdominal adhesions can cause intestinal obstructions 
which often requires immediate surgical intervention. Thirty percent of all bowel obstructions 
are caused by postoperative adhesions. 5-8 About 1% of all surgical admissions and 3% of all 
laparotomies are done for intest'1nal obstruction due to adhesions.7 The mortality rate from 
intestinal obstruction due to adhesions is 6-13%. 1· 2· 4 Some 15-20% of infertility in women is 
a consequence of adhesion formation9-13 and adhesions were identified as the primary cause 
of chronic pelvic pain in 13-26% of female patients. 14· 15 
A wide variety of therapeutic modalities to reduce the incidence of postoperative adhesion 
formation has been studied in clinical and experimental work. The results achieved with the 
different treatment modalities are inconsistent and associated with many side effects such as 
intra-abdominal haemorrhage and impaired wound healing. Until now only one strategy 
exists to reduce adhesion formation, namely the reduction, at operation, of all forms of 
peritoneal trauma and ischaemia. This necessitates avoiding desiccation and vigorous 
handling of intra-abdominal tissue and introducing as little foreign material as possib!e.16-18 
Manipulation with abdominal gauze might be traumatic to the peritoneum either because it is 
rough and abrades the peritoneum and serosa or because remnants of gauze are left behind 
in the abdomen. 19· 20 The present study was undertaken to evaluate whether a soft textile 
used in the electronics industry might have a less traumatic effect on the peritoneum than 
standard surgical gauze, and consequently lead to less adhesion formation. A reproducible 
animal model that allowed semiquantitative scoring of adhesion formation was used. 
MATERIALS AND METHODS 
Animals 
Female Wistar rats of reproductive age weighing 200-250 g were obtained from Harlan, 
Zeist, The Netherlands. They were bred under spec"1f1c pathogen-free conditions and kept 
under standard laboratory conditions (temperature 20-24°C, relative humidity 50-60%, 12 
hours light and 12 hours dark). The rats were given standard rat food and water ad libitum. 
The experimental protocol adhered to rules laid down by the Dutch Animal Experimentation 
Act and was approved by the Committee on Animal Research of the Erasmus University 
Rotterdam, The Netherlands. 
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Gauzes 
The evaluated "gauzes" were surgical Medipres gauze (van Heek Medical, Lasser, The 
Netherlands), consisting of 100% cotton and commonly used in abdominal surgery, and non· 
surgical Fastsorb cleanroom wiper (Berkshire Corporation, Great Barrington, Massachusetts, 
USA), used in the electronics industry (Figure 3.1 ). Fastsorb is a rayon-polyester blend which 
possesses strength and softness combined with a high absorbing capacity. It has low particle 
generation, minimal extractable matter and a low ion content. Fastsorb is used on abrasion-
sensitive surfaces. 
Absorbing capacity 
The absorbing capacity of both materials was evaluated using the following method. Ten 5 x 
5 em-pieces of surgical Medipres gauze (double layer) and non-surgical Fastsorb textile 
(monolayer) were saturated by immersion in water. After saturation, the materials were 
drained for 30 seconds. The pieces were weighed before and after saturation; results were 
expressed in millllitres of water absorbed per gram gauze. 
Surgical techniques 
The three adhesion models employed in this study were derived from a model described by 
van Bakkum et al.21 
Model 1. Under ether anaesthesia and aseptic but not sterile conditions, using Biogel sterile 
gloves (Regent Hospital Products, London, UK), the abdomen was shaved and cleaned with 
alcohol. Laparotomy was performed using a lower midline incision of 5 em. In the lateral 
abdominal wall, 1.5 em downwards from the abdominal incision, a standard area of 1.5 x 1.2 
em, 3 mm deep, which contained the mesothelial as well as both underlying muscular layers, 
was excised with an oval shaped punch. This severe peritoneal defect was then closed with 
three 5-0 Surgilene sutures (Braun, Melsungen, Germany). Subsequently the uterus horn 
was sutured to the lateral peritoneum, both proximally and distally from the closed peritoneal 
defect, with 6-0 Surgilene. All knots were double and fastened tightly to ensure ischaemia. 
The abdomen was closed in two layers with 5-0 polyglycolic acid and 2-0 silk sutures. 
Model 2. The same type of operation was performed with only one difference: the damage 
inflicted to the lateral peritoneum was of moderate severity and consisted only of an incision 
of 1.5 em long, 3 mm deep, which was also closed with three 5-0 Surgilene sutures. 
Model 3. In this model minimal trauma was applied to the lateral peritoneum. No wound was 
inflicted. The trauma was ischaemic only and was brought about by three 5-0 Surgilene 
sutures at 0. 7 em intervals. 
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Figure 3.1 
On the left surgical Medipres gauze and on the right non-surgical Fastsorb texti le. 
Figure 3.2 
Rubbing device used to apply standardised trauma to the uterine horn. A spring attached to 
the handle enables rubbing under a certain pressure. The device is constructed in such a 
manner that a pressure of 120 g/cm2 is applied when the indicator needle (above the spring) 
touches the blue roll. The gauze is wrapped and fixed around a hooked injection needle (1.1 
x 40 mm Luer-Lock; Braun, Melsungn, Germany). 
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Rubbing with surgical gauze and non-surgical textile was performed using a device enabling 
the application of a constant pressure of 120 g/cm2 (Figure 3.2). The uterus horn was rubbed 
ten times over its total length. 
Experimental design 
Adhesion formation after different amounts of peritoneal trauma. 
In 15 rats one lateral abdominal wall side was operated on according to adhesion model 
(severe peritoneal trauma). In nine of these animals the other side was treated according to 
adhesion model 2 (moderate peritoneal trauma) and six were treated according to adhesion 
model 3 (minimal peritoneal trauma). 
Adhesion formation in model 3 after rubbing with surgical gauze or non-surgical 
textile. 
In 30 rats minimal peritoneal trauma was inflicted to both lateral peritoneal sides (model 3). 
Both uterine horns were exposed and sutured to the lateral peritoneum. In ten rats one 
uterine horn was rubbed with surgical Medipres gauze whereas the other was not touched 
(group I); in ten animals one uterine horn was rubbed surgical Medipres gauze and the other 
one with non-surgical Fastsorb textile (group II); and in the last ten rats one uterine horn was 
rubbed with Fastsorb textile while the other was not touched (group Ill). In all cases 
randomisation was used to determine which rubbing model was to be carried out on which 
side. 
Evaluation of adhesion formation. 
Some 14 days after operation the rats were sacrificed by a humane method for assessment 
of post-surgical adhesion formation. Macroscopically the adhesions were scored according to 
their extent (quantity) and type (quality) by two independent observers. The extent of 
adhesion formation was quantified by dividing the area to be scored into eight by means of 
the three 5-0 sutures by which the defect was closed (Figure 3.3). The presence or absence 
of adhesions in the eight demarcated areas was scored. If there were adhesions in an area 
this accounted for 12.5% adhesions; a maximum of 100% adhesions could be scored. In 
each rat two lateral peritoneal sides were assessed. The type of adhesions formed was 
classified macroscopically using the ZUhlke classification (Table 3.1). 22 
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Evaluation of peritoneal damage 
Microscopic analysis of peritoneal reaction after rubbing ten times with surgical Medipres 
gauze and non-surgical Fastsorb textile was performed. Peritoneal reaction was evaluated 
directly after, and 2 and 4 hours after rubbing the uterus horn. For each time point one-third of 
the four rubbed uterus horns (two rubbed with Medipres and two with Fastsorb) were excised 
and fixed in formalin. The samples were stained with haematoxylin and eosin. The appearance 
of the mesothelial and underlying muscular layers and the infiltration of leucocytes were 
observed and compared. 
Statistical analysis 
Statistical analysis was performed using the t-test for paired samples. In two instances the 
unpaired Student's ttest for independent samples was used, as indicated in the text. Statistical 
significance was defined as p < 0.05. Data were expressed as mean adhesion percentage ± 
so. 
RESULTS 
Gauzes: absorbing capacity 
The mean absorbing capacity of non-surgical Fastsorb textile (n = 10) was 8.4 ml per g gauze 
(SO: 0.2) and that of surgical Medipres gauze (n = 10) was 6.6 ml per g gauze (SO: 0.6). This 
difference is statistically significant (p < 0.0001, Student's t test for independent samples). 
Adhesion formation after inflicting different amounts of peritoneal trauma. 
On almost all peritoneal defects adhesion formation was found after 2 weeks. No pathological 
conditions as bowel obstruction, peritonitis or abscesses were found. 
Table 3.2 shows that a significantly more adhesions were found at sites where severe (model 
1) trauma had been applied, compared with moderate (model 2) and minimal (model 3) 
peritoneal trauma (p ::; 0.05). Adhesions formed after severe and moderate trauma of the 
peritoneum were dense and thick and could be classified as Zuhlke type 2-3 and Zuhlke type 
2. The pelvic fat and the uterine horn took part in the adhesion formation. The adhesions 
formed after minimal trauma of the peritoneum were filmy and could be classified as ZUhlke 
type 1-2. Only pelvic fat took part in the adhesion formation. 
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sut re 3 
12.5% 12.5% 
12.5% 12.5% 12.5% 12.5% 
Figure 3.3 
The extent of adhesion formation was quantified by dividing the "defect" area to be scored into 
eight areas of 12.5% by means of the three sutures used to close the defect. 
Score Characteristics 
Filmy adhesion, easy to separate by blunt dissection 
2 Stronger adhesion: blunt dissection possible, partly sharp dissection necessary; 
beginning of vascularisation 
3 Strong adhesion: lysis possible by sharp dissection only; clear vascularisation 
4 Very strong adhesion: lysis possible by sharp dissection only; organs strongly 
attached with severe adhesions: damage of organs hardly preventable 
Table 3.1 
Macroscopic (morphological) classification of abdominal adhesions according to Zuhlke et 
al.zz 
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Adhesion formation in model 3 after rubbing with surgical gauze or non~surgical textile. 
Table 3.3 shows that rubbing the uterine horn with surgical Medipres gauze after infliction of 
minimal peritoneal trauma gave rise to a significantly higher mean adhesion percentage than 
infliction of minimal peritoneal trauma alone (p ~ 0.0001 ). The adhesions in the latter group 
were often filmy (Zuhlke type 1-2) involving only pelvic fat. Adhesions at srtes also rubbed by 
Medipres gauze were denser (ZUhlke type 2-3); pelvic fat, uterine horn and the bowel were 
involved in these adhesions. 
Table 3.3 shows that, after infliction of minimal peritoneal trauma, rubbing the uterus horn with 
surgical Medipres gauze induced a significantly higher mean adhesion percentage than 
rubbing the (opposite) uterus horn with non-surgical Fastsorb textile (P ~ 0.0001). The 
adhesions formed after rubbing with Medipres gauze were more dense (ZUhlke type 2-3) than 
those formed after rubbing with Fastsorb textile (Zuhlke type 1-2). In the first group the uterine 
horn, the bowel and pelvic fat were involved in adhesion formation, whereas in the Fastsorb 
group the bowel was never involved and the uterine horn rarely. 
The mean adhesion percentage found after infliction of minimal peritoneal trauma did not 
significantly differ from that observed after combining this minimal trauma with rubbing the 
uterus with non-surgical Fastsorb textile (p = 0.23). The adhesions found were all filmy, Zuhlke 
type 1 in the first group and type 1-2 in the second group; only pelvic was involved in adhesion 
formation. 
Light microscopy 
In all cases the surface of the uterine peritoneum was more damaged after rubbing with 
surgical Medipres gauze than after rubbing with non-surgical Fastsorb textile. After rubbing 
with Medipres gauze, the mesothelial layer had disappeared and the underlying muscular layer 
was partly lost and looked frayed. After rubbing with Fastsorb textile the mesothelial layer had 
disappeared for the most part but the underlying muscular layer looked smooth and was intact. 
At 2 and 4 hours after causing peritoneal damage with Medipres there were more leucocytes 
infiltrating the severely damaged area than after rubbing with Fastsorb (Figure 3.4 ). 
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Abdominal trauma n Percentage adhesion Zuhlke p1 p2 p3 
formation (SD) score 
Model1 15 60 (12.7) 2-3 0.011 
Model2 9 44 (15.5) 2 0.004 
Model3 6 21 (6.5) 1-2 0.005 
Table 3.2 
Mean adhesion percentages (SD), and ZUhlke classification of found adhesions, after inflicting 
severe (model 1 ), moderate (model 2) and minimal (model 3) peritoneal trauma. Fifteen rats 
underwent an operation according to adhesion model 1 at one lateral abdominal wall side. In 9 
of these rats the other, opposite, side was operated according to adhesion model 2 and in 6 of 
these rats according to adhesion model 3. Therefore, n is the number of peritoneal sites 
(uterine horns) assessed. Statistics p1 and p3: t test for paired samples (model 1 versus 
model 2 and model 1 versus model 3). Statistics p2: Student's t test for independent 
samples (model 2 versus model 3 ). 
Uterine horns n Percentage adhesion Zuhlke pl p2 p3 
fonnation (SD) score 
I". No touch 10 23 (9.9) 1-2 
Ib Medipres rubbing 10 58 (10.5) 2-3 < 0.0001 
II'. Medipres rubbing 10 63 (11.8) 2-3 
lib Fastsorb rubbing 10 19 (12.2) 1-2 < 0.0001 
III'. No touch 10 24(11.6) I 
Illb. Fastsorb rubbing 10 35 (24.3) 1-2 ns 
Table 3.3 
Mean adhesion percentages (SD), and ZUhlke classification of found adhesions, after inflicting 
minimal peritoneal trauma alone (the uterine horn was not touched) and after rubbing the 
uterine horn with Medipres gauze or Fastsorb textile following the infliction of minimal 
peritoneal trauma. N is the number of defected peritonea! sites (uterus horns) assessed. Statis-
tics p1 (I" versus I b), p2 (II' versus II b) and p3 (Ill' versus Ill b): !-test for paired samples (95% 
Cl = 95% confidence interval). 
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A 
B 
Figure 3.4 
Light micrograph of uterus horn surfaces after rubbing with Medipres gauze (A) and Fastsorb 
textile (B). A: the mesothelial layer has disappeared, the underlying muscular layer is partly 
lost and frayed. Reactive leucocyte cells infiltrate the severely damaged surface area. 8: The 
mesothelial layer has disappeared for the most part but the underlying muscular layer is 
intact. Magnification 1 Ox. 
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DISCUSSION 
Numerous attempts in clinical and animal studies to prevent or reduce the incidence of intra-
peritoneal adhesions have yielded limited success. 
Adhesion formation is a dynamic process consisting of several consecutive stages following 
damage to the parietal or visceral peritoneum. Different studies, in which peritoneal trauma 
was proven to be a cause of adhesion formation, 23• 24· 32 did not mention whether there was an 
association between the degree of trauma inflicted, and the extent of formed adhesions. The 
present study shows that the extent and type of post-surgical adhesion formation correlates 
significantly with the degree of peritoneal damage. At sites where severe, moderate or minimal 
peritoneal trauma was inflicted, mean adhesion percentages of 60%, 44% and 21% 
respectively were found. 
Damage to the peritoneum causes a local inflammatory reaction which leads to the formation 
of a serosanguineous exudate.23-26 In the exudate fibrin deposition will take place,25-27 and 
when two surfaces contact each other during this process a fibrinous adhesion will appear. 
Whether these adhesions are permanent of character or will eventually be lysed is dependent 
on the fibrinolytic capacity of the peritoneum. 25· 28-31 When the peritoneum is slightly damaged 
and mesothelial cells are mostly intact, there will be a dynamic balance between fibrinogenesis 
and fibrinolysis, and adhesion-free healing may take place. When the peritoneum is more 
severely damaged the underlying connective tissue will be exposed and normal serosal 
fibrinolytic activity will be lost.32 Exposed endothelial and inflammatory cells, as well as 
damaged mesothelial cells, may produce plasminogen activator inhibitor 1 and 2, factors 
mediating a reduced functional fibrinolytic activity. 29 Low fibrinolytic activity allows the fibrinous 
adhesion to organise to a fibrous permanent adhesion. 24 Therapeutic modalities, focusing on 
the different stages in adhesion formation include the use of anticoagulants and anti-
inflammatory agents,33-35 removal of fibrinous exudates by peritoneal lavages,36 the 
augmentation of fibrinolysis by use of polysorb, saccharose, vitamin E or recombinant tissue 
plasminogen activator (t-PA), 37 and the inhibition of fibroblast proliferation by use of steroids 
and 5-fluorouracil. 38 Proving clinical effectiveness remains difficult and there may be severe 
side-effects. 
Recent animal and clinical studies evaluating mechanical separation during reperitonealisation 
of two adjacent anatomical structures are more promising.39-42 Non-resorbable and resorbable 
barriers have up to now been used mainly in experimental settings, leaving minimalisation of 
peritoneal trauma as the main therapeutic modality in prevention of postoperative adhesion 
formation. 
Limitation of peritoneal injury should include attempts to reduce trauma inflicted by surgical 
gauze. Down et al19· 20 showed in two experimental studies that the abrasive effect of gauzes 
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causes adhesion formation. In various experimental models, used to evaluate the prevention of 
adhesions by different substances, peritoneal damage is created by gauze abrasion.4347 In 
1968 Saxen and Myllamiemi reviewed 309 laparotomies with adhesions present and found 
foreign-body granulomas in 61% of all cases.48 Remnants of gauze were the second most 
frequent observed foreign body materials (16%) found in these adhesions.48 
The current study shows that peritoneal manipulation with surgical Medipres gauze after 
infliction of minimal peritoneal trauma produces significantly more adhesions than inflicting 
minimal trauma alone. The dense ZUhlke type 2-3 adhesions were thereby formed not only 
between traumatised lateral peritoneum and pelvic fat but also between traumatised 
peritoneum and uterine horn and between uterine horn and bowel. This finding suggests that 
manipulation with surgical Medipres gauze causes severe trauma of the peritoneum. After 
minimal peritoneal trauma, manipulation of the peritoneum with non-surgical Fastsorb textile 
produced significantly fewer adhesions than manipulation with surgical Medipres gauze, 
suggesting a less traumatic influence on the peritoneum of Fastsorb textile. Indeed, there was 
no significant difference in the extent and type of adhesions formed after infliction of minimal 
peritoneal trauma alone and minimal trauma in combination with Fastsorb manipulation of the 
peritoneum. Thus peritoneal manipulation with non-surgical Fastsorb textile, as performed in 
the current study, does not seem to have a traumatising effect on the peritoneum. Microscopic 
analysis of rubbed uterine horns partly confirms this conclusion: after rubbing with Medipres, 
severe trauma of the surfaces was seen with many infiltrating cells, whereas rubbing with 
Fastsorb produced little tissue damage with only a small number of infiltrating cells. 
Given the fact that non-surgical Fastsorb textile meets important criteria for a gauze used for 
surgical purposes and the fact that this non-abrasive textile produces fewer adhesions than the 
usual surgical gauzes, further study of the use of non-abrasive textile in abdominal surgery is 
indicated. Fastsorb textile might be a suitable substitute for Medipres gauze in surgical 
practice. 
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Chapter IV 
Peroperative Abdominal lavage Promotes Intra-
Abdominal Adhesion Formation in the Rat 
Adapted from the original publication in the European Surgical Research 1999; 31: 196-201 
Intra-abdominal adhesions continue to pose a serious postoperative clinical problem. Per-
operative peritoneal trauma can lead to postoperative adhesion formation. In vitro studies 
show that exposure of the peritoneal surface to lavage solutions enhances peritoneal activity 
and provokes an inflammatory response. This study was designed to evaluate the in vivo 
effect of lavage solutions on the peritoneum and post-surgical adhesion formation. 
A reproducible rat model allowing semiquantitative scoring of adhesions was used to study 
adhesion formation after lavage of the abdominal cavity with RPM! medium, NaG! 0.9%, 
polyvinylpyrrolidone iodine 1% (PVP-1), Viaspan and chlorhexidine 0.02% in dilution. All 
solutions were applied during a laparotomy in which standardised minimal peritoneal trauma 
was inflicted. 
Peritoneal lavage of the abdominal cavity after the infliction of minimal peritoneal trauma 
induced significantly more adhesions than the infliction of minimal peritoneal trauma alone (p 
= 0.0001). Aggressive as well as non-aggressive lavage solutions caused extra adhesion 
formation. 
The results found in the present study correlate with observations from in vitro experiments; 
exposure of peritoneal cavity to lavage solutions traumatises the peritoneum, enhances 
peritoneal activation and thus promotes intra-abdominal adhesion formation. During surgery 
in non-contaminated abdominal cavities peritoneal lavage should not be performed. Per-
operative lavage of contaminated abdominal cavities should be viewed with caution. 
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INTRODUCTION 
Peroperative lavage following contaminated or potentially contaminated abdominal surgery 
has become common practice. Although peritoneal lavage may diminish the bacterial count 
in the abdominal cavity, 1 it does not reduce the risk of postoperative peritonitis, sepsis or 
rates of other complications of peritonitis, 2 and it may enhance peritoneal reaction and 
provoke an inflammatory response on the surface. Human mesothelial cells in culture have 
been shown to have modulated inflammatory, fibrinolytic as well as procoagulant activity 
after exposure to lavage solutions in non-toxic dilutions.3-5 When similar responses occur in 
vivo, peroperative irrigation of the abdominal cavity may disturb postoperative restoration of 
the mesothelium, physiological local defence systems and furthermore induce adhesion 
formation. lt has been observed in both mice and rats that irrigation with solutions generally 
regarded as physiological acceptable, during intra-abdominal manipulations, caused more 
adhesions than no irrigation at all. 6· 7 
Lysis of fibrous adhesions depends on the presence of an adequate amount of plasminogen 
activator activity.8· 9 Ischaemia or inflammation of the mesothelium results in a greater 
reduction of fibrinolytic activity, which leads to more fibrous adhesions, than does simple 
trauma alone. 10 Therefore, a standardised experimental rat model which induced peritoneal 
ischaemia was chosen to determine the effect of various solutions, commonly used in 
surgical practice, on peritoneal adhesion formation. 
MATERIALS AND METHODS 
Animals 
Female Wistar rats of reproductive age weighing 150-230 g obtained from Harlan, Zeist, The 
Netherlands were used. They were bred under specific pathogen-free conditions and kept 
under standard laboratory conditions (temperature 20-24°C, relative humidity 50-60%, 12 
hours light and 12 hours dark periods). The rats were fed standard rat food and water ad 
libitum. The experimental protocol adhered to rules laid down by the Dutch Animal 
Experimentation Act and was approved by the Committee on Animal Research of the 
Erasmus University Rotterdam, The Netherlands. 
lavage solutions 
The evaluated lavage solutions were: RPMI 1640 medium (Gibco, Paisly, Scotland), NaCI 
0.9% (Fresenius BV, 's Hertogenbosch, The Netherlands), polyvinylpyrrolidone iodine 1% 
(PVP-1, Asta Medica BV, Diemen, The Netherlands), Viaspan (an ex vivo storage solution, 
DuPont, Clakson, Canada) and chlorhexidine 0.02% (Vifor Medical SA, Huizen, The 
58 
Netherlands). Dilutions of the lavage solutions were prepared in medium (RPM!) for optimal 
pH (7.2-7.4) and osmolarity (280-300 mosmol/kg). All solutions were prepared under 
pathogen-free conditions. The analysed solutions were divided into non-aggressive and 
aggressive lavage solutions. Non-aggressive solutions caused only moderate activation of 
mesothelial functional properties in previous in vitro experiments. 2-5 Aggressive solutions 
provoked major mesothelial cytokine production and other functional activation of cultured 
human mesothelial cells. 3·5 
Operative procedures 
To study the effect of the different solutions on adhesion formation in rats our previously 
described reproducible rat adhesion model was used. 11 Briefly, under ether anaesthesia and 
aseptic conditions a laparotomy was performed using a lower midline incision of 5 em. Three 
Surgilene 5-0 sutures (Braun, Melsungen, Germany) were applied to both lateral peritoneal 
sides 0.7 em from each other and 1.5 em downwards from the abdominal incision. All knots 
were double knots fastened tightly to ensure local ischaemia. Both uterine horns were 
exposed and sutured to the lateral peritoneum with Surgilene 6-0 (Braun) proximally and 
distally from the three 5-0 sutures. In this way a standardised amount of minimal peritoneal 
trauma was inflicted. Subsequently the abdominal cavity was exposed to 10 ml of lavage 
solutions (25°C) for 10 minutes. After 10 minutes the fluids were suctioned out carefully. At 
least 5 ml of the lavage solutions remained within the peritoneal cavity. The abdomen was 
closed in two layers with 5-0 polyglycolic acid and 2-0 silk sutures. 
Experimental design 
Adhesion formation after peritoneal lavage with non~aggressive solutions. 
In 15 rats, standardised minimal peritoneal trauma was inflicted to both lateral peritoneal 
sides by applying 3 sutures in, and fixating the uterine horns to the lateral peritoneum. In five 
rats (group I) no peritoneal lavage was performed. The other ten rats were treated with non-
aggressive solutions. Five rats (group II) underwent lavage with 10 ml NaCI 0.9% and five 
(group Ill) with 10 ml povidone-iodine (PVP-1 diluted 1:100 in RPMI). 
Adhesion formation after peritoneal lavage with aggressive solutions. 
Again minimal peritoneal trauma was inflicted to both lateral peritoneal sides in 18 rats. Six 
rats (group IV) underwent a lavage with the non-aggressive solution RPM!, six rats (group V) 
underwent a lavage with Viaspan and six (group VI) with the aggressive lavage solution 
chlorhexidine 0.02% (diluted in 1:10 in culture medium). 
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Evaluation of adhesion formation. 
Fourteen days postoperatively the rats were sacrificed for assessment of post-surgical 
adhesion formation. Macroscopically the adhesions were scored according to their extent 
(quantity) and type (quality) by three independent observers. Quantification was assessed by 
dividing the area to be scored into eight by means of the three 5-0 sutures in the lateral 
peritoneum (Figure 4.1 ). The presence or absence of adhesions in the eight demarcated 
areas was scored. If there were adhesions in an area this accounted for 12.5% adhesions; a 
maximum of 100% adhesions could be scored. In each rat two lateral peritoneal sides were 
assessed. The type of adhesions formed was classified macroscopically using the ZUhlke 
classification (Table 4.1 ).12 
suture 1 su ure 2 sut re 3 
12.5% 12.5% 12.5% 12.5% 
12.5% 12.5% 12.5% 12.5% 
Figure 4.1 
The extent of adhesion formation was quantified by dividing the "defect" area to be scored into 
eight areas of 12.5% by means of the three sutures. 
Score Characteristics 
Filmy adhesion, easy to separate by blunt dissection 
2 Stronger adhesion: blunt dissection possible, partly sharp dissection necessary; 
beginning of vascularization 
3 Strong adhesion: lysis possible by sharp dissection only; clear vascularization 
4 Very strong adhesion: lysis possible by sharp dissection only; organs strongly 
attached with severe adhesions: damage of organs hardly preventable 
Table 4.1 
Macroscopic (morphological) classification of abdominal adhesions according to ZUhlke et 
aiY 
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Statistical analysis 
Data were expressed as mean adhesion percentage ± SO. Statistical analysis was pertormed 
using the one-way ANOVA test to determine overall differences followed by a Bonferroni post 
hoc test to analyse differences between groups if the ANOVA test showed significance. 
Statistical significance was defined asp< 0.05 
RESULTS 
In almost all peritoneal cavities, adhesions were found after 2 weeks. No pathological 
conditions as bowel obstruction, peritonitis or abscesses had occurred. 
Table 4.1 and 4.2 show that infliction of minimal (ischaemic) peritoneal trauma alone induced a 
mean adhesion percentage of 22.5% and that additional peritoneal lavage with all five lavage 
solutions gave rise to significantly higher mean adhesion percentages. 
Adhesion formation after peritoneal lavage with non-aggressive solutions 
Table 4.2 shows that peritoneal lavage with non-aggressive solutions as NaCI 0.9% or 
povidone-iodine (PVP-1) after infliction of minimal peritoneal trauma caused over 150% more 
adhesions than infliction of minimal peritoneal trauma alone (p = 0.0001). The mean adhesion 
percentage found after peritoneal lavage with NaCI 0.9% did not significantly differ from that 
observed after lavage with povidone-iodine (p = 0.61 ). Adhesions found after minimal 
ischaemic peritoneal trauma were all filmy (ZUhlke type 1 ). The adhesions formed after 
peritoneal lavage with NaCI 0.9% or povidone-iodine were more dense and could be classified 
as ZUhlke type 1-2. In all groups only pelvic fat took part in the adhesion formation. 
Adhesion formation after peritoneal lavage with aggressive solutions. 
Tables 4.2 and 4.3 show (again) that peritoneal lavage with non-aggressive solutions as RPMl 
or Viaspan after infliction of minimal peritoneal trauma induced about 100% more adhesion 
formation than infliction of minimal peritoneal trauma alone (p ~ 0.01 ). Table 4.3 also shows 
that peritoneal lavage of a minimally traumatised peritoneal cavity with chlorhexidine (0.02%; 
1:10), an aggressive solution for mesothelial cells in culture, induced significantly more 
adhesion formation than lavage of minimally traumatised peritoneum with RPMI or Viaspan (p 
~ 0.012). The adhesions found after peritoneal lavage with RPMI or Viaspan were dense 
(Zuhlke type 2) and involved pelvic fat and seldom the uterine horn. Adhesions found after 
lavage with chlorhexidine were more dense (ZUhlke type 3) and the uterine horn, the bowel 
and pelvic fat were involved in adhesion formation. 
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Lavage solution n Percentage adhesion Zuhlke p1 p2 p3 
formation (SO) score 
i, I. No lavage 5 22.5 (8.4) 1 0.0001 
Ill 
NaCI 0.9% 5 60.0 (11.4) 1-2 ns 
Ill. PVP-11% 5 63.8 (11.2) 1-2 0.0001 ll 
Table 4.2 
Mean adhesion percentages (SD) and ZUhlke classification of adhesions found after minimal 
peritoneal trauma alone (group I) and after peritoneal lavage with NaCI 0.9% (group II) or 
povidone-iodine 1% 1:100 (group Ill) following infliction of minimal peritoneal trauma. For each 
rat, the individual data concerning the 2 lateral abdominal wall sites (uterine horns) were 
averaged; n is the number of data (::::rats) per group used for analysis. Statistics p1 (I versus 
II), p2 (II versus Ill) and p3 (I versus Ill): one-way ANOVA test, with Bonferroni post hoc test. 
Lavage solution n Percentage adhesion Zuhlke p1 p2 p3 
formation (SO) ' score 
IV.RPMI 6 47.7 (12.2) 1-2 ns 
V. Vispan 6 40.6 (13.0) 2 0.012 
VI. Chlorhexidine 6 70.8 (14.1) 2 0.003 . 
Table 4.3 
Mean adhesion percentages (SD) and ZUhlke classification of adhesions found after peritoneal 
lavage with RPMI (group IV), Viaspan (group V) or chlorhexidine 0.02% 1:10 (group VI) 
following infliction of minimal peritoneal trauma. For each rat, the individual data concerning 
the 2 lateral abdominal wall sites (uterine horns) were averaged; n is the number of data(:::: 
rats) per group used for analysis. Statistics: p1 (IV versus V), p2 (V versus VI) and p3 (IV 
versus VI): one-way AN OVA test, with Bonferroni post hoc test. 
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DISCUSSION 
Intra-peritoneal postoperative adhesion formation creates a major challenge to abdominal 
surgery, as it is the main cause of mechanical bowel obstruction, unexplained abdominal pain 
and female infertility. Furthermore the presence of dense adhesions makes reoperation 
technically difficult. By far the most common cause of intra-peritoneal adhesions is previous 
surgical intervention.13 Intra-abdominal surgery will, by traumatising of the peritoneum, alter 
mesothelial activity and inflammatory responses of the peritoneum and disturb the fibrinolytic 
homeostasis.14' 15 Previous in vitro studies show that exposure of the peritoneum to different 
lavage solutions enhances mesothelial functional features and provokes an inflammatory 
response.2·5 
We have assessed the effect of peroperative peritoneal lavage, with non-aggressive and 
aggressive solutions, in vivo on postoperative adhesion formation. We used an established 
reproducible rat adhesion model in which standardised peritoneal trauma, which mimics 
peritoneal injury induced in patients during abdominal surgery, was inflicted before peritoneal 
irrigation took place. As in our previous studies the infliction of standardised minimal ischaemic 
peritoneal trauma caused a mean adhesion percentage of 22%. The present study shows that 
peritoneal lavage of areas with ischaemic injury is associated with increased adhesion 
formation. Aggressive as well as non-aggressive solutions caused significantly more 
adhesions. Peritoneal lavage with aggressive solutions increased adhesion formation 
significantly more than lavage with non-aggressive solutions. Irrigation with aggressive fluids 
gave rise to adhesions that were more dense and contained more organs than the adhesions 
formed after irrigation with non-aggressive solutions. 
Possible explanations for the induction of adhesions by lavage solutions include cellular injury, 
increased peritoneal permeability and peritoneal activation.16 We have studied cellular injury by 
measuring the release of an intracellular enzyme (LDH) in vitro and in peritoneal fluid of 
patients undergoing elective colonic surgery and noted increased levels of LDH after exposure 
to lavage solutions (unpublished data). Furthermore, permeability studies with a 
macromolecule (inulin) after treatment of mesothelial monolayers with lavage solutions showed 
disturbance of mesothelial integrity with increase permeability. This facilitated passage for 
macromolecules may cause increasing fibrous exudation to the abdominal cavity and thereby 
induce adhesion formation. In vitro studies also show an increased pro-inflammatory peritoneal 
cytokine response after exposure to various solutions. In vivo these increased cytokine 
concentrations may lead to an enhanced inflammatory response and increased adhesion 
formation.2· 5 Moreover, procoagulant and fibrinolytic properties of human mesothelial 
monolayers were also affected by various solutions in earlier in vitro experiments.5 
Notwithstanding an overall increase of responses of human mesothelial cells in culture to 
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various kinds of clinically used lavage solutions, not all solutions induced an equal effect. In the 
current in vivo study no significant difference in the extent of postsurgical adhesion formation 
was observed between exposure of the peritonea! cavity to NaC! 0.9% or povidone-iodine 1%, 
1:100. This discrepancy between in vitro and in vivo results may be explained as follows. 
Firstly, by observations indicating that the cytokine profile and peritoneal fibrinolytic activity 
differ in different species. 17-19 In humans, intra-peritoneal responses to stimuli may differ and be 
more complicated compared with responses in the rat. Secondly, povidone-iodine as a highly 
viscous solution reduced mesothelial cell activation in vitro probably by coating the cells. In vivo 
the coating effect over the entire peritoneal surface may not be as effective as in vitro. 
Studies at our laboratories have emphasised the use of scavengers to minimise human 
mesothelial cell damage and activation during oxidative stress. The trauma induced in this rat 
model was mainly ischaemic injury. Therefore, we also tested the organ preservation fluid 
Viaspan, regarded as more biocompatible as it contains lactate and oxigen radical scavengers 
(glutathione and allopurinol). Nevertheless peroperative lavage with Viaspan also induced a 
significant increase of adhesion formation. However the effect of antioxidants on mechanisms 
underlying the initiation of fibrin appeared also to be species specific in another experimental 
study.20 
In conclusion, this study is in accordance with previous in vitro experiments with human 
mesothelial cells. This study shows that exposure of the abdominal cavity to peritoneal lavage 
solutions may lead to more postoperative adhesion formation. Therefore, peroperative 
irrigation with any kind of lavage solution should be discouraged especially during surgery in 
non-contaminated abdominal cavities. Further studies to establish the composition of an ideal 
lavage solution which does not traumatise the peritoneum and which might even protect the 
peritoneum from the effects of trauma seems to be indicated. 
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PART Ill 
Surgical Peritoneal Trauma and Intra-Abdominal 
Tumour Recurrence 

Chapter V 
Reduction of Peritoneal Trauma by Using Non-
Surgical Gauze leads to less Implantation 
Metastasis of Spilled Tumour Cells 
Adapted from the original publication in the Annals of Surgery 1998; 227: 242-248 
After potentially curative resection of colorectal carcinoma, the most common site for recurrence 
is loco-regional. We previously demonstrated that surgical trauma induces a cascade of events 
leading to adhesion formation. The same mechanisms may be responsible for improved tumour 
cell adherence and growth facilitation in early local recurrence. The objective of this study was to 
evaluate whether surgical peritoneal trauma affects tumour recurrence. 
A reproducible rat model, in which peritoneal damage was inflicted by standardised rubbing of 
the peritoneum with surgical gauzes of different texture, was used to assess tumour ceff 
adherence and growth at traumatised and non-traumatised peritoneal sites. In an analogue rat 
model the effect of peritoneal trauma on "ectopic" tumour growth was investigated. The final 
experiment evaluated how soon after peritoneal trauma tumour cell adhesion and growth 
promoting factors were active and whether they could be passively transferred to naive non-
traumatised abdominal cavities. 
A significant correlation between the amount of peritoneal trauma and degree of tumour load at 
damaged peritoneal surfaces was found (p:::; 0.018). Tumour load at not directly traumatised 
remote peritoneal sites was significantly higher after severe trauma than following moderate 
trauma of the peritoneum (p ,o.005). In addition, a significant correlation between the degree of 
peritoneal trauma and the growth of "ectopic" tumours, situated under the renal capsule, was 
observed (p :::; 0.009). Within a few hours after infliction of peritoneal trauma tumour cell 
adhesion and growth promoting effects could be passively transferred to naive recipients. 
Surgical trauma is an important factor in the promotion of local tumour recurrence. The 
enhancing effect of trauma is not restricted to the inflicted site but rather has a generalised 
character. Avoidance of unnecessary surgical trauma by employing gentle techniques and 
materials is therefore indicated. 
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INTRODUCTION 
Loco-regional recurrence of colorectal adenocarcinoma remains an important complication after 
potentially curative surgical resection. Its incidence varies between 0 and 45%.14 Ways to 
prevent these loco-regional recurrences are the subject of various clinical and experimental 
studies. 5-9 The most common site for colorectal adenocarcinoma to recur is the site of the 
primary tumour; the second is the peritoneal surface.2' 6' 10· 11 The tumour cell entrapment 
hypothesis might explain this pattern of surgical treatment failure resulting in loco-regional 
recurrence. When a tumour is removed, tumour cells can leak from transacted lymphatics into 
the abdominal cavity.10 Experimental studies have shown that the proliferative and metastatic 
potentials of these spilled cells are very well preserved. Consequently exfoliated carcinoma cells 
may undergo further division and give rise to implantation of metastases.12' 13 However, 
implantation of spilled tumour cells on surfaces with intact basement membranes is an inefficient 
process, whereas implantation on damaged surfaces, resulting from intra-abdominal 
manipulation, is very efficient.10' 14 The dynamic process of peritoneal healing following 
ischaemic damage of the peritoneal surfaces, sometimes leading to adhesion formation, also 
seems to be important in the process of adhesion and growth of spilled tumour cells to the 
peritoneum.15 In clinical situations, it appears that peritoneal tumour implants may recur within a 
fibrous adhesion resulting from surgical trauma. 10 
In a rat model we recently showed that surgical trauma evoked by standard surgical gauze led to 
marked adhesion formation, which could significantly be reduced by using non-abrasive textile. 16 
The present study was undertaken to evaluate whether the intra-abdominal use of this less 
traumatic non-surgical textile would also lead to less intra-peritoneal tumour cell adhesion and 
tumour growth of spilled carc'1noma cells. In addition, exper'1ments were performed to evaluate 
whether the relationship between degree of trauma and tumour growth was merely a local 
phenomenon, or whether systemic effects might also be involved. 
MATERIALS AND METHODS 
Animals 
Female inbred WAG rats of reproductive age weighing 115-170 g (Harlan-CPB, Austerlitz, The 
Netherlands) were used. They were bred under specific pathogen-free conditions, kept under 
standard laboratory conditions (temperature 20-24°C, relative humidity 50-60%, 12 hours light/ 
12 hours dark) and fed with standard rat food and water ad libitum. The experimental protocol 
adhered to rules laid down by the Dutch Animal Experimentation Act and was approved by the 
Committee on Animal Research of Erasmus University, Rotterdam, The Netherlands. Before 
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performing any new experiments we made sure that the model used in our adhesion studies, 16 
executed on Wistar rats, were also valid in WAG rats. 
Gauzes 
The used "gauzes" were surgical Medipres gauze, consisting of 100% cotton, commonly used in 
abdominal surgery (van Heek Medical, Lasser, The Netherlands), and non-surgical Fastsorb 
cleanroom wiper, used in the electronics industry on abrasion-sensitive surfaces (Berkshire 
Corporation, Great Barrington, Massachussets, USA). Fastsorb is a rayon-polyester blend which 
possesses strength and softness combined with a high absorbing capacity. In previous 
experiments we demonstrated that non-surgical Fastsorb textile was less traumatic for the 
peritoneum and caused less adhesion formation after intra-abdominal manipulation than surgical 
Medipres gauze.16 
Tumour 
Tumour CC531 is a moderately differentiated, weakly immunogenic colonic adenocarcinoma 
induced in WAG rats by 1 ,2-dimethylhydrazine. 17 1t is transplantable in syngeneic WAG rats. The 
tumour is maintained as a cell culture in RPM I 1640 medium (Gibco, Paisley, UK) supplemented 
with 5% foetal calf serum (virus- and Mycoplasma-screened), 1% penicillin (5000 U/ml), 1% 
streptomycin (5000 U/ml) and 1% L-glutamin (200 mM). Before use in vivo tumour cells were 
harvested from stationary cultures by gentle trypsinisation (5 minutes, 3rC), centrifugation (5 
minutes, 700 g) and re-suspension in RPM! 1640, providing cell suspensions with a viability 
greater than 95%. CC531 is relatively insensitive to chemotherapy, but sensitive to the effects of 
biological response modifiers. To grow solid tumour, 1 x 108 tumour cells were injected into the 
right flank of a syngeneic WAG rat. After 6 weeks, a tumour mass with a volume of 2.5 cm3 had 
grown and could be aseptically isolated from the outer membrane of the main lesion with a 
scalpeL The harvested tumour was cut into 1 mm3 cubes (weighing 5.8- 7.2 mg) and immersed 
in a culture solution stored at 4°C. Within 1 to 4 hours after collection of the solid CC531 tumour, 
the cubes were implanted sub-rena!!y in syngeneic WAG rats. 
Operative procedures 
Under ether anaesthesia the abdomen was shaved and cleansed with alcohol 70%. Laparotomy 
was performed using a lower midline incision of 5 em. Both horns of the uterus were exposed, 
and rubbed either with severely traumatising surgical Medipres gauze, or less traumatising non-
surgical Fastsorb textile, or not manipulated at all by any gauze. Rubbing took place using a 
device enabling the application of a constant pressure of 120 gr/cm2 .16 The uterus horn was 
rubbed 10 times over its total length. Thus, three different peritoneal traumas could be inflicted. 
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After performing one of these 3 procedures, the uterus horn was subsequently sutured to the 
lateral peritoneum, both proximally and distally, using single Surgilene 6-0 sutures (B Braun, 
Melsungen AG, Germany). The abdomen was closed in 2 layers with Dexon 5-0 and silk 2-0 
sutures (B Braun). 
Experimental design 
Effect of uterus horn manipulation on intra-peritoneal tumour cell adhesion and growth 
Ten rats (group I) underwent an operation in which one uterus horn was rubbed with surgical 
gauze and the other was not manipulated. In 10 rats (group II), one uterus horn was rubbed with 
non-surgical textile and the other was not touched. In 9 rats (group Ill), one uterus horn was 
rubbed with surgical gauze and the other with non-surgical textile. Directly after manipulation of 
the peritoneum and before closing the abdomen, 0.5 x 106 CC531 tumour cells, in 1 ml RPMI 
1640, were injected intra-peritoneally (0.5 ml along the left and 0.5 ml along the right abdominal 
wall). Three weeks after surgery, the rats were sacrificed and intra-peritoneal tumour load was 
scored semiquantitatively at the following sites: right uterus horn, left uterus horn, 
subcutaneously (at the site of the operative scar), parietal peritoneum (at the lateral abdominal 
wall sides where no uterus horns were fixed), kidney, liver, retroperitoneum and omentum. The 
scoring was performed by 2 independent observers and ranged from 0 to 5 per site according to 
the peritoneal cancer index derived from an index described by Steller.18 A score of 0 meant 
there was no tumour growth, a score of 1 indicated an estimated tumour diameter less than 0.5 
em, a score of 2 a tumour diameter between 0.5 and 1 em, a score of 3 a tumour diameter 
between 1 and 2 em, a score of 4 a tumour diameter between 2 and 3 em, and a score of 5 a 
tumour diameter of more than 3 em (Figure 5.1 )- For each rat the score at all peritoneal sites, 
except for the uterus horns, were summarised, from which a mean total tumour load per rat 
could be estimated. In the present study the term tumour recurrence is sometimes used to 
illustrate tumour load, which is the assumed net result of tumour cell adhesion and tumour 
growth, because we presume intra-peritoneal injecting of tumour cells resembles the clinical 
situation of tumour cell spill during tumour resection. 
Effect of uterus horn manipulation on established "ectopic" tumour growth 
On day 1, 30 rats underwent a laparotomy using a midline incision of 2.5 em. A solid cube of 
CC531 colon tumour weighing about 6 mg was placed under the capsule of both exposed 
kidneys under microscopic vision. Thereafter, the abdomen was closed in one layer. On day 3, 
all 30 rats were operated on again. Both uterus horns and 5 em of the small bowel were rubbed, 
in 10 rats (group IV) with surgical gauze, and in 10 rats (group V) with non-surgical textile. Group 
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VI (n = 10) underwent a laparotomy only; neither the left nor the right uterus horn nor the small 
bowel were touched. Ten days after tumour implantation, the rats were sacrificed and growth of 
the sub-capsular tumours was measured by weighing the 60 e-nucleated lumps. (for each rat, 
the 2 individual data were averaged, 10 data per group were used for statistical analysis). 
Passive transfer experiments 
To evaluate whether the tumour-promoting effect of surgical trauma of the peritoneum could be 
passively transferred to naive non-traumatised rats, the following procedure was employed. 
Three rats were operated on. Two animals underwent a laparotomy, during which both uterus 
horns and a 5 em long part of small intestine were rubbed with either surgical gauze (rat 1) or 
non-surgical textile (rat 2). The third rat only underwent a laparotomy. The abdomen was closed 
in one layer. After 5 hours, these rats underwent a second laparotomy during which the 
abdominal cavity was rinsed 5 times per rat with 5 ml RPMI1640. Each time, 1 ml of the injected 
irrigant was collected. 
Subsequently, 15 naive rats were treated. In 5 rats (group VII), 1 ml of irrigant collected from rat 
1 (peritoneal manipulation with surgical gauze) and 0.5 x 106 CC531 tumour cells in 1 ml RPMI 
1640 were injected intra-peritoneally along the inner left and right abdominal walls. In 5 rats 
(group VIII), the same procedure was performed with the irrigants collected from rat 2 (peritoneal 
manipulation with non-surgical textile). In the last group (group IX), irrigants collected from rat 3 
(no peritoneal manipulation) were used. To ensure that all fluids were injected intra-peritoneally, 
the drop test was performed. In this test a drop of saline solution is placed within the open lumen 
of the injecting needle from which it should disappear as soon as the needle enters the 
peritoneal cavity because of its relative negative pressure. 
After 3 weeks, the rats were sacrificed and tumour load was scored semiquantitatively at the 
sites depicted in Table 5.4. 
Statistical analysis 
The median and range of intra-peritoneal tumour load at each site, of the total tumour load and 
the means and standard deviations (SO) of the sub-renal tumour weights were calculated per 
group. Statistical analysis was performed using the Wilcoxon matched pairs test if two groups 
were compared and the non-parametric Kruskai-Wallis test if three groups were compared. If the 
latter overall test indicated significance, comparisons between groups were made using the 
Mann-Whitney U test. Statistical significance was defined as p < 0.05. 
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Figure 5.1 
Examples of tumour load score at directly traumatised peritoneal sites. A: Tumour load at a 
uterus horn severely traumatised by rubbing with surgical Medipres gauze (score 5). B: 
Tumour load at a uterus horn mildly traumatised by rubbing with non-surgical Fastsorb textile 
(score 2) . ...,. Uterus horn, t> tumour load. 
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RESULTS 
Effect of uterus horn manipulation on intra-peritoneal tumour cell adhesion and growth 
Table 5.1 summarises the results observed at the site of the uterus horns. In three different 
experiments, a significant correlation was found between tumour load and the degree of 
peritoneal trauma imposed by rubbing. Rubbing with severely traumatising surgical gauze 
produced the highest tumour load, whereas no rubbing resulted in the lowest (group I; p = 
0.005). Rubbing with mildly traumatising non-surgical textile evoked a low degree of tumour load, 
but it was still significantly more than when no rubbing had taken place (group II; p = 0.018). At 
the site of the uterus horns, the tumours were often located in adhesions. Table 5.2 shows the 
tumour load at the non-manipulated remote peritoneal sites in rats from groups I, II and Ill. It 
shows significant differences in tumour load at 2 abdominal sites (the retroperitoneum (p ::;; 0.01) 
and the omentum (p ~ 0.01 )) between group II (non-surgical textile) and groups I and Ill (surgical 
gauze). A significant difference in total tumour load between the same groups (II versus I and II 
versus Ill) was found (p::;; 0.005). Differences in tumour load at the other 3 peritoneal sites were 
not significant. 
Effect of uterus horn manipulation on established "ectopic" tumour growth 
The mean weight of the sub-renal tumours was measured 10 days after tumour implantation, 7 
days after manipulation with surgical gauze or non-surgical textile. Significant differences in 
mean tumour weight between the 3 groups were found (Table 5.3). Again, a significant 
correlation between degree of peritoneal trauma and tumour growth was observed: the mean 
weight of the "ectopic" tumour was the highest in rats that were rubbed with surgical gauze 
(group IV) and significantly lower in rats rubbed with non-surgical textile (group V) (p = 0.009). 
When the peritoneum was not touched (group VI), the lowest mean tumour weight was found, 
significantly lower than after rubbing with non-surgical textile (p = 0.002) or surgical gauze (p < 
0.0001 ). 
Passive transfer experiments 
The median total peritoneal tumour load in rats injected with irrigants collected from abdominal 
cavities, manipulated with surgical gauze or non-surgical textile or not differed significantly from 
each other (Table 5.4, p::;; 0.016). These differences were mainly due to differences at the site of 
the omentum and the kidney. As in the previous experiments, a decreasing gradient of tumour 
load was found, from surgical (group VII) to non-surgical (group VIII) to non-traumatised (group 
IX) abdominal cavities. 
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Uterus horns n Median tumour load (range) p1 p2 p3 
1'. No touch 10 0.0 (0-2) 
lb. Medipres rubbing 10 4.5 (3-5) 0.005 
I Ia. No touch 10 0.0 (0-2) 
II'- Fastsorb rubbing 10 2.0 (0-3) 0.018 
Ill'. Medipres rubbing 9 5.0 (4-5) 
Ill'- Fastsorb rubbing 9 1.0 (0-3) 0.008 
Table 5.1 
Median tumour load (range) at uterus horns severely traumatised by rubbing with surgical gauze 
(group lb and Ill'), at uterus hams mildly traumatised by rubbing with non-surgical textile (group 
lib and I lib) and at not directly traumatised uterus horns (group II' and Ill'). N is the number of 
uterus horns assessed. Statistics p1 (I' versus lb), p2 (II' versus lib) and p3 (Ill' versus lllb ): 
Wilcoxon Matched pairs test. 
Abdominal sites Tumour load Tumour load Tumour load p1 p2 p3 
I. Medipres II. Fastsorb Ill. M& F 
n = 10 n = 10 n=9 
Subcutis 0 (1-3) 2 (0-3) 1 (0-4) ns ns ns 
Parietal peritoneum 0 (0-2) 0 (0-1) 0 (0-1) ns ns ns 
Kidney 1 (0-2) 1 (0-2) 1 (0-2) ns ns ns 
Liver 2 (0-3) 1 (0-2) 2 (1-3) ns ns ns 
Retroperitoneum 2 (1-3) 1 (0-2) 2 (1-3) 0.007 0.01 ns 
Omentum 2 (0-3) 1 (0-1) 2 (2-4) 0.01 0.0001 ns 
Total 1.5 (0-3) 1.0 (0-3) 1.5(0-4) 0.005 0.001 ns 
Table 5.2 
Median tumour load (range) at different not directly traumatised peritoneal sites in rats having 
been intra-abdominally manipulated by severely traumatising surgical gauze (group 1), mildly 
traumatising non-surgical textile (group II) or a combination of both materials (group Ill). N is the 
number of treated rats. Statistics p1 (I versus II), p2 (II versus Ill) and p3 (I versus Ill): Kruskai-
Wallis test, with a Mann-Whitney U post-hoc test. 
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Uterus horns n Mean tumour weight (mg) p1 p2 p3 
(SO) 
IV. Medipres rubbing 10 34.14 (7.2) 0.009 
V. Fastsorb rubbing 10 28.01 (6.5) <0.0001 
VI. No touch 10 17.80 (6.1) 0.002 
Table 5.3 
Mean tumour weight (SO) of the sub-renal tumours after intra-abdominal rubbing with severely 
traumatising surgical gauze (group IV), with mildly traumatising non-surgical textile (group V) and 
after no rubbing of the peritoneum at a!! (group VI). N is the number of operated rats, per rat the 
mean weight of two sub-renal tumours were assessed and used for analysis. Statistics p1 (IV 
versus V), p2 (V versus VI) and p3 (IV versus VI): Kruskai-Wallis test, with a Mann-Whitney U 
post-hoc test. 
Abdominal sites Tumour load Tumour load Tumour load p1 p2 p3 
VII. Medipres VIII. Fastsorb IX. No touch 
n = 10 n = 10 n = 10 
Left uterus horn 0 (0-0) 0 (0-0) 0 (0-0) ns ns ns 
Right uterus horn 0 (0-0) 0 (0-0) 0 (0-0) ns ns ns 
Subcutis 0 (0-0) 0 (0-0) 0 (0-0) ns ns ns 
Parietal peritoneum 0 (0-0) 0 (0-0) 0 (0-0) ns ns ns 
Kidney 2 (0-3) 1 (0-2) 0 (0-0) ns 0.03 0.03 
1 
Liver 2 (1-3) 1 (0-2) 0 (0-2) ns ns ns 
I 
Retroperitoneum 1 (0-3) 1 (0-2) 1 (0-2) ns ns ns 
Omentum 3 (2-5) 1 (0-3) 0 (0-2) 0.03 ns 0.008 
Total 0 (0-5) 0 (0-3) 0 (0-2) 0.02 0.002 0.008 
Table 5.4 
: 
I 
Median tumour load (range) at different peritoneal sites in rats intra-abdominally injected with 
irrigant obtained from rats that underwent rubbing of the peritoneum with severely traumatising 
surgical gauze (group VII), mildly traumatising non-surgical textile (group VIII), or no rubbing at 
all (group IX). N is the number of treated rats. Statistics: p1 (VII versus VIII), p2 (VIII versus IX) 
and p3 (VII versus IX): Kruskai-Wallis test, with a Mann-Whitney U post-hoc test. 
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DISCUSSION 
Experimental and clinical studies suggest that surgical trauma promotes tumour cell adherence 
and tumour growth.15' 19-22 The mechanism by which surgical trauma promotes these processes 
is not completely understood but is probably multi-factorial, because tumour cell adherence as 
well as local and regional tumour growth can be enhanced. It seems that trauma leads to a 
process during which locally and regionally active tumour promoting agents are produced.15· 19 
We recently demonstrated that surgical Medipres gauze was more traumatising to the 
peritoneum than non-surgical Fastsorb textile, leading to significantly more adhesion formation. 16 
Our current data suggest that the factors responsible for the formation of post-surgical 
adhesions also play a role in the adhesion and growth of tumour cells to the peritoneum. The 
most impressive tumour load was observed at sites where abrasion of the mesothelium was 
most severe. The degree of tumour recurrence at traumatised sites was highly correlated with 
the degree of trauma; abrasion with surgical gauze produced the highest tumour load whereas 
untouched peritoneum showed the lowest tumour burden and surfaces traumatised by non-
surgical textile presented intermediate tumour encumbrance. The finding that traumatised 
surfaces are privileged sites for tumour cells has been demonstrated before.15' n 24 It is 
conceivable that the process of enhanced tumour recurrence in traumatised tissue is biphasic. 
Firstly, trauma of the peritoneum and the ensuing inflammatory response will lead to 
upregulation of adhesion molecules, thus promoting the anchoring of tumour cells. Second, the 
subsequent healing of the peritoneum leads to growth promotion of the adhered tumour cells 
through the action of locally produced growth factors. 
Using the same tumour model as in the present study, we recently demonstrated that the 
phenomenon of enhanced tumour recurrence as it relates to trauma and healing also occurs in 
other experimental settings. It was found that laparoscopic removal of a bowel segment led to 
less adherence and growth of intra-peritoneal tumour cells than when conventional surgery was 
performed, again indicating that the degree of surgical trauma was proportional to the extent of 
tumour recurrence.22 In addition, we observed that the growth of a regenerating liver following 
partial hepatectomy led to a marked propagation of intra-hepatic tumour growth.25· 26 
Interestingly, our present results indicate that the sequelae of peritoneal trauma with regard to 
tumour recurrence are not confined to the inflicted site itself, but appear to have a generalised 
character. We showed that trauma led to more tumour at the traumatised site and also at non-
traumatised peritoneum. Again, the amount of tumour at these loco-regional sites correlated with 
the severity of the inflicted trauma. This clear correlation was also found in the experiment in 
which we studied the effect of peritoneal trauma on tumour growth under the renal capsule. 
Even in this "ectopic" tumour model, the consequences of the intra-abdominal trauma were 
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demonstrable. Because promotion of adherence was irrelevant in this model, this experiment 
also revealed that trauma could evoke enhancement of the growth of an established tumour. 
Gutman et al made comparable observations, finding that a regenerating liver induced enhanced 
tumour growth not only in the liver but also at distant sites. 27 
Our final experiment, in which we demonstrated that within a few hours after infliction of 
peritoneal trauma, the effects on tumour recurrence could be passively transferred to naive 
recipients, supports the notion that trauma per se has a marked effect, most likely on tumour cell 
adhesion. 
Taken together, the current experiments suggest that both tumour cell adherence and tumour 
growth are modified by surgical trauma. It is clear that the present model provides unique 
possibilities to further unravel the similarities and differences between the processes of adhesion 
formation and tumour cell adhesion and tumour growth. Variables such as kinetics of adhesion 
molecule expression with regard to inflammatory cytokines and growth factors and the role of 
mesothelial hyaluronic acid and CD44 are currently being investigated. These studies may lead 
to sophisticated tools to prevent the unwanted side effects of surgery. On the other hand, the 
present study clearly indicates that these unwanted side effects already can partly be omitted by 
employing delicate surgery, using non-abrasive gauze material. 
79 
REFERENCES 
1. Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of 
rectal cancer after potentially curative surgery. Cancer 1983; 52: 1317-1329. 
2. McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB. Local recurrence after potentially 
curative resection for rectal cancer in a series of 1008 patients. Br J Surg 1985; 72: 34-37. 
3. Long RT, Edwards RH. Implantation metastasis as a cause of local recurrence of colorectal 
carcinoma. Am J Surg 1989; 157: 194-201. 
4. Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic 
carcinoma: Implications for adjuvant therapy. Dis Colon Rectum 1991; 34:723-727. 
5. Eggermont AMM, Steller EP, Marquet RL, Jeekel J, Sugarbaker PH. Local regional promotion of 
tumour growth after abdominal surgery is dominant over immunotherapy with interleukin-2 and 
!ymphokine activated killer cells. Cancer Detect Prev 1988; 12:421-429. 
6. Cunliffe WJ, Sugarbaker PH. Gastrointestinal malignancy: rationale for adjuvant therapy using 
early postoperative intra-peritoneal chemotherapy. Br J Surg 1989; 76: 1082-1090. 
7. Eggermont AMM, Sugarbaker PH. lmmunogenicity of the tumour determines the outcome of the 
immunotherapy with interleukin-2, ABPP, and cyclo-phosphamide of micro- and macroscopic 
intra-peritoneal tumour. Cancer Detect Prev 1990; 14:483-490. 
8. Hubens G, Willems G. Factors influencing the implantation of colon cancer cells on the colonic 
suture line in rats. Eur Surg Res 1990; 22: 356-364. 
9. Reinbach 0, McGregor JR, O'Dwyer OJ. Effect of suture material on tumour cell adherence at 
sites of colonic injury. Br J Surg 1993; 80: 774-776. 
10 Sugarbaker PH. A perspective on clinical research strategies in carcinoma of the large bowel. 
World J Surg 1991; 15: 609-616. 
11. Galandiuk S, Wienand HS, Moertel CG, Cha SS, Fitzgibbons RJ Jr, Pemberton JH, Wolff BG. 
Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg 
Gynecol Obstet 1992; 174: 27-32. 
12. Umpleby HC, Fermor B, Symes MO, Williamson RCN. Viability of exfoliated colorectal carcinoma 
cells. Br J Surg 1984; 71: 659-663. 
13. Fermor B, Umpleby HC, Lever JV, Symes MO, Williamson RCN. Proliferative and metastatic 
potential of exfoliated colorectal cancer cells. J Nat! Cancer 1986; 76: 347-349. 
14. Fisher B, Fisher ER, Fedustea N. Trauma and localisation of the tumour cells. Cancer 1967; 20: 
23-30. 
15. Eggermont AMM, Steller EP, Sugarbaker PH. Laparotomy enhances intra-peritoneal tumour 
growth and abrogates the anti-tumour effects interleukin-2 and lymphokine-activated killer cells. 
Surgery 1987; 102: 71-78. 
16. Tol van den MP, Stijn I, Bonthuis F, Marquet RC, Jeekel J. Reduction of intra-peritoneal adhesion 
formation by use of nonabrasive gauze. Br J Surg 1997; 84: 1410-1415. 
17. Marquet RL, Westbroek DL, Jeekel J. Interferon treatment of a transplantable colon 
adenocarcinoma, importance of tumour site. lnt J Cancer 1984; 33: 688-692. 
80 
18. Steller EP, Ottow RT, Eggermont AMM, Marquet RL, Sugarbaker PH. Local conditions in the 
host influence immunotherapy with interleukin-2 and LAK cells. Cancer Detect. Prev. 1988; 
12: 81-90. 
19. Weese JL, Ottery FD, Emoto SE. Do operations facilitate tumour growth? An experimental model 
in rats. Surgery 1986; 100:273-277. 
20. Ratajczak HV, Lange RW, Sothern RB, Hagen KL, Vescei P, Wu J, Halberg F, Thomas PT. 
Surgical influence on murine immunity and tumour growth: relationship of body temperature and 
hormones with splenocytes. Proc Soc Exp Bioi Med 1992; 199: 432-440. 
21. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusion and 
prognosis in colorectal cancer. N Eng! J Med 1993; 328: 1372-1376. 
22. Bouvy NO, Marquet RL, Hamming JF, Jeekel J, Bonjer HJ. Laparoscopic surgery in the rat 
beneficial effect on body weight and tumour take. Surg Endosc 1996; 10: 490-494. 
23. Murthy SM, Goldschmidt RA, Rao LN, Ammirati M, Buchmann T, Scanlon EF. The influence of 
surgical trauma on experimental metastasis. Cancer 1989; 64: 2035-2044. 
24. Lee JY, Murphy SM, Scanlon EF. Effect of trauma on implantation of metastatic tumour in bone in 
mice. J Surg Onco/1994; 56: 178-184. 
25. Jong de KP, Lont HE, Bijma AM, Brouwers MAM, Vries de EGE, Veen van ML, Marquet RL, 
Slooff MJH, Terpstra OT. The effect of partial hepatectomy on tumour growth in rats: In vivo and in 
vitro studies. Hepatology 1995; 22: 1263-1272. 
26. Slooter GO, Marquet RL, Jeekel J, IJzermans JNM. Tumour growth stimulation after partial 
hepatectomy can be reduced by treatment with tumour necrosis factor a. Br J Surg 1995; 82: 129-
132. 
27. Gutman M, Sing RK, Price JE, Fan D, Fidler IJ. Accelerated growth of human colon cancer cells 
in nude mice undergoing liver regeneration. Invasion Metastasis 1994-1995; 14: 362-371. 
81 

Chapter VI 
Glove Powder Promotes Adhesion Formation and 
Facilitates Intra-Peritoneal Tumour Cell Adhesion 
and Growth 
Adapted from the original publication in the British Journal of Surgery 2001; 88: 1258-1263 
The presence of foreign material in the abdominal cavity during surgery irritates the 
peritoneal surface leading to an inflammatory reaction of the peritoneum. This defensive 
mechanism can provoke adhesion formation. The same peritoneal defence cascade is 
thought to play a role in the process of intra-abdominal tumour recurrence. The aim of this 
study was to evaluate whether the adhesion provoking effect of glove powder could be 
reproduced in our rat adhesion model and to evaluate whether glove powder also promotes 
intra-abdominal tumour recurrence in our rat tumour cell adhesion and growth model. 
Reproducible rat models allowing semiquantitative scoring of adhesion formation and tumour 
load were used to observe adhesion formation and tumour recurrence in three different 
groups of rats. One group was treated by intra-abdominal application of powder obtained 
from starch-powdered gloves, one by application of pure starch and in one group no 
application of powder took place. 
Local application of glove powder or pure starch on minimally and severely traumatised 
peritoneum gave rise to a, comparable, significantly higher percentage of adhesion formation 
than infliction of peritoneal trauma alone (p < 0.0001). Peritoneal application of glove powder 
or pure starch induced significantly more intra-abdominal tumour load than when no powder 
was applied (p s-0.002) 
Starch induced peritoneal trauma not only leads to more adhesion formation but also to 
increased adhesion and growth of free intra-abdominal tumour cells. This finding adds to the 
already existing evidence that intra-abdominal contamination with starch from starch 
powdered gloves should be avoided. Since good powder-free alternatives are available there 
is no longer any justification for the use of powdered gloves during intra-abdominal surgery 
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INTRODUCTION 
Postoperative adhesions are abnormal unions between peritoneal surfaces which occur after 
almost every intra-abdominal surgical intervention and can lead to a number of 
complications. A variety of therapeutic modalities to reduce postoperative adhesion formation 
has been studied but clinical useful therapy is currently not available. The sole available 
strategy to reduce postoperative adhesions is prevention by limiting peroperative trauma of 
the peritoneum. Over a period of 45 years, several studies have shown that exposure of 
peritoneum to starch powder present on surgical gloves leads to an inflammatory response 
of the peritoneum and contributes to adhesion formation. 1-6 Exposure of already injured 
peritoneal surfaces to starch enhances the intensity of the peritoneal reaction and gives rise 
to more and stronger adhesions than peritoneal trauma or starch alone.7 ' 8 In previously 
described rat studies we showed that surgical trauma of the peritoneum promotes adhesion 
formation and that the intensity of inflicted trauma correlates with the extent of adhesion 
formation. 9 One aim of the present study was to evaluate whether the experimentally and 
clinically observed effect of glove powder on peritoneal adhesion formation could be 
reproduced in our rat adhesion model and to differentiate whether starch powder alone or 
also other glove contents are responsible for peritoneal damage and subsequent adhesions. 
Following potentially curative resection of gastro-intestinal carcinoma, local recurrence and 
peritoneal dissemination are common in tumour recurrence. 10 Distribution patterns of first 
peritoneal recurrence show that the resection site is preferential, and combined recurrence 
on peritoneal surfaces and resection site is common. 11 Early preoperative tumour cell 
seeding and peroperative shedding of tumour cells, due to handling the tumour and leakage 
from dissected lymphatic channels, are the most likely causes of tumour recurrence. 11 The 
tumour cell entrapment theory proposes that the fibrinous exudate, formed as an initial 
response to surgical trauma of the peritoneum, facilitates implantation of cancer cells onto 
raw tissue. 11 The dynamic cascade of peritoneal healing, induced by peritoneal damage, 
leading to adhesion formation also seems to be important in the process of intra-peritoneal 
adhesion and growth of tumour cells. Indeed, previously described clinical and experimental 
studies showed that surgical trauma may promote intra-abdominal tumour recurrence. 12"14 
The degree of inflicted trauma correlated with the extent of intra-abdominal tumour !oad. 14 
The secondary aim of this study was, therefore, to analyse whether the traumatic effect of 
glove powder on peritoneum also promotes intra-abdominal tumour recurrence. 
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MATERIALS AND METHODS 
Animals 
Female inbred WAG rats of reproductive age weighing 120-160 g were obtained from 
Harlan-CPS, Austerlitz, The Netherlands. They were bred under specific pathogen-free 
conditions, kept under standard laboratory conditions (temperature 20-24 oc, relative humidity 
50-60%, 12 hours light and 12 hours dark cycles) and fed with standard rat food and water 
ad libitum. The experimental protocol adhered to rules laid down by the Dutch Animal 
Experimentation Act and was approved by the Committee on Animal Research of the 
Erasmus University Rotterdam, The Netherlands. 
Surgical gloves; isolation of glove powder 
Starch-powdered gloves (Baxter, Utrecht, The Netherlands) were cut into pieces of 1 x 1cm. 
The glove parts were washed in phosphate buffered saline (PBS) by gentle stirring during 24 
hours. Subsequently the suspension was filtered over a stericup filter with a pore size of 0.22 
~m (Millipore, Ettenleur, The Netherlands). The particles left behind on the filter were 
centrifuged (2500 rpm, 10 minutes). The supernatant was removed and the pellets were left 
to dry under sterile conditions for 24 hours. The obtained powder was used for further 
experiments. 
Pure starch 
It might be possible that enforcing the described process of isolating powder from starch 
powdered gloves accidentally extricated other glove contents. To investigate whether starch 
alone or in combination with other glove contents were responsible for any effects on 
adhesion formation and tumour cell adhesion and growth all experiments were also 
performed with pure starch obtained from Regent Hospital Products, London, UK. 
Three mg of glove powder or pure starch was used in subsequent experiments. This dose is 
large compared to the amount of glove powder that might be left in the peritoneal cavity 
during laparotomy in humans. However laparotomy in humans lasts longer than in rats so 
glove powder will obviously irritate the peritoneum for a longer period. 
Tumour 
Tumour CC531 is a moderately differentiated, weakly immunogenic colonic adenocarcinoma 
induced in WAG rats by 1 ,2-dimethylhydrazine.15 It is transplantable in syngeneic WAG rats. 
The tumour is maintained as a cell culture in RPMI 1640 medium supplemented with 5% 
foetal calf serum (virus- and Mycoplasma-screened), 1% penicillin (5000 U/ml), 1% 
streptomycin (5000 U/ml) and 1% L-glutamin (200 mM). Medium and all supplements were 
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obtained from Life Technologicals BV, Breda, The Netherlands. Cells were passaged once a 
week using trypsin (0.05%) and EDTA (0.02%). Before use in vivo tumour cells were 
harvested from stationary cultures by gentle trypsinisation (5 minutes, 3T'C), centrifugation 
(5 minutes, 700 g) and re-suspension in RPM! 1640, providing cell suspensions with a 
viability greater than 95%. CC531 is relatively insensitive to chemotherapy but is sensitive to 
the effects of biologic response modifiers. 
Operative procedures 
To study the effect of starch-powdered glove particles on adhesion formation in rats our 
previously described reproduc·lble rat adhesion model was used? Briefly, under ether 
anaesthesia and aseptic conditions a laparotomy was pertormed using a lower midline 
incision of 5 em. Three Surgilene 5-0 sutures (Braun, Melsungen, Germany) were applied to 
both lateral peritoneal sides 0.7 em apart and 1.5 em away from the abdominal incision. All 
knots were double, fastened tightly to ensure local ischaemia. Both uterus horns were 
exposed, not handled and sutured to the lateral peritoneum with Surgilene 6-0 (Braun) 
proximally and distally from the three 5-0 sutures. In this way a standardised amount of 
minimal peritoneal trauma was inflicted. Standardised severe peritoneal trauma was inflicted 
by additively rubbing the exposed uterus horns with severely traumatising surgical Medipres 
gauze (van Heek Medical, Lasser, The Netherlands) before suturing them to the lateral 
abdominal wall. Rubbing was pertormed with a device that enabled the application of a 
constant pressure of 120 g/cm2 . The uterus horns were rubbed 10 times over their total 
length. 
Minimally and severely traumatised peritoneal sides were (further) treated locally by 
application of 3 mg of powder obtained from the starch-powdered gloves, by application of 3 
mg of pure starch (Regent Hospital Products) or were not exposed to any kind of powder at 
all. The abdomen was closed in two layers with 5-0 polyglycolic acid and 2-0 silk sutures 
(Braun). 
To study the effect of glove powder and pure starch on local tumour recurrence our 
previously designed reproducible tumour adhesion and growth model was used.14 Under 
ether anaesthesia and aseptic conditions a laparotomy was pertormed using a lower midline 
incision of 5 em. Both uterus horns were exposed and sutured to the lateral peritoneum both 
proximally and distally, using Surgilene 6-0 sutures. Peritoneum of the uterus horn and 
lateral abdominal wall side was treated locally by application of 3 mg of glove powder, by 
application of 3 mg of pure starch or was not exposed to any kind of powder at all. The 
abdomen was closed in two layers with Dexon 5-0 and 2-0 silk sutures. 
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Experimental design 
Adhesion formation after infliction of minimal peritoneal trauma and additive 
application of glove powder or starch 
In 20 rats standardised minimal peritoneal trauma was inflicted to both lateral peritoneal 
sides by applying the three sutures and fixating the uterus horns to the lateral peritoneum. In 
10 rats (group I) glove powder was applied on one uterus horn while the other uterus horn 
was not exposed. In the other 10 rats (group II) pure starch was applied on one uterus horn 
while the other one was not exposed. 
Adhesion formation after infliction of severe peritoneal trauma and additive 
application of glove powder or starch 
In 19 rats standardised severe peritoneal trauma was inflicted to both lateral peritoneal sides 
by means of the three sutures in the lateral peritoneum and rubbing of the uterus horns. In 9 
rats (group Ill) glove powder and in 10 rats (group IV) pure starch was applied on one uterus 
horn while in both groups the other uterus horn was not exposed to powder or starch. 
Effect of glove powder and starch on intra~peritoneal tumour cell adhesion and growth 
Nine rats (group V) underwent an operation during which both uterus horns were exposed 
and sutured to the lateral peritoneum. No powder was applied. Before closing the abdomen, 
0.5 x 106 CC531 tumour cells, in 1 ml RPMI 1640, were injected intra-peritoneally (0.5 ml 
along the left and 0.5 ml along the right abdominal wall). Nine rats (group VI) underwent the 
same operative procedure with the additional application of 3 mg of glove powder on each 
uterus horn. Nine rats (group VII) underwent the same procedure during which 3 mg of pure 
starch was applied on both uterus horns. 
Evaluation of adhesion formation 
Fourteen days after laparotomy the rats were sacrificed for assessment of intra-abdominal 
adhesion formation. Macroscopically the adhesions were scored according to their extent 
(quantity) and type (quality) by two independent observers. The extent of adhesion formation 
was quantified by dividing the area to be scored into eight by means of the three 5-0 sutures 
in the lateral peritoneum (Figure 3.3, Chapter 3). The presence or absence of adhesions in 
the eight demarcated areas was scored. Adhesions in an area accounted for 12.5% 
adhesions; thus a maximum of 100% adhesions could be scored. In each rat two lateral 
peritoneal sides were assessed. The type of adhesions formed was classified 
macroscopically using the Zuhlke classification (Table 3.1, Chapter 3). 16 
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Evaluation of intra-peritoneal tumour cell adhesion and growth 
Twenty-one days after surgery all rats were sacrificed and intra-peritoneal tumour load was 
scored semiquantitatively at the following sites: right uterus horn, left uterus horn, 
subcutaneously (at the site of the operative scar), parietal peritoneum (at the lateral abdominal 
wall sides where no uterus horns were fixed), kidney, liver, retroperitoneum and omentum. The 
scoring was performed by two independent observers and ranged from 0 to 5 per site (Table 
6.1 ). For each rat the score at peritoneal sites, except for the uterus horns, was added and 
averaged, from which a mean total tumour load per rat could be estimated. In the present 
study the term tumour recurrence is used to illustrate tumour load, which is the assumed net 
result of tumour cell adhesion and tumour growth, because we presume intra-peritoneal 
injecting of tumour cells resembles the clinical situation of tumour cell spill during tumour 
resection. 
Score Characteristics 
0 No tumour growth 
Estimated tumour diameter of less than 0.5 em 
2 Estimated tumour diameter between 0.5 and 1 em 
3 Estimated tumour diameter between 1 and 2 em 
4 Estimated tumour diameter between 2 and 3 em 
5 Estimated tumour diameter more than 3 em 
Table 6.1 
Tumour scoring system derived from the peritoneal cancer index described by Steller. 17 
Statistical analysis 
The mean adhesion percentage and standard deviation was calculated per group. Statistical 
analysis was performed with a t test for paired samples where dependent samples were 
concerned and an unpaired Student's ttest where independent samples were concerned. 
The median and range of intra-peritoneal tumour load at each site and of the total tumour 
load were calculated per group. Statistical analysis was performed using the non-parametric 
Kruskall Wallis test to determine overall differences followed by the non-parametric Mann-
Whitney U test to compare differences between groups. Statistical significance was defined 
asp< 0.05. 
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RESULTS 
None of the rats were found to have adhesions at the initial operation. There were no 
postoperative complications e.g. bowel obstructions, peritonitis or tumour overgrowth. 
Adhesion formation after infliction of minimal peritoneal trauma and additive 
application of glove powder or starch 
Table 6.2 shows that application of glove powder, after minimal peritoneal trauma, led to 
significantly more adhesion formation than minimal peritoneal trauma alone (p < 0.0001 ). 
Local application of pure starch also induced a significantly higher mean adhesion 
percentage than minimal peritoneal trauma alone (p < 0.0001 ). The mean adhesion 
percentage found in the glove powder group did not differ significantly from that of the pure 
starch group (p = 0.112). Adhesions formed after minimal peritoneal trauma were filmy 
(Zuhlke type 1-2) involving only pelvic fat. Adhesions found after local application of glove 
powder or pure starch were stronger (ZUhlke type 2-3) and involved pelvic fat, uterus horn 
and small bowel. 
Adhesion formation after infliction of severe peritoneal trauma and additive 
application of glove powder or starch 
Table 6.3 shows that local application of powder obtained from starch-powdered gloves or 
pure starch induced additional adhesion formation, even in the presence of severe trauma to 
the peritoneal surface. Both gave rise to a significantly higher mean adhesion percentage 
than severe peritoneal trauma alone (p < 0.0001 ). As in the previous experiment there was 
no significant difference in the adhesion inducing capacity of glove powder and pure starch 
(P = 0.47). Adhesions found after Medipres rubbing of the uterus horn were dense and thick 
(ZUhlke type 2-3} while application of glove powder or pure starch on severely traumatised 
peritoneum lead to even stronger adhesions (Zuhlke type 3). 
Effect of glove powder and starch on intraNperitoneal tumour cell adhesion and growth 
Table 6.4 summarises results observed at peritoneal sites where glove powder or pure 
starch were applied (uterus horns) in comparison to controls. Glove powder as well as pure 
starch evoked a significant increase in tumour load at the uterus horns (p < 0.0001 ). 
Application of glove powder or pure starch gave rise to similar results (p = 0.395}. 
The median total peritoneal tumour load in rats treated with glove powder or pure starch, 
measured at peritoneal sites other than the uterus horns, differed significantly from the 
median total peritoneal tumour load in controls (Table 6.5, p = 0.002 and p = 0.001 
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respectively). These differences were mainly due to differences at the site of the subcutis 
and the omentum. Again treatment with glove powder or pure starch did not induce a 
significant different extent of total tumour load (p = 0.588). 
Uterus horns n Percentage adhesion Zuhlke p1 p2 p3 
formation (SD) score 
1'. No powder 10 33 (10.5) 1-2 
lb. Glove powder 10 84 (13.3) 2-3 <0.0001 
II'. No starch 10 35 (9.9) 1-2 
lib Pure starch 10 81 (8.8) 2-3 <0.0001 ns 
Table 6.2 
Mean adhesion percentage (SO), and ZUhlke classification of found adhesions, after inflicting 
minimal peritoneal trauma alone and after application of glove powder or pure starch 
following the infliction of minimal peritoneal trauma. N is the number of defected peritoneal 
sites (uterus horns) assessed. Statistics p1 (I' versus lb ) and p2 (II' versus lib): t test for 
paired samples. Statistics p3: unpaired Student's t test (lb versus lib). 
Uterus horns n Percentage adhesion Zuhlke p1 p2 p3 
formation (SD) score 
lila. Medipres rubbing 9 72 (10.4) 2-3 
Ill b. Medipres rubbing 9 97 (5.5) 3 <0.0001 
& Glove powder 
IVa_ Medipres rubbing 10 71 (10.3) 2 
IVb Medipres rubbing 10 96 (6.08) 3 <0.0001 ns 
& Pure starch 
' 
Table 6.3 
Mean adhesion percentage (SO), and ZUhlke classification of found adhesions, after inflicting 
severe peritoneal trauma alone and after application of glove powder or pure starch following 
the infliction of severe peritoneal trauma. N is the number of defected peritoneal sites (uterus 
horns) assessed. Statistics p1 (Ill' versus lllb) and p2 (IV' versus IVb): t test for paired 
samples. Statistics p3: unpaired Student's t test (lllb versus IVb ). 
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Uterus horns n Median tumour load (range) p1 p2 p3 
V. No powder 9 0 (0-1) <0.0001 
VI. Glove powder 9 4 (3-5) ns 
VII. Pure starch 9 4 (3-5) <0.0001 
Table 6.4 
Median tumour load (range) at uterus horns which were only fixed to the lateral peritoneum 
(group V), at uterus horns which were treated with glove powder after fixation (group VI) and 
at uterus horns treated with pure starch after fixation (group VII). For each rat, the individual 
data concerning the 2 uterus horn sites were averaged; n is the number of data (= rats) per 
group used for analysis. Statistics p1 (V versus VI), p2 (VI versus VII) and p3 (V versus VII): 
Kruskall Wallis test with Mann-Whitney U post hoc test. 
Abdominal sites Tumour load Tumour load Tumour load p1 p2 p3 
V. No powder VI. Glove powder VII. Pure starch 
n=9 n=9 n=9 
Subcutis 1 (0-1) 1 (1-4) 1 (1-3) 0.006 ns 0.006 
Parietal peritoneum 1 (0-1) 1 (0-2) 1 (0-2) ns ns 0.039 
Kidney 1 (0-2) 1 (1-2) 1 (0-2) ns ns ns 
Liver 0 (0-2) 1 (0-2) 1 (0-2) ns ns ns 
Retroperitoneum 1 (0-3) 1 (1-2) 1 (1-3) ns ns ns 
Omentum 1 (0-2) 2 (1-4) 2 (1-3) 0.037 ns 0.037 
Total 0.8 (0-2) 1.3 (1-2) 1.3(1-2) 0.002 ns 0~ 
Table 6.5 
Median tumour load (range) at different peritoneal sites in rats having undergone a 
laparotomy followed by fixation of the uterus only (group V), or laparotomy followed by 
fixation of the uterus horn and additive application of glove powder (group VI) or pure starch 
(group VII). N is number of treated rats. Statistics p1 (V versus VI), p2 (VI versus VII) and p3 
(V versus VII): Kruskall Wallis test with Mann-Whitney U post hoc test. 
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DISCUSSION 
Since the introduction of surgical gloves in 1896, several components and additives have 
been used in the glove industry to facilitate manufacturing and to Jessen the hazards 
associated with glove use.4 Modern gloves are made of two main components: rubber and 
glove lubricants. Glove lubricants have been associated with a number of iatrogenic 
problems in surgical patients. 4 Especially starch powder in surgical gloves can lead to 
serious complications such as granulomatous peritonitis, adhesion formation and infection 
potentiation. 18 These conditions themselves give rise to serious, sometimes even lethal, 
complications such as intestinal obstruction, infertility, chronic pelvic pain, complicated and 
technically difficult re-operations. The exact pathogenic mechanisms behind the undesirable 
reactions to starch granules are not clear and may be diverse. 19 A possible (host defence) 
cascade by which starch increases the propensity of tissues to form adhesions starts with 
irritation of the peritoneum by starch particles which leads to reduced fibrinolysis and 
activation of neutrophils and marophages.20· 21 Activated macrophages produce oxygen free 
radicals, prostaglandin E2 , thromboxane 82 , and various cytokines which are part of the 
fibrotic processY Our rat adhesion model previously showed that the degree of peritoneal 
trauma correlated with the extent of adhesion formation. 9 In the currently described 
experiments using the same rat model powder obtained from starch-powdered gloves as well 
as pure starch significantly increased adhesion formation. There was no difference in the 
adhesion inducing capacity of glove powder or pure starch. These results fortify the 
hypothesis that starch is the main component of powdered gloves that provokes adhesion 
formation due to a traumatising effect on the peritoneum. 
We previously suggested that the peritoneal defence mechanism triggered by surgical 
trauma to the peritoneum not only promotes adhesion formation but also stimulates tumour 
recurrence. 14 Several theories speculate on the underlying mechanisms of the adhesion and 
growth of spilled tumour cells. According to the theory of metastatic efficiency, implantation of 
tumour cells onto raw tissue surfaces is an efficient process as opposed to inefficient 
implantation on intact surfaces. 11 The fibrin entrapment hypothesis proposes that tumour 
cells are trapped in fibrin at the resection site and abraded peritoneal surfaces, hereby 
providing protection from host defence mechanisms.22 In peritoneal wound healing 
inflammatory and mesothelial cells produce an abundance of cytokines and growth factors 
which might also be beneficial for tumour cell adhesion and tumour growth. 23"25 Indeed a 
significant correlation between the intensity of surgical trauma to the peritoneum and the 
degree of tumour recurrence could be demonstrated in a rat tumour adhesion and growth 
model.14 In the current experiments, using the same experimental model, the traumatising 
effect of glove powder and pure starch promoted adhesion and growth of free intra-
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abdominal tumour cells. The most impressive tumour load was found at directly traumatised 
peritoneal sites (sites on which glove powder or starch was applied). However the tumour 
cell adhesion and growth promoting effects of glove powder and starch were not confined to 
the traumatised sites, as tumour load also was significantly higher at remote peritoneal sites. 
Despite the evidence in support of starch induced complications, a considerable number of 
general surgeons continues to wear starch powdered gloves.26 It has been shown that 
careful washing of powdered gloves with saline fails to remove all the starch and even results 
in clumping of the residual starch granules.7 Cleansing with povidone-iodine and sterile water 
did reduce the amount of starch particles, 27 but our previous study in rats showed that 
povidone-iodine itself induces adhesion formation.28 This study shows that starch induced 
peritoneal trauma not only leads to adhesion formation but also to adhesion and growth of 
free intra-abdominally tumour cells. Providing substantial reason to avoid peroperative intra-
abdominal contamination with starch from powdered gloves. Since good powder-free 
alternatives are available there is no longer any justification for the use of powdered gloves 
during intra-abdominal surgery. 
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PART IV 
Pathways of Adhesion Formation and Intra-
Abdominal Tumour Recurrence after Surgical 
Peritoneal Trauma; Possible Methods for Prevention 

Chapter VII 
The Inflammatory Sequelae of Surgery Provoke 
Enhanced Tumour Recurrence; a Crucial Role for 
Neutrophils and Cytokines 
Submitted for publication 
After potentially curat;ve resection of colorectal carcinoma, the most common site for recurrence 
is loco-regional. In rat studies we previously demonstrated that surgical peritoneal trauma is an 
important factor in the promotion of local tumour recurrence and that within a few hours after 
peritoneal trauma, surgical related factors in the abdominal cavity could be captivated in a 
lavage fluid and enhance tumour recurrence in naive recipients. The objective of this study was 
to evaluate the role of different individual inflammatory mediators, produced after abdominal 
surgery and captivated in a lavage fluid, in loco-regional tumour recurrence. 
Using our reproducible rat model post trauma lavage fluid was collected and separated in a 
cellular and supernatant component, the latter containing soluble factors. Tumour recurrence 
was determined after injection of naive recipients with either component of the lavage fluid. The 
effect of soluble factors in the lavage fluid on tumour cell adhesion to a mesothelial monolayer 
was investigated in an in vitro model. In an additional experiment, different intensities of surgical 
peritoneal trauma were inflicted to identify the cell compilation in the traumatised abdominal 
cavity. Cytokine and growth factors concentrations were determined in the supernatant. 
Intra-peritoneal injection of naive recipients with both components of the post trauma collected 
lavage fluid resulted in statistically significant more tumour recurrence than injection with RPM/ 
(p <; 0.01). The cellular component produced the highest tumour load. In vitro tumour cell 
adhesion to the mesothelium was not affected by soluble factors in the lavage fluid Analysis of 
the lavage fluid, gathered after minimal or severe peritoneal trauma, demonstrated a significant 
influx of neutrophils (PMN) after infliction of severe peritoneal trauma (p < 0.0001). The acute 
phase cytokines IL-1{3, IL-6 and TNF-a were present irrespective of trauma-intensity. Statistically 
significant more IGF-1 was detected in the lavage fluids of severely traumatised rats (p < 
0.0001). 
It seems in vivo tumour recurrence is mainly promoted by the cellular component of the post-
surgical inflammatory process. Cytokines also enhance in vivo recurrence, but play an inferior 
role. IGF-1 may facilitate the growth of lodged tumour cells. 
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INTRODUCTION 
Surgical treatment of gastro-intestinal malignancies is often complicated by loco-regional 
recurrence. 1 Regardless of this detrimental adversity, surgery remains the best treatment option. 
In a clinical trial, Busch et al put forward an association between recurrent disease and the 
extent of surgical injury.2 In experimental models, post-surgically produced factors have been 
shown to augment local and remote tumour growth. Experimental and clinical studies have 
demonstrated that enhanced tumour cell adherence and tumour growth are inevitable 
repercussions of surgical trauma. 1· H We previously demonstrated that within a few hours after 
infliction of peritoneal trauma, surgically related factors in the abdominal cavity could be 
captivated in a lavage fluid and enhance tumour recurrence in naive, non-operated recipients.7 
Surgery is an inflammatory stimulus that activates the body's immune response. The ensuing 
inftux of polymorph nuclear leukocytes (PMN) and mononuclear cells to the surgically 
traumatised site is mediated through chemotactic factors like IL-8 (CINC in rats) and pro-
infllammatory cytokines such as ll-1 13 or TN F-a and is the first line of defence. a-.-10 
Insights in the host defence mechanisms of the peritoneum have demonstrated that peritoneal 
lymphocytes, sub-mesothelial monocytes, PMN and mesothelial cells act in an orchestrated 
response under the control of locally expressed cytokines, chemokines and adhesion molecules. 
The peritoneal membrane and the mesothelium in particular, as a site for the production of 
mediators, play a pivotal role in the activation and control of inflammation.11 ' 12 
Inflammatory products produced after abdominal surgery might participate directly or indirectly in 
effective tumour recurrence. In this study, we focus our attention on the individual capacity of 
the, by peritoneal trauma released, inflammatory peritoneal cells and soluble factors to ascertain 
which element is responsible for enhanced tumour recurrence. In an experimental model post 
surgically produced tumour enhancing factors are captivated in a lavage fluid, and passively 
transferred to naive recipients. The in vivo and in vitro studies presented in this paper investigate 
a possible correlation between the inflammatory cells and the cell free soluble factors present in 
the abdominal cavity after surgical trauma and postoperative tumour cell adhesion and growth. 
MATERIALS AND METHODS 
Animals 
Female inbred rats of the WAG strain, weighing 155-200 g, were obtained from Harlan-CPB, 
Zeist, The Netherlands. The rats were bred under specific pathogen-free conditions, kept under 
standard laboratory conditions (temperature 20-24'C, relative humidity 50-60%, 12 hours light/ 
12 hours dark) and fed with laboratory diet and water ad libitum. The experimental protocol 
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adhered to rules laid down by the Dutch Animal Experimentation Act and was approved by the 
Committee on Animal Research of Erasmus University, Rotterdam, The Netherlands. 
Tumour 
Tumour CC531 is a moderately differentiated, weakly immunogenic colonic adenocarcinoma 
induced in the WAG/Rij rat by 1 ,2-dimethylhydrazine. It is transplantable in syngeneic WAG rats. 
A cell line was established from this carcinoma and maintained by serial passage after 
trypsinization in culture medium. 13 CC531 tumour cells were cultured in RPMI 1640 medium 
supplemented with 5% foetal calf serum (virus- and Mycoplasma-screened), L-glutamin (2 mM) 
and penicillin (105 U/L). Medium and all supplements were obtained from Life Technologicals 
BV, Breda, The Netherlands. Cells were passaged once a week using trypsin (0.05%) and 
EDTA (0.02%). Viability was measured by trypan blue exclusion and always exceeded 90%. 
Mesothelial cell culture 
Mesothelial cells (MC) were isolated from the small bowel mesentery of rats as described 
before-" Mesothelial monolayers were established in 96 well plates (Greiner, The Netherlands) 
precoated with collagen type I (15 ~em', Boehringer Mannheim, Mannheim, Germany). The 
plates were incubated at 3rC, in a humidified atmosphere of 5% C02 in air. Medium consisted 
of RPMI enriched with 10% FCS, glutamin (2 mM), penicillin (105 U/L) and fungizone (1.25 
mg/L) and was replaced daily with fresh medium. Monolayers reached confluence in 2 days as 
determined by microscopic evaluation. 
Tumour cell labelling 
The dye solution, calcein-AM, used to quantify tumour cell adhesion was prepared by dissolving 
50 ~g calcein (Molecular Probes, Leiden, The Netherlands) in 5 ftl anhydrous dimethyl 
sulphoxide and adding this solution to 5 ml of RPMI medium supplemented with 0.5% bovine 
serum albumin (RPMI/0.5%BSA). Trypsinized CC531 cells (1 x 106 cells/ml) were incubated in 
this solution at 37°C for 45 minutes with occasional mixing. Before adding to the mesothelial 
monolayers, the labelled cells were washed twice with RPMI/0.5%BSA to remove free dye. 
Operative procedures 
Under ether anaesthesia, of 14 rats the abdomen was shaved and cleansed with alcohol 70%. 
Laparotomy was performed using a lower midline incision of 5 em; exposure and rubbing of both 
uterus hams and a 5 em long part of the smal~ intestine with surgical Medipres gauze inflicted 
subsequent trauma to the peritoneum. Rubbing was performed with a device enabling the 
application of a constant pressure of 120 gr/cm2 .7 The uterus hom was rubbed 10 times over its 
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total length. In this way a standardised amount of peritoneal trauma can be inflicted. The 
abdomen was closed in one layer with silk 2-0 sutures (Braun, Melsungen AG, Germany). After 
5 hours a second laparotomy was performed during which the abdominal cavity was lavaged 
with 5 ml RPMI 1640 medium. After massaging the abdomen the remaining fluid was aspired, 
pooled and kept on ice until further processing. 
Experimental design 
Effect of inflammatory cells and cell free soluble factors on intra-peritoneal tumour cell 
adhesion and growth; in vivo experiment 
The collected post trauma lavage fluid was centrifuged, the cell pellet re-suspended to original 
volume with RPM I and thus divided into a "cellular'' component containing the different cell types 
present in the abdominal cavity after surgical trauma and a "supernatant" containing soluble 
components produced after surgical peritoneal trauma. 
Subsequently 24 rats were divided into three groups. Group I served as a control group 
receiving RPMI 1640 medium. Group II was acceptor for the cellular component of the post 
trauma lavage fluid and group Ill for the supernatant. Of all three components, 3 ml was injected 
intra-peritoneally together with 0.5 million CC531 cells (in 0.5 ml RPMI) without opening the 
abdominal cavity. In this way, the factors contained by the different components represented the 
mediators after surgical abdominal trauma, without inflicting additional trauma. 
Evaluation of intra peritoneal tumour cell adhesion and growth 
Tumour scoring took place three weeks after tumour injection. The rats were sacrificed and intra-
peritoneal tumour load was scored semiquantitatively at the following peritoneal sites: parietal 
peritoneum, kidney, liver, retroperitoneum, omentum and mesentery. The scoring was 
performed by two independent observers using a tumour scoring system derived from the 
peritoneal cancer index described by Steller and ranging from 0 to 5 per abdominal site 
(Table 6.1, Chapter 6). 15 For each rat the score at all peritoneal sites was summarised, from 
which a mean total tumour load per rat could be estimated. In the present study the term 
tumour recurrence is sometimes used to illustrate tumour load, which is the net result of 
tumour cell adhesion and tumour growth, because we presume that intra-peritoneal injecting 
of tumour cells resembles the clinical situation of tumour cell spill during tumour resection. 
Tumour cell adhesion assay; in vitro experiment 
To demonstrate an effect of surgery related soluble factors on tumour cell adhesion to the 
mesothelial cells of the peritoneum, a standardised tumour cell adhesion model was used.16 
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After confluence, overnight pre-incubation of the mesothelial monolayers took place with 200 ~I 
of the supernatant samples of lavage fluids collected directly after a midline laparotomy (minimal 
peritoneal trauma, n = 1 0), 5 hours after a midline laparotomy during which the peritoneum was 
traumatised by rubbing with surgical gauze (severe peritoneal trauma, n = 14) or RPMI 1640 
medium enriched with 10% FCS. Non pre-incubated monolayers in mesothelial cell culture 
medium served as standardised control. 
Medium was removed from the monolayers and 200 ~I RPMI/0.5%BSA containing 30,000 
calcein labelled tumour cells was added. Plates were centrifuged for 1 minute at 80 g on a 
Heraeus centrifuge and incubated for 1 hour at 3rC to allow cell adhesion. After this, the 
medium of each well was removed and washed twice with 200 J..ll RPMI/0.5%BSA. Fluorescence 
of adherent cells was measured on a Perkin Elmer plate reader using 485 excitation and 530 
emission filters. On each plate a standard curve was prepared by adding different numbers of 
labelled tumour cells to the wells. The amount of tumour cells adhered was determined by 
calibrating the measured fluorescence of the experimental wells on the standard. 
Cell differentiation and ELISA 
Lavage ftuid was collected directly after performing a midline laparotomy without handling of 
intra-abdominal structures (minimal peritoneal trauma, n = 1 0) and 5 hours after a midline 
laparotomy during which the peritoneum was traumatised by rubbing with surgical gauze (severe 
peritoneal trauma, n = 14). The collected lavage fluid samples were kept individually on ice and 
were separated in a cellular component and a supernatant. 
The cellular component was re-suspended in RPMI medium, total cell amount was determined 
and HE stained cytocentrifuge slides were made for cell differentiation. Under a light microscope 
at a magnification of 1 OOx, 100 cells were counted in duplicate and classified into granulocytes 
(eosinophils, neutrophils and mast cells) and lymphoid cells (mononuclear phagocytes and 
lymphocytes). Cell classification was done on duplicate slides. 
The supernatants were filtered over a low binding 0.45 ).lm filter and stored at -Booc for further 
analysis. The presence of the acute phase cytokines IL-1~, IL-6 and TNF-a in addition to the 
growth factor IGF-1 were determined by ELISA (Biomedical Diagnostics, Brugge, Belgium) and 
RIA (Biosource Europe, Fleurus, Belgium). 
Statistical analysis 
The median and range of intra-peritoneal tumour load at each site, of the total tumour load, of 
cell counts in lavage fluids and of different soluble factors in the supernatant of lavage fluids 
were calculated per group. Statistical analysis was performed using the non-parametric Kruskal-
Wallis analysis of variance to determine overall differences If the latter overall test indicated 
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significance, comparisons between groups were made using the Mann-Whitney U test. The 
mean and standard deviation of in vitro tumour cell adhesion was calculated per group. Data 
were statistically analysed using analysis of variance (ANOVA) to determine overall differences, 
followed by the Newman-Keuls post hoc test to compare between groups. Statistical significance 
was defined asp< 0.05. 
RESULTS 
Effect of inflammatory cells and cell free soluble factors on intra-peritoneal tumour cell 
adhesion and growth; in vivo experiment 
After intra-peritoneal injection of the lavage fluid samples collected after surgical trauma, diffuse 
peritoneal tumour load was found in all groups. However, injection with the cellular component of 
the lavage fluid resulted in the highest amount of recurrence. When compared to the control 
group (RPMI) both the cellular factors and the supernatant caused significantly enhanced 
tumour recurrence (p ;;;; 0.01 ). Injection of tumour cells with RPM I alone resulted in a total of 31% 
tumour load whereas injection with the cells or supernatant resulted in 79% and 67% total 
tumour load (Figure 7.1 ). 
Impressive differences in peritoneal tumour deposits were observed between the groups 
receiving the cellular part and the supernatant of the lavage fluid. When taking the tumour size 
into account an obvious shift towards larger tumours is evident in the first group. Whereas no 
tumours larger than 2 em were found in the control or supernatant injected group, 38% of the 
tumours in the cellular injected group were scored in this range (Figure 7.2). Table 7.1 shows the 
distribution of tumour deposits at the different peritoneal sites. Statistically significant differences 
in tumour load were scored in liver, retroperitoneum, omentum, and mesentery between 
supernatant and cellular fraction (p.; 0.01 ). 
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Figure 7.1 
Differences in median percentages of total peritoneal tumour load (range) after passive transfer 
of RPMI only, the cellular fraction or the supernatant of lavage fluid collected after infliction of 
severe peritoneal trauma. The percentage total tumour load was defined after scoring the 
presence or absence of a tumour irrespective of tumour size. P1 (I versus II) = 0.001, p2 (II 
versus Ill) = 0.003 and p3 (I versus Ill) = O.G1. Statistics: Kruskai-Wallis test, with a Mann-
Whitney U post-hoc test. 
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Figure 7.2 
Comparison of median percentages of different tumour sizes (range) after passive transfer of 
RPMI only, the cellular fraction or the supernatant of lavage fluid collected after infliction of 
severe peritoneal trauma. Open bars represent RPMI, cross-hatched bars the cellular fraction 
and the filled bars the supernatant fraction. Statistics: Kruskai-Wallis test, with a Mann-Whitney 
U post-hoc test. 
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1 Abdominal sites Tumour load Tumour load Tumour load p1 p2 p3 
I.RPMI II. Cells Ill. Supernatant 
n=8 n=S n=S 
Parietal peritoneum 0 (0-0) 0.0 (0-0) 0.0 (0-0) ns ns ns 
Kidney 0 (0-3) 2.5(0-4) 1.0 (0-2) ns ns ns 
Liver 1 (0-1) 4.0 (2-5) 2.5 (0-3) 0.001 0.01 0.01 
Retroperitoneum 0 (0-2) 3.5 (3-5) 2.5 (0-3) 0.000 0.007 0.007 
Omentum 0 (0-2) 4.5 (4-5) 3.0 (0-5) 0.000 0.005 0.004 
Mesentery 0 (0-2) 2.0 (1-3) 0.5 (0-2) 0.007 0.03 ns 
Total 0 0 (0-3) 3.0 (0-5) 1.0 (0-5) 0.001 0.003 0.01 
Table 7.1 
Median tumour load (range) at different abdominal sites in rats having been injected with RPM I 
medium (group 1), the cellular fraction of the lavage fluid (group II), or the supernatant of the 
lavage fluid (group Ill). N is the number of treated rats. The p-value 1 represents differences 
between groups I and II; p-value 2 represents differences between group II and Ill; p-value 3 
represents differences between groups I and Ill. Statistics: Kruskai-Wallis test, with a Mann-
Whitney U post-hoc test. 
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Figure 7.3 
Percentage tumour cell adhesion versus control after pre-incubation of mesothelial cells with 
supernatant of lavage fluids gathered after infliction of different intensities of surgical peritoneal 
trauma. Mean values (SO) are shown (n = 6 per fluid sample). There was no difference in cell 
adhesion between groups. Statistics: AN OVA test with Newman-Keuls post hoc test. 
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Tumour cell adhesion assay; in vitro experiment 
Figure 7.3 shows the percentage of tumour cell adhesion versus the standardised control of 
adhesion assay, consisting of mesothelial cell culture medium. Control cell adhesion consisted 
of 23% from the total amount of cells added (data not shown). RPM I did not affect tumour cell 
adhesion, nor did lavage fluid samples from both surgically traumatised groups. 
Effect of surgical trauma on peritoneal cell compilation 
There was no change in the total cell amount between minimally (laparotomy only) and severely 
(laparotomy and rubbing) traumatised rats (Figure 7.4). In the cell differentiation however, a 
significant reversal was seen regarding the ratio of granulocytes and lymphoid cells, with a 22-
78% ratio of granulocyte-lymphoid cells in the minimally traumatised group versus a 78-22% 
ration in the severely traumatised group (p < 0.0001) (Figure 7.5). The granulocyte component 
consisted for 99.5% out of PMN cells. 
Effect of surgical trauma on cytokine and growth factor production 
IL-1 13 was detected in 7 out of 14 lavage fluid samples of the severely traumatised rats ranging 
from 20-72 pg/ml and in 2 out of 10 of the minimally traumatised rats ranging from 37 to 69 
pg/ml. IL-6 was present in 13 samples of the severely traumatised (range 54-848 pg/ml) and all 
samples of the minimally traumatised group (range 72-1194 pg/ml), TNF-a in 2 and 5 samples of 
the minimally and severely traumatised rats (67 and 170 pg/ml and ranging from 35 to 110 
pg/ml) respectively. IGF-1 was present in all samples, however statistically significant more IGF-1 
was detected in lavage ftuid from the severely traumatised rats (p < 0.0001) (Figure 7.5). 
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Figure 7.4 
Differences in total cell amount in lavage fluids gathered from minimally and severely 
traumatised peritoneal cavities. Median and range are shown. Statistics: Mann-Whitney U test. 
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minimal trauma severe trauma 
Differentiation of cellular fraction of lavage fluids taken from minimally and severely traumatised 
abdominal cavities. Open bars represent the median percentage lymphoid cells and filled bars 
the median percentage granulocytes. There was a significant shift towards granulocyte ration 
after severe trauma from 22 to 78%, p = 0.0001. Statistics: Mann-Whitney U test. 
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Figure 7.6 
Median and range of IGF-1 concentration in the supernatant fraction of lavage fluids of differently 
traumatised rats. Statistically significant more IGF-1 was found in abdominal cavities of severely 
than in cavities of minimally traumatised rats, p < 0.0001. No IGF-1 was found in RPM I. Statistics: 
Kruskai-Wallis test, with a Mann-Whitney U post-hoc test. 
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DISCUSSION 
The success of surgical treatment in patients with gastro-intestinal cancer is often limited due to 
local recurrence or peritoneal carcinosis by peroperatively seeded tumour cells. 1 In this study, a 
cell seeding model was used to mimic the clinical situation of free intra-peritoneal tumour cells 
and associates the combination of cell adhesion and growth ultimately leading to manifest 
tumour recurrence. The presented results give evidence that the inflammatory sequelae of 
surgery enhance peritoneal tumour recurrence. In an experimental rat model, we previously 
demonstrated that components produced after surgical peritoneal trauma, which can be 
captivated in a lavage fluid collected from peritoneally traumatised abdominal cavities, could 
enhance tumour recurrence in naive recipients. 7 The current study demonstrates that separated 
components of lavage fluid collected after infliction of peritoneal trauma i.e. inflammatory cells 
and soluble factors, each lead to enhanced tumour recurrence. 
The cellular fraction however, led to the greatest tumour load manifested by large tumours. More 
detailed analysis of the cellular fraction revealed a trauma related influx of granulocytes i.e. PMN 
into the abdominal cavity. Similar shifts in cell differentiation have also been shown in other 
animal models following peritoneal trauma.9• 10' 17 The shift of primarily monocytes to PMN will 
evidently affect the homeostatic milieu of the peritoneum. PMN generate reactive oxygen 
metabolites and discharge contents of granular organelles into either phagocytic vacuoles or the 
local environment to ingest foreign particles or microorganisms. Both oxygen-dependent and 
oxygen-independent processes participate in the killing of bacteria and also in damage to host 
tissue.10' 18• 19 In vitro increased adhesion of activated PMN to a mesothelial monolayer has been 
shown to induce retraction, gap formation and detachment ending with substantial mesothelial 
cell injury.20 Mesothelial cell injury leads to exposure of underlying extra cellular matrix 
components. Experimental studies have demonstrated a preferential adhesion of tumour cells to 
these denuded areas.21 Effective inhibition of tissue injury by PMN has been achieved by 
blocking of cell adhesion molecules used to enter the inflamed tissue20· 22 and scavenging of 
reactive oxygen species. 23' 24 
A relation has been demonstrated between the extent of tissue trauma and tumour recurrence. 
In order to diminish tissue trauma and tumour recurrence, minimal invasive surgery is 
promoted.3• 7' 21 Diminished tumour recurrence after laparoscopic surgery as compared to 
conventional surgery has attributed to this phenomenon.3· 21 In addition, laparoscopic surgery 
appears to impact on the cellular components of the immune response less than laparotomy.5· 25 
Carbon dioxide pneumoperitoneum has been shown to impair peritoneal macrophage cytokine 
production (IL-1, TNT-a) and coincides with diminished neutrophil superoxide anion release and 
chemotaxis.26 
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In a peritonitis model, Pruimboom et al also showed a non-significant increase in cells in the 
peritoneal cavity. In the peritoneal cell compilation a pronounced increase of PMN was seen on 
the first day followed by an influx of macrophages from day 1 until seven days after induction of 
peritonitis. PMN produced inflammatory mediators, however the capacity of these cells was very 
low in comparison with peritoneal macrophages. 9' 10 In this study, the supernatant fraction of the 
lavage fluid, containing inflammatory factors produced after surgical trauma also enhanced 
tumour recurrence in vivo. In vitro, no difference was seen in the cell adhesion between lavage 
fluid taken from differently traumatised rats versus control. 
The presence of the acute phase cytokines IL-1~, IL-6 and TNF-a was detected in the ftuid 
although no significant differences in the concentration were observed between minimally and 
severely traumatised rats. IL -1 ~ and TN F-a have been shown to upregulate cell adhesion 
molecules on mesothelial cells, which are used by PMN for adhesion.20 In addition, cytokine 
activated mesothelial cells produce chemoattractant cytokines such as IL-8 (CINC in rats), 
required for PMN recruitment. 12' 27 In this way, the mesothelium and inflammatory cells in the 
abdominal cavity may perpetuate a cytokine loop, resulting in extreme activation of the 
inflammatory process. However, when omitting inflammatory cells, as done in vitro, the sole 
effect of cytokines present in the peritoneal fluid does not affect cell adhesion. The in vivo effect 
may therefore be direct, based on the additional trauma inflicted by inflammatory cells. High 
concentrations of IL-1 f) and TN F-a have been demonstrated to upregulate adhesion molecule 
expression and therefore enhance the possibility of cell adhesion.12' 27 Taking this into account a 
direct cytokine effect may occur locally, at the site where cytokines are produced. In this study 
this effect may be missed as the absolute concentration of cytokines is diluted by lavaging with 
excess fluid. 
Growth factors play a vital role in post surgical wound healing. Insulin like growth factor-1 (IGF-1) 
is released during the first stage of wound healing.28 Previous in vitro experiments demonstrated 
IGF-1 does not affect tumour cell adhesion but was a potent growth stimulant for tumour and 
mesothelial cells.29 Clinical and experimental studies have demonstrated that surgery is followed 
by a rapid decrease of IGF-1 in serum. 30' 31 This apparent suppression of IGF-1 system is thought 
to be caused by an increased efflux of IGF-1 from the blood to the peripheral tissues.30 In this 
study, significantly higher IGF-1 concentrations were found in the abdominal lavage fluids from 
severely traumatised rats. The origin of IGF-1 could be the proposed efflux from the blood or 
could be the result of local production by mesothelial cells. 14 IGF-1 stimulation and over-
production has been shown in several types of carcinoma and may support an autocrine growth 
loop of the tumour cells. IGF-1 is also potently capable of priming PMN for an enhanced 
respiratory burst that may lead to additional peritoneal tissue damage.32 In this way, tumour cells 
can use the hosts immune response in wound healing for their own benefit. 
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In conclusion, the studies brought forward in this paper provide evidence that the intra-
abdominal release of inflammatory sequelae after surgery promote local tumour recurrence and 
that this effect is mainly based on the cellular component of the inflammatory process. 
Extrapolation of the presented results to the clinical situation is limited as the inflammatory 
response in animals deviates from humans. There is, however, limited species variation in the 
first line of defence after surgical peritoneal traumatisation when taking PMN influx and 
macrophage activation into account.10 Preventing tissue damage by inflammatory cells therefore 
may provide a novel strategy to defeat progression and metastasis of cancer. Manipulation of 
the intricate cytokine network may cause unwanted side effects in the wound healing process. 
Tackling of reactive oxygen products, however, seems a feasible way of preventing cellular 
tissue damage ultimately resulting in diminished tumour recurrence. 
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Chapter XIII 
Preventing Intra-Abdominal Influx of Neutrophils 
after Surgical Peritoneal Trauma Reduces Adhesion 
Formation and Local Tumour Recurrence 
Submitted for publication 
Peritoneal trauma activates a cascade of peritoneal defence mechanisms responsible for 
postoperative adhesion formation. The same cascade is thought to play a key role in the 
process of intra-abdominal tumour recurrence. We previously demonstrated that within a few 
hours after peritoneal trauma, surgery related factors in the abdominal cavity could be 
captivated in a lavage fluid and enhance tumour recurrence in naive recipients. The 
inflammatory cells contained by the lavage fluid proved to have the strongest tumour 
recurrence promoting effect. FAGS analysis of the inflammatory cells demonstrated a trauma 
related influx of neutrophils (PMN) in the abdominal cavity. We evaluated if intra-peritoneal 
injection of anti-neutrophil serum (ANS) could reduce post-traumatic intra-abdominal PMN 
influx, and if so, whether this influenced adhesion formation and tumour recurrence. 
Total cell amount and differentiation of cellular parts of post-traumatic lavage fluids were 
estimated in four groups of rats. Reproducible rat models allowing semiquantitative scoring of 
adhesion formation and intra-abdominal tumour load were used to observe adhesions and 
tumour recurrence in the same four groups. In one group minimal peritoneal trauma was 
inflicted {day 0). The other groups underwent severe peritoneal trauma (day 0) without or 
with intra-peritoneal injections of 3 doses (day-1, 0, +1) or 1 dose ANS (day -1). 
Severe peritoneal trauma provoked a significant intra-abdominal PMN influx, this influx could 
be prevented by ANS treatment (3 and 1 dose) (p <:"0.02). Treatment with 3 doses ANS also 
significantly decreased blood lymphocyte, monocyte and PMN counts (p <:" 0.02) while 
treatment with 1 dose only affected blood PMN counts (P = 0.009). Treatment of severely 
traumatised rats with 3 doses ANS reduced adhesion formation (p = 0.0001) and induced 
tumour load significantly (p :5 0.002), whereas treatment with 1 dose ANS caused statistically 
significant tess tumour recurrence (p < 0.0001). 
Intra-abdominal influx of PMN after surgical peritoneal trauma plays a crucial role in 
postoperative adhesion formation and in the process of adhesion and growth of spilled 
tumour cells. A well-balanced prevention of post-traumatic intra-abdominal PMN influx 
reduces adhesion formation and local tumour recurrence. 
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INTRODUCTION 
Postoperative adhesion formation as well as loco-regional tumour recurrence of colorectal 
carcinomas remain important complications of potentially curative surgical intra-abdominal 
interventions. For neither problem clinically relevant curative treatment modalities are 
available yet. The pathogenesis of the processes responsible for postoperative adhesion 
formation and intra-abdominal tumour recurrence is only partly clarified. We previously 
suggested that the dynamic cascade of peritoneal healing, following peritoneal damage, not 
only plays an important role in postoperative adhesion formation but also in the process of 
intra-abdominal tumour recurrence,1 which is in agreement with the tumour cell entrapment 
hypothesis.2 A clinical trial performed at our institute indeed demonstrated an association 
between recurrent tumour disease and the extent of surgical injury.3 It has also become 
evident from experimental studies that enhanced tumour cell adherence and tumour growth 
are inevitable repercussions of surgical peritoneal trauma. 1• 4 -6 We demonstrated earlier that 
within a few hours after infliction of peritoneal trauma, factors in the abdominal cavity could 
be captivated in a lavage fluid and enhance tumour recurrence in naive, non-operated 
recipients. 1 Separated components of these lavage fluids i.e. inflammatory cells and soluble 
factors, could each enhance tumour recurrence, however the cellular fraction led to the 
greatest tumour load. More detailed analysis of the cellular fraction revealed a peritoneal 
trauma related influx of polymorph nuclear leucocytes (PMN) in the abdominal cavity. 7 
Similar shifts in cell differentiation following peritoneal trauma have been demonstrated in 
other animal models. 8• 9· 10 A role of PMN in the pathophysiological cascade leading to 
adhesion formation has also been suggested earlier. 11 · 12· 13 
Assuming that the observed post-traumatic intra-abdominal influx of PMN is an important 
factor in the communal dynamic cascade of peritoneal defence, responsible for both 
adhesion formation and local tumour recurrence, prevention of PMN influx might influence 
both processes and open up the way to novel therapeutic strategies. The present study was 
performed to evaluate whether post-traumatic intra-abdominal PMN influx could be reduced 
by treatment with anti-neutrophil serum (ANS), and if so, whether this reduction could 
influence postoperative adhesion formation and local tumour recurrence. 
MATERIALS AND METHODS 
Animals 
Female inbred WAG rats of reproductive age weighing 140-180 g were obtained from 
Harlan-CPS, Austerlitz, The Netherlands. They were bred under specific pathogen-free 
conditions, kept under standard laboratory conditions (temperature 20-24°C, relative humidity 
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50-60%, 12 hours light and 12 hours dark cycles), and fed with standard rat food and water 
ad libitum. The experimental protocol adhered to rules laid down by the Dutch Animal 
Experimentation Act and was approved by the Committee on Animal Research of the 
Erasmus University Rotterdam, The Netherlands. 
Rabbit anti-rat neutrophil serum 
Polyclonal rabbit anti-rat neutrophil serum (ANS) was purchased from Accurate, Westbury, 
NY, USA ANS can deplete blood neutrophils by 99.9% when administered intra-peritoneally 
in a dose of 2 ml per kg bodyweight. 14· 15 The number of blood neutrophils remains at this low 
level until administration of ANS is stopped. In this dose ANS is not specific for neutrophils 
only, because the number of blood monocytes, lymphocytes and, to a lesser extent, the 
platelets decrease as well, i.e. by 100%, 80% and 25% respectively. 15 
In our experiments rats were either given a single dose of 1 ml ANS per kg bodyweight by 
intra-peritoneal injection 1 day before laparotomy (day -1) or received two additional intra-
peritoneal injections of 0.5 ml ANS per kg for 2 consecutive days (day 0 and +1 ). 
Tumour 
Tumour CC531 is a moderately differentiated, weakly immunogenic colonic adenocarcinoma 
induced in WAG rats by 1 ,2-dimethylhydrazine. 16 It is transplantable in syngeneic WAG rats. 
The tumour is maintained as a cell culture in RPMI 1640 medium supplemented with 5% 
foetal calf serum (virus- and Mycoplasma-screened), 1% penicillin (5000 U/ml), 1% 
streptomycin (5000 U/ml), and 1% L-glutamine (200 mmol). Medium and all supplements 
were obtained from Life Technologicals BV, Breda, The Netherlands. Cells were passaged 
once a week using trypsin (0.05%) and EDTA (0.02%). Before use in vivo, tumour cells were 
harvested from stationary cultures by gentle trypsinisation (5 minutes, 3TC), centrifugation 
(5 minutes, 700 g), and re-suspension in RPMI 1640, providing cell suspensions with a 
viability greater than 90%. CC531 is relatively insensitive to chemotherapy but is sensitive to 
the effects of biologic response modifiers. 
Operative procedures 
To investigate whether treatment with ANS interferes with adhesion formation our previously 
described reproducible rat adhesion model was used. 17 Briefly, under ether anaesthesia and 
aseptic conditions a laparotomy was performed using a lower midline incision of 5 em. Three 
Surgilene 5-0 sutures (Braun, Melsungen, Germany) were applied to both lateral peritoneal 
sides 0.7 em from each other and 1.5 em downwards from the abdominal incision. All knots 
were double knots fastened tightly to ensure local ischaemia. Both uterus horns were 
exposed, not touched and sutured to the lateral peritoneum with Surgilene 6-0 (Braun) 
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proximally and distally from the three 5-0 sutures. In this way a standardised amount of 
minimal peritoneal trauma was inflicted. Severe peritoneal trauma was inflicted by additively 
rubbing the exposed uterus horns with surgical Medipres gauze (van Heek Medical, Lasser, 
The Netherlands) before suturing them to the lateral abdominal wall. Rubbing was performed 
with a device enabling the application of a constant pressure of 120 g/cm2 . The uterus horns 
were rubbed 10 times over their total length. The abdomen was closed in two !ayers with 5-0 
polyglycolic acid and 2-0 silk sutures (Braun). 
To study the effect of treatment with ANS on local tumour recurrence our reproducible 
tumour adhesion and growth mode! was used.1 Under ether anaesthesia and aseptic 
conditions a laparotomy was performed using a lower midline incision of 5 em. Both uterus 
horns were exposed, not touched or rubbed with surgical Medipres gauze, and sutured to the 
lateral peritoneum both proximally and distally using Surgilene 6-0 sutures. In this way a 
standardised amount of minimal (only two sutures, no rubbing) or severe (rubbing and two 
sutures) peritoneal trauma was inflicted. Before closing the abdomen, 0.5 x 106 CC531 
tumour cells, in 1 ml RPM! 1640, were injected intra-peritoneally. The abdomen was closed 
in two layers with 5-0 polyglycolic acid and 2-0 silk sutures. 
Experimental design 
Effect of ANS treatment on cell content in peritoneal cavity and blood 
To investigate the influence of ANS treatment on intra-abdominal neutrophil cell count and on 
the rat immune system the following procedures were performed. Under ether anaesthesia 
eighty-five rats underwent a laparotomy. In 10 rats (group A) standardised minimal peritoneal 
trauma was inflicted by exposing both uterus horns without rubbing them. In 25 rats (group 
B) standardised severe peritoneal trauma was inflicted by rubbing both exposed uterus horns 
and a 5 em long part of the small intestine with surgical Medipres gauze. In 25 rats (group C) 
severe peritoneal trauma was inflicted in rats treated with 3 intra-peritoneal doses of ANS, on 
day -1, 0 and +1. In 25 rats (group D) severe peritoneal trauma was inflicted after a single 
intra-peritoneal injection of ANSon day -1. After 5 hours (t1), 72 hours (t2), 96 hours(!,), 144 
hours (t,) and 192 hours (ts) 5 rats of each group were operated for the second time. During 
this second laparotomy the abdominal cavity was lavaged with 5 ml RPMI 1640 medium. 
After massaging the abdomen the remaining fluid was aspirated and individually kept on ice 
until further processing. 
Blood samples were obtained by cardiac puncture. 
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Adhesion formation after treatment with 3 doses of ANS 
In 10 rats (group I) standardised minimal peritoneal trauma was inflicted to both lateral 
peritoneal sides. In 10 rats (group II) standardised severe peritoneal trauma was inflicted to 
both lateral peritoneal sides. In 10 rats (group Ill) severe peritoneal trauma was inflicted 
during treatment with intra-peritoneal injections of ANSon days -1, 0, and +1 peri operatively. 
lntra~peritoneal tumour cell adhesion and growth after treatment with ANS 
Nine rats (group IV) underwent minimal peritoneal trauma and nine (group V) severe 
peritoneal trauma. Nine rats (group VI) underwent severe peritoneal trauma and intra-
peritoneal injection of ANSon days -1, 0 and +1 perioperatively. Before closing the abdomen 
0.5 x 106 CC531 tumour cells, in 1 ml RPMI 1640, were injected intra-peritoneally, 0.5 ml 
along the left and 0.5 ml along the right abdominal wall. 
Minimal or severe peritoneal trauma was inflicted in 2 groups of 10 rats (group VII and VIII). 
In 10 rats (group IX) severe peritoneal trauma was inflicted after a single intra-peritoneal 
ANS injection on day -1. Before closing the abdomen 0.5 x 106 CC531 tumour cells were 
injected into the abdominal cavity. 
Evaluation of cell content in peritoneal cavity and blood 
The collected lavage fluid samples were separated in a supernatant and a cellular 
component by centrifugation (1500 rpm, 5 minutes). The cellular component was re-
suspended in RPM! medium, total cell amount was determined and HE stained 
cytocentrifuge slides were made for cell differentiation. At a magniftcation of 100 x, 100 cells 
were counted in duplicate and classified into granulocytes (neutrophils, eosinophils, 
basophils and mast cells) and lymphoid cells (mononuclear phagocytes and lymphocy1es). 
Total blood leukocyte counts were determined with a micro cell counter, and duplicate 
differential counts were carried out on May-Grl.inwald and Giemsa-stained blood smears. 
Evaluation of adhesion formation 
Two weeks after surgery, the rats were sacrificed for assessment of intra-abdominal 
adhesion formation. Macroscopically the adhesions were scored according to their extent 
(quantity) and type (quality) by two independent observers. The ex1ent of adhesion formation 
was quantified by dividing the area to be scored into eight by means of the three 5-0 sutures 
in the lateral peritoneum (Figure 3.3, Chapter 3). The presence or absence of adhesions in 
the eight demarcated areas was scored. If there were adhesions in an area this accounted 
for 12.5% adhesions; a maximum of 100% adhesions could be scored. In each rat two lateral 
peritoneal sides were assessed. The type of adhesions formed was classified 
macroscopically using the ZUhlke classification (Table 3.1, Chapter 3).18 
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Evaluation of intra-peritoneal tumour cell adhesion and growth 
Three weeks after laparotomy all rats were sacrificed and intra-peritoneal tumour load was 
scored semiquantitatively at the following peritoneal sites: right uterus horn, left uterus horn, 
subcutaniously (at the site of the operative scar), parietal peritoneum (at the lateral 
abdominal wall sides where no uterus horns were fixed), kidney, liver, retroperitoneum, and 
omentum. The scoring was performed by two independent observers using a tumour scoring 
system derived from the peritoneal cancer index described by Steller and ranging from 0 to 5 
per abdominal site (Table 6.1, Chapter 6).19 For each rat the score at all peritoneal sites, 
except for the uterus horns, was summarised, from which a mean total tumour load per rat 
could be estimated. In the present study the term tumour recurrence is sometimes used to 
illustrate tumour load, which is the net result of tumour cell adhesion and tumour growth, 
because we presume that intra-peritoneal injecting of tumour cells resembles the clinical 
situation of tumour cell spill during tumour resection. 
Statistical analysis 
Median and range from different cell counts were estimated per group. Statistical analysis 
was performed using the non-parametric Kruskall Wallis test to determine overall differences 
followed by the non-parametric Mann-Whitney U test to compare differences between groups 
The mean adhesion percentage and standard deviation was calculated per group. Data were 
statistically analysed using the one-way ANOVA test to determine overall differences. If the 
ANOVA test was significant on a 5% level, the Student Newman Keuls post hoc test was 
carried out to make a comparison between groups. 
The median and range of intra-peritoneal tumour load at each scored abdominal site and of 
the total tumour load were calculated per group. Statistical analysis was performed the 
Kruskall Wallis test followed by the Mann-Whitney U post hoc test. Statistical significance 
was defined asp< 0.05. 
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RESUlTS 
Effect of ANS treatment on cell content in peritoneal cavity and blood 
There was a significantly higher total intra-abdominal cell count after infliction of severe 
peritoneal trauma than after infliction of minimal peritoneal trauma until 72 hours after the 
operation (p = 0.009) (Figure 8.1 ). Figure 8.1 also shows that intra-peritoneal administration 
of 3 doses of ANS as well as 1 dose of ANS significantly decreased the total intra-abdominal 
cell count after infliction of severe peritoneal trauma for at least 96 hours postoperatively (p < 
0.05). After treatment with 1 dose of ANS the total cell count seemed to increase earlier and 
faster than after treatment with 3 doses, but differences were not significant at any time point 
(p ~ 0.386) (Figure 8.1 ). A reversal was seen in the differential cell counts of lavage fluids 
regarding the granulocyte-lymphocyte ratio, with a 43-57% ratio in the mildly traumatised 
group (A) versus an 81-19% ratio in the severely traumaf1sed group (B) (p = 0.009). This 
reversal was seen till 96 hours postoperatively (Figure 8.2). Treating the rats with 3 doses 
(group C) as well as 1 dose (group D) of ANS did annul this reversal: a 23-77% ratio was 
found in both groups (t1-t3 , p,; 0.01) (Figure 8.2) at all time points. The total number of PMN's 
found in abdominal lavage fluids at different time points are depicted in Figure 8.3. Up till 96 
hours after laparotomy severely traumatised peritoneal cavities contained significantly higher 
numbers of neutrophils than mildly traumatised cavities or severely traumatised peritoneal 
cavities treated with of ANS (p 5 0.02). 
Figure 8.4 summarises the results of blood differential cell counts in the 4 groups at different 
time points. Lymphocyte, monocyte and neutrophil counts did not differ significantly in 
severely or mildly peritoneally traumatised rats. Treatment with 3 doses of ANS significantly 
decreased these cell counts for a period of at least 96 hours (p ::; 0.02). This effect was not 
seen after treatment with 1 dose of ANS. 
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Figure 8.1 
Median total cell count (range) in abdominal lavage fluids after infliction of minimal (group A, 
open bars) or severe (group B, filled bars) peritoneal trauma and after infliction of severe 
peritoneal trauma in rats treated with 3 (group C, chequered bars) or 1 (group D, cross-
hatched bars) intra-peritoneal doses of ANS. Fluids were collected 5 (t,), 72 (t2), 96 (t3), 144 
(4), and 192 hours (t5) postoperatively. Statistics p1 (A versus B), p2 (A versus C), p3 (A 
versus D), p4 (B versus C), p5 (B versus D), p6 (C versus D): Kruskall Wallis test with Mann-
Whitney U post hoc test. T1; p1-p5 = 0.009, p6 ns. T,; p1, p4, p5 = 0.009, p2, p3 = 0.014, p6 
ns. T3; p4 = 0.021, p5 = 0.048, p6 ns. T4; p4-p6 ns. T5; p4-p6 ns. 
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Figure 8.2 
Median percentage of neutrophils (range} in lavage fluids taken from abdominal cavities after 
minimal (group A, open bars) or severe (group B, filled bars) peritoneal trauma and after 
severe peritoneal trauma in rats treated with 3 (group C, chequered bars) or 1 (group D, 
cross-hatched bars) intra-peritoneal doses of ANS. Fluids were collected 5 (t1), 72 (t2), 96 
(t,), 144 (4), and 192 hours (t5) postoperatively. Statistics p1 (A versus B), p2 (A versus C), 
p3 (A versus D), p4 (B versus C), p5 (B versus D), p6 (C versus D): Kruskall Wallis test with 
Mann-Whitney U post hoc test. T1; p1-p5 = 0.009, p6 ns. T,; p1, p4, p5 = 0.009, p2 = 0.03, 
p3 = 0.004, p6 ns. T,; p4, p5 = 0.01, p6 ns. T,; p4-p6 ns. T5; p4-p6 ns. 
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Figure 8.3 
Median neutrophil granulocyt count (range) in abdominal lavage fluids after infliction of 
minimal (group A, open bars) or severe (group B, filled bars) peritoneal trauma and after 
infliction of severe peritoneal trauma in rats treated with 3 (group C, chequered bars) or 1 
(group D, cross-hatched bars) intra-peritoneal doses of ANS. Fluids were collected 5 (t1), 72 
(t,), 96 (t,), 144 (t.), and 192 hours (t5) postoperatively. Statistics p1 (A versus B), p2 (A 
versus C), p3 (A versus D), p4 (B versus C), p5 (B versus D), p6 (C versus D): Kruskall 
Wallis test with Mann-Whitney U post hoc test. T1; p1, p4, p5 = 0.009, p2 = 0.02. p3 = 0.014, 
p6 ns. T,; p1-p5 = 0.009, p6 ns. T3 ; p4, p5 = 0.021, p6 ns. T4; p4-p6 ns. T5; p4-p6 ns. 
Figure 8.4 
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Median blood lymphocyte count after infliction of minimal (group A, open bars) or severe 
(group B, filled bars) peritoneal trauma and after infliction of severe peritoneal trauma in rats 
treated with 3 (group C, chequered bars) or 1 (group D, cross-hatched bars) intra-peritoneal 
doses of ANS. Blood samples were obtained 5 (t1), 72 (t,), 96 (!,}, 144 (t.). and 192 hours (t5) 
postoperatively. Statistics p1 (A versus B), p2 (A versus C), p3 (A versus D), p4 (B versus 
C), p5 (B versus D), p6 (C versus D): Kruskall Wallis test with Mann-Whitney U post hoc test. 
T,; p1, p3, p5 ns, p2, p4 = 0.009. p6 = 0.018. T2; p1, p3, p5 ns, p2 = 0.014, p4 = 0.009, p6 = 
0.027. T3 ; p4 = 0.021, p5 ns, p6 = 0.043. T4; p4-p6 ns. T5 ; p4-p6 ns. 
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Adhesion formation after treatment with 3 doses of ANS 
Part of table 8.1 shows that the infliction of severe peritoneal trauma induced significantly 
more adhesions than infliction of minimal peritoneal trauma {p = 0.0001 ). It also shows that 
injection of 3 doses of ANS significantly reduced adhesion formation after infliction of severe 
peritoneal trauma {p = 0.0001 ), although the mean adhesion percentage was still significantly 
higher than after infliction of minimal trauma (p = 0.0001 ). 
Intra-peritoneal tumour cell adhesion and growth after treatment with 3 doses of ANS 
Table 8.2 shows that the median tumour load at severely traumatised peritoneal sites was 
significantly higher than the median tumour load at minimally traumatised peritoneal sites (p 
< 0.0001 ). Surprisingly, intra-peritoneal injection of 3 doses of ANS induced significantly 
more tumour load at severely traumatised peritoneal sites (p = 0.002), but also at all other 
not directly traumatised sites of the peritoneum (p = 0.001 ), than in controls (Table 8.2). The 
median total tumour load after infliction of minimal peritoneal trauma was always significantly 
lower than after infliction of severe peritoneal trauma irrespective of ANS treatment or not (p 
< 0.0001 ). These differences were due to significant differences at subcutis, kidney and 
omentum (p s 0.037) (Table 8.2). 
Intra-peritoneal tumour cell adhesion and growth after treatment with 1 dose of ANS 
Table 8.3 shows that, treatment with a single dose of ANS significantly reduced median 
tumour load at severely traumatised peritoneal sites (p < 0.001 ), and at remote peritoneal 
sites in severely traumatised abdominal cavities (p < 0.0001) when compared to median 
tumour load found at these sites in severely traumatised rats not treated with ANS. 
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'Uterus horns n Percentage adhesion Zuhlke p1 p2 ! p3 
formation (SO) score 
I. No touch 10 22.5 (7.9) 1 0.0001 
II. Medipres rubbing 10 76.3 (7.1) 2-3 0.0001 
Ill. Medipres rubbing 10 46.9 (10.6) 1-2 0.0001 
& 3xANS ip 
Table 8.1 
Mean adhesion percentages (SO), and ZUhlke classification of found adhesions, after infliction 
of minimal peritoneal trauma (group 1), severe peritoneal trauma (group II) and after infliction of 
severe peritoneal trauma and treatment with 3 intra-peritoneal doses of ANS (group Ill). For 
each rat, the individual data concerning the 2 lateral abdominal wall sites (uterus horns) were 
averaged; n is the number of data(::::: rats) per group used for analysis. Statistics p1 (I versus 
II), p2 (II versus Ill) and p3 (I versus Ill): one-way ANOVA test, with Student Newman Keuls 
post hoc test 
Abdominal sites Tumour load Tumour load Tumour load p1 p2 p3 
IV. No touch V. Medipres VI. 3xANS 
n=9 n=9 n=9 
erus horns 0 (0-0) 4.2 (4-5) 5 (5-5) <0.0001 0.002 <0.0001 
Subcutis 1 (1-2) 3 (1-4) 5 (4-5) 0.01 <0.0001 <0.0001 
1 
Parietal peritoneum 0 (0-0) 0.5(0-1) 3 (3-4) ns <0.0001 <0.0001 
!Kidney 1 (0-2) 2.5 (2-3) 4 (3-4) 0.001 <0.0001 <0.0001 
Liver 0.5 (0-2) 1 (0-2) 3 (2-4) ns 0.001 0.001 
Retroperitoneum 0 (0-0) 0 (0-1) 2 (1-3) ns <0.0001 <0.0001 
Omentum 1 (0-2) 2 (1-3) 5 (4-5) 0.037 <0.0001 <0.0001 
Total 0.8 (0-2) 1.8 (1-2) 3.7 (3-5) <0.0001 0.001 <0.0001 
Table 8.2 
Median tumour load (range) at none traumatised uterus horns (group VI), at uterus horns 
severely traumatised by rubbing with surgical Medipres gauze (group V) and at uterus horns 
severely traumatised by rubbing with surgical gauze during treatment w'1th 3 intra-peritoneal 
doses of ANS (group VI). For each rat, the individual data concerning the 2 uterus horn sites 
were averaged. Median tumour load (range) at different not directly traumatised peritoneal 
sites and median total tumour load following laparotomy (group IV), laparotomy and severe 
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peritoneal traumatasation (group V) and laparotomy, severe traumatisation and treatment 
with 3 intra-peritoneal doses of ANS (group VI). N is the number of treated rats. Statistics p1 
(IV versus V), p2 (V versus VI) and p3 (IV versus VI): Kruskall Wallis test with Mann-Whitney 
U post hoc test. 
Abdominal sites Tumour load Tumour load Tumour load p1 p2 p3 
VII. No touch VIII. Medipres IX. 1x ANS 
n = 10 n = 10 n = 10 
Uterus horns 0 (0-2) 5 (4-5) 2.2 (1-4) <0.0001 <0.0001 <0.0001 
Subcutis 1 (1-2) 3 (2-5) 2 (1-3) <0.0001 0.002 0.007 
Parietal peritoneum 0 (0-0) 0 (0-1) 0 (0-1) ns ns ns 
Kidney 1 (0-2) 2 (0-3) 1 (0-2) 0.002 0.002 ns 
Liver 0 (0-2) 0.5 (0-2) 0 (0-1) ns ns ns 
Retroperitoneum 0 (0-0) 0 (0-1) 0 (0-1) ns ns ns 
Omentum 1 (1-3) 3 (2-4) 1.5(1-3) 0.001 0.001 ns 
Total 0.6 (0-2) 1.6(1-2) 0.8 (0-2) <0.0001 <0.0001 ns 
Table 8.3 
Median tumour load (range) at none traumatised uterus horns (group VII), at uterus horns 
severely traumatised by rubbing with surgical Medipres gauze (group VIII) and at uterus 
horns severely traumatised by rubbing with surgical gauze after treatment with 1 intra-
peritoneal dose of ANS (group IX). For each rat, the individual data concerning the 2 uterus 
horn sites were averaged. Median tumour load (range) at different not directly traumatised 
peritoneal sites and median total tumour load following laparotomy (group VII), laparotomy 
and severe peritoneal traumatisation (group VIII) and laparotomy, severe traumatisation and 
treatment with 1 intra-peritoneal dose of ANS (group IX). N is the number of treated rats. 
Statistics p1 (VII versus VIII), p2 (VIII versus IX) and p3 (VII versus IX): Kruskall Wallis test 
with Mann-Whitney U post hoc test. 
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DISCUSSION 
We and others showed earlier that peritoneal trauma promotes postoperative adhesion 
formation, induces local tumour recurrence at traumatised peritoneal sites and even 
increases tumour growth at extra-peritoneal sites. 1· 3 · 4· 5· 6 · 17· 20· 21 
The pathogenesis of the processes leading to postoperative adhesion formation and intra-
abdominal tumour recurrence is multifactorial and only partly clarified. We previously 
suggested that one common cascade of reactfons following peritoneal damage, is responsible 
for both pathological conditions. 1 Following peritoneal trauma, a variety of cytokines and 
other inflammatory mediators are produced by activated mesothelial cells and by stampeded 
inflammatory cells.22 · 23 The production of mesothelial and inflammatory cell derived 
chemokines such as IL-8 (CINC in rats), MCP-1 and IL-1~ will cause post-traumatic 
migration of PMN and monocytes to the injured peritoneal cavity in order to promote the 
peritoneal healing process.24"28 However, these mediators and recruited cells not only serve 
peritoneal healing, but are believed to be responsible for adhesion formation and tumour cell 
adhesion and growth as well.7 · 12· 29 We showed that lavage fluids collected after infliction of 
peritoneal trauma could enhance tumour recurrence in nai've, non-operated recipients. 1 
Detailed analysis of the cellular fraction of these lavage fluids revealed a trauma related 
influx of PMN in the abdominal cavity.7 PMN's generate reactive oxygen metabolites and 
discharge contents of granular organelles into either phagocytic vacuoles or the local 
environment to ingest foreign particles or microorganisms. Both oxygen-dependent and 
oxygen-independent processes participate in the killing of bacteria but also may (further) 
damage surrounding host tissue. 8· 30· 31 The coincidence of post-traumatic intra-abdomina! 
PMN influx with adhesion formation and tumour eel! adhesion and growth is no solid prove 
for the role of PMN in these pathogenetic processes. Effective inhibition of tissue injury by 
PMN has been achieved by neutralising PMN chemoattractants, 32 blocking of PMN adhesion 
molecules33· 34 and scavenging of reactive oxygen species, 35' 36 but whether this affected 
adhesion formation or tumour recurrence has not been investigated. For pathogenetic 
disorders of other organ systems, the role of PMN could be demonstrated by blocking of 
PMN adhesion molecules which resulted in attenuated inflammatory tissue injury and 
decreased organ failure.37-40 
The present study shows that infliction of severe peritoneal trauma provokes a significant 
intra-abdominal PMN influx during a period of at least 96 hours. This influx could be 
prevented by treatment with 3 doses of ANS. Averting the post-traumatic intra-abdominal 
PMN influx by intra-peritoneal injection of 3 doses of ANS significantly reduced adhesion 
formation which indicates that neutrophils play a crucial role in the dynamic cascade of 
adhesion formation. However, intra-peritoneal injection of 3 doses of ANS did not decrease 
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local total tumour load but significantly increased tumour recurrence. Treatment with 3 doses 
of ANS also significantly decreased blood lymphocyte, monocyte and PMN counts, thereby 
seriously compromising the rat immune system. It is conceivable that this 
immunosuppression does not have an effect on adhesion formation but does promote 
tumour growth. The effect of ANSon growth of the weakly immunogenic CC531 tumour may 
be twofold: inhibitory by reducing PMN influx and stimulatory by the additional 
immunosuppression. We observed earlier that immunosuppression leads to enhanced 
growth of the tumour used in the current experiments.41 Treatment of severely peritoneally 
traumatised rats with 1 dose of ANS did still annul the post-traumatic PMN influx, but more 
selectively than 3 doses, because it did not influence blood lymphocyte and monocyte count 
The last experiments showed that a more selective reduction of post-traumatic PMN influx, 
without causing immunosuppression, was possible and indeed significantly lowered tumour 
cell adhesion and growth. 
In conclusion, these studies demonstrated the adhesion and tumour promoting effect of 
PMN's. Preventing tissue damage by reduction of inflammatory cells like PMN's or by 
prohibiting their intra-abdominal influx might provide a novel strategy in averting adhesion 
formation and tumour recurrence. Wound healing processes rely on the same biological 
mechanisms as adhesion formation and possibly, tumour recurrence, thus manipulation of 
PMN has to be done selectively and in moderation to prevent unwanted side effects. Our rat 
models may be helpful in further unravelling the cascade of both processes to find the perfect 
balance between wanted and unwanted effects of manipulation of the post-traumatic 
inflammatory response. 
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Chapter IX 
Hyaluronic-Based Coating Solution for Prevention of 
Surgical Adhesions Has no Major Effect on 
Adhesion and Growth of Intra-Peritoneal Tumour 
Cells 
Adapted from the original publication in the European Journal of Surgery 1999; 165: 791-795 
We recently demonstrated that surgical peritoneal trauma induces a cascade of defensive 
events that can lead to adhesion formation and adhesion and growth of peroperatively spilled 
tumour cells. Placement of an absorbable barrier of hyaluronic acid/carboxymethylcellu/ose 
(Seprafilm™) or low viscosity 0.4% HA (Sepracoat™) bet\Neen injured peritoneal sites during 
abdominal surgery can reduce postoperative adhesion formation. The objective of our study 
was to find out whether the use of the HA containing solutions might effect the adhesion and 
growth of free intra-abdominal tumour cells. 
Rat mesothelial cells were cultured in mono/ayers and adhesion of CC531 tumour cells was 
measured after pre-incubation of the mono/ayers with Sepracoat™ or PBS. Reproducible rat 
models allowing semiquantitative scoring of tumour load were used to observe the effect of 
Sepracoat™ on local tumour cell adhesion and grovvth at minimally and severely traumatised 
and remote, not directly traumatised, peritoneal sites. 
Sepracoat™ had a small but significant inhibitory effect on the adhesion of CC531 tumour cells 
to mesothelial cell mono/ayers in vitro (p < 0. 05). However, we were unable to repeat these 
effects in our in vivo rat models, the peroperative inoculation of Sepracoat™ did not reduce 
postoperative tumour load at directly minimally or severely, or indirectly traumatised peritoneal 
surfaces. 
Sepracoat™ may inhibit adhesion of tumour cells to the mesothelium in culture but in the 
currently used dose it had no appreciable effect on intra-abdominal tumour cell adhesion and 
grovvth in rats. 
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INTRODUCTION 
Peritoneal trauma is, as we recently demonstrated, not only is a causal factor for adhesion 
formation, but also for the enhanced adhesion and growth of tumour cells.1· 2 Using a 
reproducible rat model, a significant correlation was found between the amount of peritoneal 
trauma and the degree of tumour recurrence. Remarkably, this was not only observed at the 
traumatised site, but also distantly at non-abraded peritoneal surfaces. 
A new development in the field of adhesion prevention is the use of bioabsorbable formulations 
based on hyaluronic acid (HA). Seprafilm ™ is a membrane composed of hyaluronic acid and 
carboxymethylcellulose with proven efficacy against adhesion formation in animals and 
humans.3-5 SepracoatTM is a more manageable coating solution, that contains 0.4% of sodium 
hyaluronate in phosphate buffered saline (PBS). Precursor formulations of the latter product 
have been demonstrated to prevent adhesion formation in various animal models.6' 7 
Hyaluronic acid (HA) is a major component of the extra-cellular matrix (ECM) and is also 
secreted by mesothelial cells. ECM and mesothelial cells, either exposed or activated by 
surgery, play major roles in the dynamic process of tumour cell adhesion. It has been 
demonstrated that the presence of a HA-containing coat on mesothelial celts interferes with the 
adhesion of tumour cells in vitro. 8 
The aim of the present study was to investigate whether Sepracoat™ might interfere with intra-
peritoneal tumour cell adhesion. We investigated this in vitro by assessing the adherence of 
tumour cells to cultured rat mesothelial cell monolayers, and in vivo in a well-defined 
reproducible tumour adhesion and growth model. 1 
MATERIALS AND METHODS 
Animals 
Female inbred WAG rats of reproductive age weighing 200-250 g were obtained from Harlan, 
Zeist, The Netherlands. They were bred under specific pathogen-free conditions and kept 
under standard laboratory conditions (temperature 20-24°C, relative humidity 50-60%, 12 hours 
light and 12 hours dark cycles). The rats were given standard food and water ad libitum. The 
experimental protocol adhered to rules laid down by the Dutch Animal Experimentation Act and 
was approved by the Committee on Animal Research of the Erasmus University Rotterdam. 
Sepracoat TM 
Sepracoat™ coating solution is a sterile-filtered, non-pyrogenic 0.4% (w/w) solution of sodium 
hyaluronate in phosphate buffered saline (PBS). It was provided by the manufacturer 
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(Genzyme Corporation, Boston, Massachussets, USA}. 
Tumour 
Tumour CC531 is a 1,2 dimethylhydrazine~induced weakly immunogenic, moderately 
differentiated colon adenocarcinoma, transplantable in syngeneic WAG rats.9 The tumour is 
maintained in cell culture in RPMI-1640 medium supplemented with 5% foetal calf serum 
(virus- and Mycoplasma-screened), 1% penicillin (5000 U/ml}, 1% streptomycin (5000 U/mL}, 
and 1% L-glutammine (200 mM}. All supplements were obtained from Gibco, Paisley, UK. Cells 
were passaged once a week using trypsin (0.05%) and EDTA (0.02%). Before their use, cells 
were trypsinised (5 minutes, 3rC}, centrifuged (5 minutes, 700g}, re-suspended in RPMI-1640 
and counted. Viability was measured by trypan blue exclusion and always exceeded 95%. 
Tumour cells were injected within 4 hours after being obtained. CC531 is relatively insensitive 
to chemotherapy but is sensitive to the effect of biologic response modifiers. 
Mesothelial cell culture 
Mesothelial cells were isolated from the small bowel mesentery of male WAG rats as described 
previously. 10 In brief, during a laparotomy under ether anaesthesia window like transparent 
triangular sheets of mesentery were isolated and collected in Hank's Balanced Salt Solution 
(HBSS} containing 5% human serum albumin (CLB, Amsterdam, The Netherlands}, penicillin 
(5000 U/mL}, 1% L-glutammine (200 mM} and fungizone (1.25 mg/L}. After washing the sheets 
twice in this medium, they were incubated in a mixture of collagenase (1g/L) and dispase (2.4 x 
103 U/L} (Boehringer, Mannheim, Germany}. Following incubation during 15 minutes at 37'C 
and continuous gentle shaking, the detached mesothelial cells were pelleted by centrifugation 
at 300 g for 5 minutes. Cell viability was determined by trypan blue and always exceeded 95%. 
The isolated mesothelial cells were re-suspended in culture medium consisting of RPMI 1640 
supplemented with 10% foetal call serum, penicillin (5000 U/ml), 1% L-glutamin (200 mM} and 
fungizone (1.25 mg/L}. Medium and al supplements were obtained from Life Technologicals 
BV, Breda, The Netherlands. The mesentery derived cells grew forming a mesothelial 
monolayer in 48 well plates (Greiner, The Netherlands}, pre-coated with collagen type I (15 
~glcm' collagen S} (cell biology Roche Diagnostics, Almere, The Netherlands}. The identity of 
mesothelial cells was illustrated by positive immunohistochemical staining for vimentin and 
keratin, and the absence of von Willebrand factor-staining, as reported previously. 1° Cells for 
staining were harvested from confluent mesothelial cell monolayers with the typical 
cobblestone appearance. For all experiments, primary cell cultures were used. Isolated 
mesenteries from at least three different rats were used. 
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Operative procedures 
To study the effect of Sepracoat™ on tumour cell adhesion and growth in minimally traumatised 
abdominal cavities a laparotomy mode! allowing semiquantitative scoring of tumour load was 
used. Under ether anaesthesia the abdomen was opened using a lower midline incision of 5 
em. Both uterus horns were left untouched, thus not damaged. Laparotomy was the only 
minimal surgical injury inflicted to the peritoneum. Sepracoat™ or PBS was instilled into the 
abdominal cavity. Half a million CC531 tumour cells, in 1 ml RPMI 1640, were left behind in the 
abdominal cavity and the abdomen was closed in two layers with Dexon 5-0 and silk 2-0 
sutures (Braun, Melsungen, Germany). 
To study the effect of Sepracoat™ on tumour cell adhesion and growth at minimally and 
severely traumatised peritoneal sites our reproducible tumour adhesion and growth model was 
used.2 Briefly, under ether anaesthesia a laparotomy was performed using a lower midline 
incision of 5 em. Sepracoat™ or PBS was instilled into the abdominal cavity. One uterus horn 
was exposed, not touched and sutured to the lateral peritoneum both proximally and distally 
with Surgilene 6-0 (Braun). In this way a standardised amount of minimal peritoneal trauma 
was inflicted. The other uterus horn was exposed and rubbed with severely traumatising 
surgical Medipres gauze (van Heek Medical, Lasser The Netherlands) before suturing it to the 
lateral abdominal wall. Rubbing was performed with a device enabling the application of a 
constant pressure of 120 g/cm2 . The uterus horn was rubbed 10 times over its total length. A 
standardised amount of severe peritoneal trauma was inflicted this way. Half a million CC531 
tumour cells, in 1 ml RPM I 1640, were injected intra-peritoneally and the abdomen was closed 
in two layers with Dexon 5-0 and silk 2-0 sutures (Braun). 
Experimental design 
Effect of Sepracoat™ on tumour cell adhesion to cultured mesothelial cell monolayers 
(in vitro) 
After mesothelial monolayers, established in 48 well plates pre-coated with collagen, reached 
confluence (usually after 2 days as determined by light microscopy), culture medium was 
aspired and an arbitrarily chosen amount of 200 JJI of Sepracoat™ per well was added. This 
was left to settle for 3 minutes after which 5 x 104 CC531 cells in 1 ml of culture medium were 
added. Non-treated mesothelial monolayers served as controls. Tumour cell adhesion to the 
monolayer was assessed at 1, 2, 4 and 8 hours by measuring the DNA content of the cells per 
well, after washing away superfluous non-adherent cells, as described previously.11 Specific 
adherence was calculated by substraction of the DNA content of control monolayers. 
Mesothelial monolayers and cultures of CC531 were also cultured separately with Sepracoatru 
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to investigate its possible interference with norma! cell growth in both circumstances. 
Effect of Sepracoat™ on tumour cell adhesion and growth in minimally traumatised 
abdominal cavities (in vivo) 
Eighteen rats underwent a laparotomy during which both uterus horns were left untouched. In 9 
rats (group I) 3 ml of Sepracoat™ and in 9 rats (group II) 3 ml of PBS was instilled in the 
abdominal cavity. Before closing the abdomen, 0.5 x 106 CC531 tumour cells, in 1 ml RPM I 
1640, were injected intra-peritoneally (0.5 ml along the left and 0.5 ml along the right 
abdominal wall). 
Effect of Sepracoat™ on tumour cell adhesion and growth at minimally and severely 
traumatised peritoneal sites (in vivo) 
In 5 rats (group Ill) 3 ml of Sepracoat™ and in 4 rats (group IV) 3 ml of PBS was inoculated 
after opening the abdominal cavity. Subsequently, in all 9 rats both uterus horns were exposed 
and sutured to the lateral peritoneum. All right uterus horns were rubbed with severely 
traumatising Medipres gauze before fixation and all left uterus horns remained untouched. 
Before closing the abdomen, 0.5 x 106 CC531 tumour cells, in 1 ml RPMI 1640, were 
inoculated intra-peritoneally (0.5 ml along the left and 0.5 ml along the right abdominal wall). 
Evaluation of intraRperitoneal tumour cell adhesion and growth 
Three weeks postoperatively the rats were sacrificed and tumour load was scored 
semiquantitatively at the following sites: right uterus hom, left uterus hom, subcutaneously (at 
the site of the operative scar), parietal peritoneum (at the lateral abdominal wall sides where no 
uterus horns were fixated), kidney, liver, retroperitoneum and omentum. The scoring was 
performed by 2 independent observers using a tumour scoring system derived from the 
peritoneal cancer index described by Steller and ranging from 0 to 5 per abdominal site (Table 
6.1, Chapter 6).12 For each rat the score at all peritoneal sites, except for the uterus horns, were 
summarised, from which a mean total tumour load per rat could be estimated. In the present 
study the term tumour recurrence is sometimes used to illustrate tumour load, which is the 
assumed in vivo net result of tumour cell adhesion and tumour growth, because we presume 
intra-peritoneal injecting of tumour cells resembles the clinical situation of tumour cell spill 
during tumour resection. 
Statistical analysis 
The mean and standard deviation of in vitro tumour cell adhesion was calculated per group. 
Data were statistically analysed using analysis of variance (ANOVA) to determine overall 
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differences, followed by the Newman-Keuls post hoc test to compare between groups. Statistical 
significance was defined as p < 0.05. The median and range of intra-peritoneal tumour load at 
each site and of the total tumour load were calculated per group. Statistical analysis was 
performed using the non-parametric Mann-Whitney U test. Statistical significance was 
def1ned as p < 0.05. 
RESULTS 
Effect of Sepracoat™ on tumour cell adhesion to cultured mesothelial cell monolayers 
(in vitro) 
SepracoatTM had no effect on growth or survival of mesothelial cells and CC531 tumour cells 
{data not shown). The effect of Sepracoat™ on the adhesion of tumour cells to mesothelial cell 
monolayers is shown in figure 9.1. Although the differences were small, tumour cell adhesion in 
the presence of Sepracoat™ was significantly less than in controls at all time points (p < 0.05) 
Effect of Sepracoat™ on tumour cell adhesion and growth in minimally traumatised 
abdominal cavities (in vivo) 
Table 9.1 shows that intra-abdominal injection of Sepracoat™ after infliction of minimal 
peritoneal trauma did not significantly decrease the median total tumour load '1n comparison to 
the median total tumour load found in abdominal cavities injected with PBS (p = 0.6). Only at 
one peritoneal site (the parietal peritoneum) the median tumour load was significantly lower in 
the group injected with SepracoatrM than in the control group injected with PBS (p = 0.03). 
Effect of Sepracoat™ on tumour cell adhesion and growth at minimally and severely 
traumatised peritoneal sites {in vivo) 
Table 9.2 shows that neither at the severely nor at the minimally traumatised peritoneum of the 
uterus horn the median tumour load could be significantly impaired by intra-abdominal 
inoculation of SepracoatTM before peritoneal traumatisation (p:;.:: 0.8). 
The median tumour load at not directly traumatised peritoneal sites and the median total 
tumour load did not differ significantly in groups intra-abdominally treated with SepracoatTM or 
PBS (p ~ 0.05) (Table 9.3). 
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Time dependent adhesion of CC531 tumour cells to mesothelial monolayers in the presence 
(filled bars) or absence (open bars) of Sepracoat'"- P < 0.05 at all time points. The number of 
cells adhering was estimated by DNA measurements (ng of DNA per well). Data were 
expressed as the mean and SO. Statistics: ANOVA test with Newman-Keuls post hoc test. 
Abdominal sites Tumour load Tumour load p 
I. Sepracoat TM II. PBS 
n= 9 n=9 
Uterus horns 0 (0-0) 0 (0-0) ns 
Subcutis 3 (0-4) 3 (1-3) ns 
Parietal peritoneum 0 (0-1) 1 (0-3) 0.03 
Kidney 2 (0-4) 2 (0-3) ns 
Liver 1 (1-3) 1 (0-3) ns 
Retroperitoneum 1 (0-3) 1 (0-3) ns 
Omentum 2 (1-4) 2 (1-4) ns 
Total 2 (0-4) 2 (0-4) ns 
Table 9.1 
Median tumour load (range) at different not directly traumatised peritoneal sites in rats having 
undergone a laparotomy followed by injection of 3 ml Sepracoat'M (group I) or 3 ml PBS (group 
II). For each rat, the individual data concerning the 2 uterus horn sites were averaged·, n is the 
number of data(= rats) per group used for analysis. Statistics: Mann-Whitney U test. 
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Abdominal sites Tumour load Tumour load p 
Ill. Sepracoat™ IV. PBS 
n=5 n=4 
Medipres rubbing 4 (2-4) 4 (2-4) ns 
No touch 4 (2-4) 3 (2-4) ns 
Table 9.2 
Median tumour load {range) at uterus horns severely traumatised by rubbing with Medipres 
gauze and at not directly traumatised uterus horns in rats inoculated with 3 ml Sepracoat™ 
(group Ill) or 3 ml PBS (group IV). N is the number of data (uterus horns) per group used for 
analysis. Statistics: Mann-Whitney U test. 
Abdominal sites Tumour load Tumour load p 
Ill. Sepracoat™ IV. PBS 
n=5 n=4 
Subcutis 3 (0-4) 3 (1-3) ns 
Parietal peritoneum 0 (0-0) 0 (0-0) ns 
Kidney 1 (0-2) 1 (0-2) ns 
Liver 1 (0-2) 1 (0-3) ns 
Retroperitoneum 1 (0-3) 1 (0-3) ns 
Omentum 2 (1-4) 2 (2-4) ns 
Total 2 (0-4) 1.5(0-4) ns 
Table 9.3 
Median tumour load (range) at different not directly traumatised peritoneal sites in rats having 
undergone a laparotomy followed by inoculation of 3 ml SepracoatTM (group Ill) or 3 ml PBS 
(group IV). In all rats at least one uterus hom was rubbed with severely traumatising Medipres 
gauze. N is the number of data(= rats) per group used for analysis. Statistics: Mann-Whitney U 
test. 
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DISCUSSION 
Sheets and solutions containing HA have clinically and experimentally shown to be effective in 
preventing surgery-induced adhesion formation. 3.8 HA is an important component of the extra 
cellular matrix (ECM) and mesothelial cells, both of which play pivotal roles in tumour cell 
adhesion. HA is a principal ligand for CD44 which is an ubiquitous, multistructural and 
multifunctional surface adhesion molecule regulating cell-cell and cell-matrix interactions.13 
CD44 and its variants are present on many cancer cell types and have found to be involved in 
local tumour progression and metastasis. 14· 15 C044 is also present on tumour CC531.16 
Therefore, a major objective of the current study was to investigate whether peroperative 
application of a HA containing solution, i.e. Sepracoat™, might affect the local adhesion and 
growth of "spilled" tumour cells. We anticipated that pre-treatment with Sepracoat™ might 
reduce the severity of peritoneal trauma by protecting the mesothelial cell lining, and thus 
prevent activation of the mesothelium and exposure of ECM. Consequently, tumour cell 
adhesion might have been decreased, especially at traumatised sites. The results obtained in 
the tumour adhesion and growth model indicate that this was not the case. If anything, 
Sepracoat™ seemed to enhance tumour cell adhesion to traumatised peritoneal sites, resulting 
in a higher score at the uterine horns and subcutis, however the differences were not 
statistically significant. It is noteworthy that there was no difference between the tumour load 
scores at the rubbed and unabraided uterus horns. A difference might have been expected 
because of the recently demonstrated relationship between degree of trauma and tumour 
load.2 The explanation for this seemingly discrepancy is that local intra-peritoneal trauma does 
affect the whole peritoneal cavity. The existence of this emanation phenomenon has currently 
been demonstrated by van den To! et al.2 In the laparotomy model the inflicted surgical trauma 
was relatively mild and consisted of laparotomy only. We previously demonstrated that this 
procedure suffices to enhance the intra-peritoneal adhesion and growth of CC531 tumour cells 
considerably, as compared to the minimal outgrowth occurring in rats that did not undergo 
surgery. 17 Sepracoat™ applied in this mild surgical setting may, theoretically, act in two 
opposite directions. Firstly, it may decrease mesothelial activation and consequently tumour 
cell adhesion by preventing dissication. On the other hand, Sepracoat™ applied on an intact 
mesothelial surface may improve tumour cell adhesion by providing numerous sites for HA-
CD44 interaction. The results in our in vitro studies do not support the hypothesis that 
Sepracoat™ may improve tumour cell adhesion; on the contrary the adhesion of tumour cells to 
mesothelial monolayers was inhibited. Our in vivo results in the laparotomy model were 
obvious; except for one site, there were no significant differences in tumour load scores 
between the two groups. Possibly this was the net result of the two opposing mechanisms 
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described above. 
In conclusion, although the in vitro results indicate that Sepracoat™ may inhibit the adhesion of 
tumour cells to mesothelial surfaces, this effect had no impact in vivo, when it had neither a 
beneficial nor a detrimental effect on intra-abdominal tumour cell adhesion and growth in the 
models used. 
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Chapter X 
lcodextrin® Is a Potent Inhibitor of Postoperative 
Adhesion Formation in Rats but Does not Affect 
Intra-Peritoneal Tumour Cell Adhesion and Growth 
Submitted for publication 
Postoperative adhesion formation and intra-abdominal tumour recurrence are significant 
clinical problems causing severe morbidity and mortality. Peroperative peritoneal trauma 
activates a cascade of peritoneal defence mechanisms responsible for postoperative 
adhesion formation. The same cascade may, according to our previous studies, play a key 
role in the process of intra-abdominal tumour recurrence after "curative" resection of 
co/orectal carcinomas. The purpose of the present study was to evaluate the influence of a 
new glucose polymer solution, which physically separates peroperatively injured peritoneal 
surfaces (icodextrin®), on postoperative intra-abdominal adhesion formation and tumour 
recurrence. 
Reproducible rat models allowing semiquantitative scoring of adhesion formation or tumour 
load were used in three different groups of rats. After the infliction of severe peritoneal 
trauma one group was treated by peroperative intra-abdominal instillation of a 7.5% 
icodextrin® solution, one by instillation of RPM/ (placebo) and in one group there was no 
instil/ate (controls). 
Treatment of severely peritoneally traumatised rats with icodextrin® caused a more than 60% 
reduction in postoperative adhesion formation (p < 0.0001), while RPM/ treatment had no 
significant effect. Peroperative intra-abdominal treatment with icodextrin® did not affect intra-
peritoneal tumour cell adhesion and growth of free intra-abdominal tumour cells in severely 
traumatised peritoneal cavities. 
/codextrin® was found to be a well tolerated, safe and easy to use solution that effectively 
reduces extent and severity of postoperative adhesion formation in rats without promoting or 
inhibiting tumour recurrence. 
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INTRODUCTION 
Postoperative adhesion formation is a major, up till now unavoidable complication of any kind 
of abdominal surgery. Postoperative adhesions occur in 55-100% of patients undergoing 
surgery, with an average of approximately 85%.w These adhesions can result in bowel, 
fertility and abdominal syndromes. Adhesions are the cause of 30% of all bowel 
obstructions, 4-6 of 15-20% of infertility in women7• 8 and of 13-26% of chronic pelvic pain in 
women. 9· 10 Adhesions also increase the technical difficulty and the risk of intraoperative 
complications at subsequent surgery. 11 Clearly, in addition to morbidity and mortality 
adhesion formation also has financial consequences.12-14 A simple cost effective method to 
reduce or prevent adhesion formation is therefore needed. 
Different animal and clinical studies have indicated that placement of absorbable barriers like 
expanded polytetraflouroethylene (Preclude®), polaxamer 407, oxidized regenerated 
cellulose (INTERCEED®), or hyaluronic acid/carboxymethylcellulose (Seprafllm™) between 
injured peritoneal sites, or the peroperative intra-abdominal application of a viscous solution 
such as ionically cross-linked 0.5% hyaluronic acid (lntergel™), 32% dextran 70 (Hyskon®) or 
low viscosity 0.04% hyaluronic acid (Sepracoat™), can reduce postoperative adhesion 
formation.1S-23 A major disadvantage of the site-specific adjuvants is that the surgeon must 
augur adhesion formation sites to determine barrier placement Non site-specific adjuvants 
show doubtful adhesion preventive qualities and are associated with undesirable local and 
systemic side effects like oedema, body weight and central venous pressure increase, and 
transient liver function disturbances.24•26 To overcome these problems, a glucose polymer 
solution already successfully and safely used in peritonea! dialysis was recently further 
developed into a fluid that is absorbed only slowly, allowing prolonged "hydroflotation" of the 
peritoneal cavity.27" 28 One aim of this study was to further evaluate the adhesion reducing 
effect of this new glucose polymer solution, icodextrin®, in a well-defined rat adhesion model. 
Despite intentionally curative resection for gastro-intestinal carcinoma, local recurrence and 
peritoneal dissemination are a common cause for post-surgical tumour recurrence. 29 
Distribution patterns of first peritoneal recurrence show that the resection site is preferential, 
and combined recurrence on peritoneal surfaces and resection site is common.30 We and 
others previously suggested that the dynamic cascade of peritoneal healing, induced by 
peritoneal damage, leading to adhesion formation also seems to be important in the process 
of intra-peritoneal adhesion and growth of tumour cells. 30' 31 Indeed previously described 
clinical and experimental studies showed that surgical trauma may promote intra-abdominal 
tumour recurrence. 31 .33 The degree of inflicted peritoneal trauma correlated with the extent of 
intra-abdominal tumour load. 31 The second aim of this study was to analyse the effect of 
icodextrin® on tumour recurrence. Using a reproducible rat tumour adhesion and growth 
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model we analysed whether icodextrin® might reduce or possibly promote the adhesion and 
growth of intra-peritoneally injected tumour cells. 
MATERIALS AND METHODS 
Animals 
Female inbred WAG rats of reproductive age weighing 145-190 g were obtained from 
Harlan-CPS, Austerlitz, The Netherlands. The rats were bred under specific pathogen-free 
conditions. The animals were kept under standard laboratory conditions (temperature 20-
24"C, relative humidity 50-60%, 12 hours light and 12 hours dark cycles), fed with standard 
rat food and water ad libitum and quarantined in our University facilities for at least two days 
prior to use. The experimental protocol adhered to rules laid down by the Dutch Animal 
Experimentation Act and was approved by the Committee on Animal Research of the 
Erasmus University Rotterdam, The Netherlands. 
lcodextrin® 
We used the 7.5 % solution of icodextrin, which is regularly used for peritoneal dialysis 
(Extraneal™, Baxter Healthcare Inc.). lcodextrin is a biodegradable, biocompatible, a-1,4 
linked glucose polymer. The large icodextrin molecule is not digested intra-abdominally but 
is, via the lymphatic system, gradually absorbed into the bloodstream where it is partitioned 
sequentially by the enzymes a-amylase and maltase to maltose and glucose. Previous 
experimental and clinical studies assessed the safety, tolerability and preliminary 
effectiveness with regard to reducing postoperative adhesion formation. A volume of 20 ml 
per kg bodyweight has been indicated as the optimal applicable volume. 27· 28 
Tumour 
Tumour CC531 is a 1 ,2-dimethylhydrazine-induced, moderately differentiated, weakly 
immunogenic colonic adenocarcinoma transplantable in syngeneic WAG rats. 34 The tumour 
is maintained as a cell culture in RPM! 1640 medium supplemented with 5% foetal calf 
serum (virus- and Mycoplasma-screened), 1% penicillin (5000 U/mL), 1% streptomycin (5000 
U/mL) and 1% L-glutamine (200 mmol). Medium and all supplements were obtained from 
Life Technologicals BV, Breda, The Netherlands. Cells were passaged once a week using 
trypsin (0.05%) and EDTA (0.02%). Before use in vivo, tumour cells were harvested from 
stationary cultures by gentle trypsinisation (5 minutes, 3rC), centrifugation (5 minutes, 700 
g) and re-suspension in RPM I 1640, providing cell suspensions with a viability greater than 
90%. CC531 is relatively insensitive to chemotherapy but is sensitive to the effects of biologic 
response modifiers. 
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Operative procedures 
To study the effect of icodextrin® on adhesion formation our previously described 
reproducible rat adhesion model was used.35 Briefly, under ether anaesthesia and aseptic 
conditions a laparotomy was performed using a lower midline incision of 5 em. Three 
Surgilene 5-0 sutures (Braun, Melsungen, Germany) were applied to both lateral peritoneal 
sides 0.7 em from each other and 1.5 em downwards from the abdominal ·Incision. All knots 
were double knots fastened tightly to ensure local ischemia. Both uterus horns were 
exposed, rubbed with surgical Medipres gauze (van Heek Medical, Lasser, The Netherlands) 
and sutured to the lateral peritoneum with Surgilene 6-0 (Braun) proximally and distally from 
the three 5-0 sutures. Rubbing was performed with a device enabling the application of a 
constant pressure of 120 g/cm2 . The uterus horns were rubbed 10 times over their total 
length. In this way a standardised amount of severe peritoneal trauma was inflicted. Before 
closing the abdominal cavity the rats were treated by intra-abdominal instillation of 
icodextr"1n®, RPMI (placebo) or received no further treatment (controls). The abdomen was 
closed in two layers with 5-0 polyglycolic acid and 2-0 silk sutures (Braun). 
To study the effect of icodextrin® on local tumour recurrence our previously designed 
reproducible tumour adhesion and growth model was used. 31 Under ether anaesthesia and 
aseptic conditions a laparotomy was performed using a !ower midline ·Incision of 5 em. Both 
uterus horns were exposed, rubbed 10 times with surgical Medipres gauze and sutured to 
the lateral peritoneum both proximally and distally, using Surgilene 6-0 sutures. In this way a 
standardised amount of severe peritoneal trauma was inflicted. After traumatising the 
peritoneum icodextrin®, RPMI (placebo) or nothing (control) was administered intra-
abdominally. Before closing the abdomen, 0.5 x 106 CC531 tumour cells, in 1 ml RPM I 1640, 
were injected intra-peritoneally. The abdomen was closed in two layers with 5-0 polyglycolic 
acid and 2-0 silk sutures. 
Experimental design 
Effect of icodextrin® on adhesion formation 
In 30 rats standardised severe peritonea! trauma was inflicted to both lateral peritoneal sides 
by applying 3 sutures in, and fixating the rubbed uterus horn to the lateral peritoneum. At the 
end of surgery in 10 rats (group I) 3 ml icodextrin® and in 10 rats (group II) 3 ml RPMI 
(placebo) was instilled intra-abdominally prior to closure of the abdomen. In 1 0 rats (group Ill) 
there was no instillate (controls). 
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Effect of icodextrin® on tumour cell adhesion and growth 
In 30 rats standardised severe peritoneal trauma was inflicted by rubbing the exposed uterus 
horns and fixating them to the lateral peritoneum. In 10 rats (group IV) 3 ml icodextrin® and in 
10 rats (group V) 3 ml RPM I (placebo) was administered intra-abdominally after traumatising 
the peritoneum. Ten rats (group VI) received no treatment (controls). Before closing he 
abdomen the CC531 tumour cells were injected intra-peritoneally in all groups. 
Evaluation of adhesion formation 
Fourteen days after laparotomy all rats were sacrificed for assessment of intra-abdominal 
adhesion formation. Macroscopically the adhesions were scored according to their extent 
(quantity) and type (quality) by two independent observers. The extent of adhesion formation 
was quantified by dividing the area to be scored into eight segments marked by the three 5-0 
sutures in the lateral peritoneum (Figure 3.3, Chapter 3). The presence or absence of 
adhesions in the eight demarcated areas was scored. If there were adhesions in an area this 
accounted for 12.5% adhesions; a maximum of 100% adhesions could be scored. In each rat 
two lateral peritoneal sides were assessed. The type of adhesions formed was classified 
macroscopically using the Zuhlke classification (Table 3.1, Chapter 3). 36 
Evaluation of intra-peritoneal tumour cell adhesion and growth 
Twenty-one days after surgery all rats were sacrificed and intra-peritoneal tumour load was 
scored semiquantitatively at the following peritoneal sites: right uterus horn, left uterus horn, 
subcutaniously (at the site of the operative scar), parietal peritoneum (at the lateral 
abdominal wall sides where no uterus horns were fixated), kidney, liver, retroperitoneum, and 
omentum. The scoring was performed by two independent observers using a tumour scoring 
system derived from the peritoneal cancer index described by Steller and ranging from 0 to 5 
per abdominal site (Table 6.1, Chapter 6).37 For each rat the score at all peritoneal sites, 
except for the uterus horns, was summarised, from which a mean total tumour load per rat 
could be estimated. In the present study the term tumour recurrence is sometimes used to 
illustrate tumour load, which is the net result of tumour cell adhesion and tumour growth, 
because we presume that intra-peritoneal injection of tumour cells resembles the clinical 
situation of tumour cell spill during tumour resection. 
Statistical analysis 
The mean adhesion percentage and standard deviation was calculated per group. Data were 
statistically analysed using the one-way ANOVA test to determine overall differences. If the 
ANOVA test was significant on a 5% level, the Student Newman Keuls post hoc test was 
carried out to make a comparison between groups. 
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The median and range of intra-peritoneal tumour load at each scored abdominal site and of 
the total tumour load were calculated per group. Statistical analysis was performed using the 
non-parametric Kruskall Wallis test to determine overall differences followed by the Mann-
Whitney U test to compare differences between groups. Statistical significance was defined 
asp< 0.05. 
RESULTS 
None of the rats were found to have adhesions at the initial operation. There were no 
postoperative complications e.g. bowel obstructions, peritonitis or tumour overgrowth. No 
leaking of fluids from the abdominal wounds and no postoperative bulging of abdomens was 
observed. No remnant fluids were found at necropsy at day 14 or day 21. 
Effect of icodextrin® on adhesion formation 
Table 10.1 shows that icodextrin® significantly reduced postoperative adhesion formation 
after severe peritoneal trauma (p < 0.0001 ). The mean adhesion percentage found after 
peroperative instillation of RPMI did not differ significantly from that of controls. The 
adhesions formed in the icodextrin® group were filmy (Zuhlke type 1-2) involving only pelvic 
fat. Adhesions found after administration of RPM I and in controls were stronger (ZUhlke type 
2-3), involving pelvic fat, uterine horn and small boweL 
Effect of icodextrin® on tumour cell adhesion and growth 
Table 10.2 shows the tumour scores at directly traumatised peritoneal sites, at remote non-
traumatised peritoneal sites and also depicts the total tumour load. Treatment with 
icodextrin® or RPM I did not significantly affect tumour load on severely traumatised uterus 
horns. The median total tumour scores (at not directly traumatised peritoneal sites) were 
similar in the three experimental groups. At one peritoneal site (retroperitoneum) the tumour 
score in the icodextrin® group was significantly lower than in the control group (p = 0.007). 
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Uterus horns n Percentage adhesion Zuhlke p1 p2 p3 
formation (SD) score 
I. Medipres rubbing 10 19.3 (8.0) 1-2 0.0001 
& 3 ml icodextrin® 
II. Medipres rubbing 10 65.0 (7.3) 2-3 ns 
&3ml RPMI 
Ill. Medipres rubbing 10 69.9 (14.9) 2-3 0.0001 
Table 10.1 
Mean adhesion percentages (SO), and ZUhlke classification of found adhesions, after infliction 
of severe peritoneal trauma and intra-abdominal instillation of icodextrin® (group I) or RPMI 
(group II) and in non-treated controls (group Ill). For each rat, the individual data concerning 
the 2 lateral abdominal wall sites (uterus horns) were averaged; n is the number of data (= 
rats) per group used for analysis. Statistics p1 (I versus II), p2 (II versus Ill) and p3 (I versus 
Ill): one-way ANOVA test, with Student Newman Keuls post hoc test. 
Abdominal sites Tumour load Tumour load Tumour load p1 p2 p3 
IV. lcodextrin® V. RPMI VI. No treatment 
n = 10 n = 10 n = 10 
Uterus horns 5 (3.5-5) 5 (4-5) 5 (5-5) ns ns ns 
Subcutis 3 (2-3) 3 (2-4) 3 (2-4) ns ns ns 
Parietal peritoneum 0 (0-2) 0 (0-1) 0 (0-1) ns ns ns 
Kidney 2 (0-4) 2 (1-3) 2 (1-3) ns ns ns 
Liver 1 (1-1) 1 (0-2) 1 (1-2) ns ns ns 
Retroperitoneum 0 (0-0) 0 (0-1) 1 (0-1) ns ns 0.007 
Omentum 2.5 (2-4) 3 (2-4) 3 (1-4) ns ns ns 
Total 1.6(1-2) 1.7 (1-2) 1.8(1-2) ns ns ns 
Table 10.2 
! 
Median tumour load (range) at severely traumatised uterus horns, at non-traumatised 
peritoneal sites, and the median total tumour load after intra-abdomina! instillation of 
icodextrin® (group IV), intra-abdominal instillation of RPMI (group V) or in non-treated 
controls (group VI). For each rat, the individual data concerning the 2 uterus horn sites were 
averaged. N is the number of treated rats. Statistics p1 (IV versus V), p2 (V versus VI) and 
p3 (IV versus VI): Kruskall Wallis test with Mann-Whitney U post hoc test. 
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DISCUSSION 
The aetiology of adhesion formation is only partly understood but the process is initiated by 
traumatising the peritoneal surface either by surgical action, by endometriosis, or by 
infection.35· 38"40 The formation of an adhesion commences with injury to two layers of the 
peritoneum, one opposite the other, and the resulting exudation contributes to the deposit of 
fibrin and adhesion between the two membranes.41 ' 42 Whether such adhesions are 
permanent or will eventually be lysed, is assumed to be dependent on the fibrinolytic 
capacity of the peritoneum.4244 A wide variety of therapeutic modalities affecting different 
levels in the cascade of f1binogenesis and fibrinolysis have been studied experimentally and 
clinically.45-48 Results are inconsistent and associated with many side effects such as intra-
abdominal haemorrhage and impaired wound healing. Avoiding per- and postoperative 
contact between traumatised peritoneal surfaces might bring us closer to reducing 
postoperative adhesion formation. Increasing the physiological liquid interface between two 
peritoneal surfaces is liable to reduce the initial adhesion phenomena at its origin. Indeed in 
a rat model, postoperative peritoneal dialysis significantly reduced adhesion formation, 
presumably due to a flotation effect and dilution of the fibrin exudates.49 Obviously, 
postoperative peritoneal dialysis is not feasible in the clinical setting but these results 
stimulated further investigations. Various liquids have been installed peroperatively in the 
peritoneal cavity with the hope that "hydroflotation" would enable traumatised surfaces to be 
kept separate for a while. 21 -23 Unfortunately these liquids were absorbed too quickly to bring 
about clinical successful adhesion prevention50 or caused unwanted side effects.25· 26 
Separating peritoneal surfaces by means of slow absorption solutions, allowing prolonged 
postoperative "hydrofoliation" of the peritoneal cavity might have a more efficient anti-
adhesive effect. lcodextrin is a large a-1,4 linked glucose polymer broken down sequentially 
by the enzymes a-amylase and maltase to maltose and glucose. Amylase is widely 
distributed throughout the body but '1s not or hardly present in the peritoneal cavity of humans 
and rats. When administered peroperatively, icodextrin is largely retained within the 
abdominal cavity for up to five days during which the polymer is gradually absorbed through 
the lymphatic system into the systemic circulation. 51 lcodextrin 7.5%, although iso-osmolar, 
induces ultrafiltration through colloid osmosis and the presence of the polymer is presumed 
to create a constant fluid layer between peritoneal surtaces.52 Theoretically, the fluid acts to 
reduce the formation of adhesions by a 5-day period of "hydroflotation" of the total abdominal 
cavity, the time of maximum risk of adhesion formation. 53· 54 This study showed that after 
severe surgical peritoneal trauma icodextrin® significantly reduced the extent and severity of 
adhesion formation. 
152 
We have previously suggested that the peritoneal defence mechanism triggered by surgical 
trauma to the peritoneum not only promotes adhesion formation but also stimulates tumour 
recurrence. 31 Several theories speculate on the underlying mechanisms of the adhesion and 
growth of spilled tumour cells. Implantation of tumour cells onto raw tissue surfaces is an 
efficient process as opposed to implantation on intact surfaces. 30 The fibrin entrapment 
hypothesis proposes that tumour cells are trapped in fibrin at the resection site and abraded 
peritoneal surfaces, hereby providing protection from host defence mechanisms. 55 Whether 
postoperative "hydroflotation", could also keep free intra-abdominal tumour cells from 
adhering to damaged peritoneum was doubtful since icodextrin® does not prohibit disruption 
of the mesothelial cell lining and exposure of the underlying extracellular matrix playing a 
pivotal in adhesion of tumour cells. Results obtained in our tumour adhesion and growth 
model showed that tumour load at traumatised peritoneal surfaces indeed was not reduced 
by peroperative intra-abdominal icodextrin® treatment. This does not mean that there is no 
analogy in the processes of adhesion formation and tumour recurrence. Apparently it is not 
possible to keep free floating tumour cells from an injured peritoneal surface by a liquid 
barrier in which tumour cells suspend and stay alive. Physically, icodextrin® does not form a 
barrier between tumour cells and damaged peritoneal surfaces as it does between two 
injured peritoneal surfaces. lcodextrin® might be a medium in which tumour cells can 
proliferate and augment motility, increasing their metastatic ability. The results of this study 
did not support this hypothesis since total peritoneal tumour load at traumatised and remote 
peritoneal sites was not increased by icodextrin®, on the contrary tumour load at one remote 
peritoneal site was even s'1gnificantly reduced in the icodextrin® treated group. 
In conclusion the current study showed that the novel glucose polymer solution, icodextrin®, 
used as an intraoperative intra-abdominal instillate was well tolerated, safe, easy to use and 
significantly reduced postoperative adhesion formation without promoting or inhibiting tumour 
recurrence. lcodextrin® therefore seems to be a good modality to prevent intra-peritoneal 
adhesion formation and may be used safely in oncological surgery. 
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PARTV 
General Discussion and Summary 

Chapter XI 
General Discussion 
Surgical peritoneal trauma and postoperative adhesions 
Peritoneal trauma causes a disturbance of the normal intra-abdominal inflammatory and 
fibrinogenetic defences leading to a disrupted equilibrium between mediators of the 
inflammatory response and between fibrinigenesis and fibrinolysis and thus induces post-
surgical adhesions. Due to a lack of complete understanding of the dynamic process of 
peritoneal healing and its derailment, literature abounds on all kinds of methods to prevent 
adhesion formation. The results achieved with the different treatment modalities are 
inconsistent and associated with many side effects such as impaired wound healing, 
reduction of the immune system, intra-abdominal haemorrhage and gastrointestinal bleeding. 
Until today, only one technique is effective in reducing the occurrence of post-surgical 
adhesions to some extent. This technique aims to avoid manipulations which are known to 
provoke adhesion formation. 1·5 That includes preventing unnecessary desiccation, handling, 
clamping or suturing (ischaemia) of tissue and spilling of foreign material during operative 
intervention.4' 5 Also, general agreement exists that it is unnecessary and even unwanted to 
close the peritoneum postoperatively. 6-17 However, although peritoneal trauma was proven to 
be a cause of adhesion formation, a link between the degree of peritoneal trauma and the 
extent of formed adhesions was never demonstrated. 6· 18· 19 Therefore, the first aim of the 
experiments described in this thesis was to analyse whether the extent and type of post-
surgical adhesion formation correlates with the degree of peritoneal damage inflicted. In order 
to evaluate this, we developed a reproducible rat model, allowing semiquantitative and 
qualitative scoring of adhesions in vivo in which the clinical situation of post-surgical 
adhesion formation was imitated. Results of the first experiments showed that the extent of 
adhesion formation correlated significantly with the inflicted degree of peritoneal damage. 
Furthermore one of the aims of studies portrayed in this thesis was to identify whether agents 
like surgical gauze, lavage solutions and glove powder, not yet generally considered as 
traumatic for the peritoneum and commonly used in general surgical practice, indeed were 
traumatic and could consequently cause postoperative adhesions. We also investigated less 
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traumatic alternatives for these agents. Experimental results demonstrated that intra-
abdominal manipulation with surgical Medipres gauze was very traumatic to the peritoneum 
and induced significantly more adhesion formation than manipulation of the peritoneum with 
less traumatic non-surgical Fastsorb textile. Moreover, there was no significant difference in 
the extent and type of adhesions formed after infliction of minimal peritoneal trauma alone or in 
combination with Fastsorb manipulation, suggesting Fastsorb is hardly traumatic for the 
peritoneum. Given these results and the fact that non-surgical Fastsorb textile meets important 
criteria for surgical abdominal swabs, this non-abrasive textile might be a suitable substitute for 
Medipres gauze in surgical practice. Further experiments showed that exposure of the 
abdominal cavity to lavage solutions, often used in the end stage of abdominal interventions, 
also traumatised the peritoneum and engendered significant adhesions formation. During 
surgery in non-contaminated abdominal cavities peritoneal lavage should not be performed 
and per-operative lavage of contaminated abdominal cavities should be viewed with caution. 
Last but not least, because powdered gloves are still universally used in abdominal surgery, 
we performed the studies demonstrating that local application of glove powder on minimally 
and severely traumatised peritoneum gave rise to a significantly higher percentage of 
adhesion formation than infliction of peritoneal trauma alone. This finding adds to the already 
existing evidence20-25 that intra-abdominal contamination with starch by the use of starch 
powdered gloves should be avoided. 
Surgical peritoneal trauma and tumour recurrence 
Most attempts at treating intra-abdominal tumour recurrence, like local or regional chemo-
and radiotherapy and photodynamic therapy,27-30 are aimed at annulling manifest peritoneal 
tumour foci but do not focus on prohibiting the postoperative arising of local tumour 
recurrence. A different approach to diminishing post-surgical intra-abdominal tumour 
recurrence is to interfere with the primary implantation and growth process of intra-
abdominally spilled free tumour cells. This necessitates a profound understanding of the 
underlying pathophysiologic mechanisms leading to local tumour recurrence. Subsequent 
studies described in this thesis were aimed at unravelling the !inks between surgical 
peritoneal trauma and the process of postoperative adhesion formation and intra-abdominal 
tumour recurrence and analysing the similarities amongst the latter. 
The observed preference of tumours to recur at surgically traumatised sites26• 31 -35 and the 
theory of metastatic efficiency and the tumour cell entrapment hypothesis26 brings up the 
question whether the dynamic peritoneal healing process, which when not in balance can 
lead to adhesion formation, also plays a role in the process of local tumour recurrence. This 
ascertainment and theoretic perceptions led us to investigate if a correlation existed between 
surgical peritoneal trauma and intra-abdominal tumour recurrence. 
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In order to meet this purpose and evaluate patterns of tumour recurrence in vivo, different rat 
models were used. We developed a reproducible rat tumour adhesion and growth model, 
analogous to the rat adhesion model, allowing semiquantitative scoring of tumour load in 
which the clinical situation of free intra-abdominal tumour cells was mimicked. This model 
associates the combination of cell adhesion and growth, ultimately leading to manifest 
tumour load. The amount of tumour recurrence at directly and not directly traumatised 
peritoneal sites appeared to be highly correlated with the degree of peritoneal trauma. The most 
impressive tumour load was observed at severely traumatised peritoneal sites. However, 
enhanced tumour recurrence was also seen at not directly traumatised peritoneal sites and the 
amount of tumour at these loco-regional sites also correlated with the severity of the trauma. 
This indicates that the sequelae of peritoneal trauma with regard to tumour recurrence are not 
confined to the inflicted site itself, but appear to have a generalised character. In a previously 
developed sub-renal capsule assay, the effect of surgical peritoneal trauma on the growth of 
extra-peritoneal tumours could be reproduced. Because promotion of adherence was 
irrelevant in this model it represents the systemic effects on tumour growth that may occur 
after surgical injury. After placing a solid tumour in the extra-peritoneal space, the intensity of 
surgical trauma correlated with the extra-peritoneal tumour growth, suggesting that systemic 
factors produced after surgical peritoneal trauma indeed play an important role in enhanced 
tumour growth. The apparent generalised character of tumour recurrence led to the 
hypothesis that factors produced after peritoneal trauma, may influence loco-regional and 
distant aspects of tumour recurrence. When these factors were captivated in a peritoneal 
lavage fluid and passively transferred to naive recipients, this hypothesis was confirmed. To 
study merely the effect of tumour cell adhesion an in vitro model was designed. Culturing a 
monolayer of mesothelial cells on a matrix coating mimicked the peritoneum. Tumour cell 
adhesion to mesothelial cells could be studied after pre-incubating the mesothelial monolayer 
with different substances. In experiments using this model, described by van Rossen et al, 36 
cytokines and growth factors, produced by exposed endothelial cells, damaged mesothelial 
cells and inflammatory cells during peritoneal wound healing,3741 proved to be significant 
promoting factors in tumour cell adhesion to mesothelium. Supported by these results the 
initial impetus to separate the generalised term "tumour recurrence" into the more elementary 
mechanisms of tumour cell adhesion and growth was made. Both components may 
contribute evenly to successful intra-abdominal tumour recurrence and both are modified by 
surgical trauma. 
As mentioned before, previous experiments showed that exposure of peritoneal cavity to 
surgical gauzes, lavage solutions and glove powder traumatised the peritoneum and 
promoted postoperative adhesion formation. Since subsequent data suggest that the factors 
responsible for the formation of post-surgical adhesions also play a role in the adhesion and 
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growth of tumour cells to the peritoneum we investigated whether surgical gauze and glove 
powder also could induce more tumour recurrence. The studies demonstrated that surgical 
Medipres gauze induced significantly more tumour load than non-surgical Fastsorb textile and 
peritoneal application of glove powder or pure starch induced significantly more intra-
abdominal tumour load than when no powder was applied. Avoiding unnecessary 
peroperative peritoneal trauma by employing gentle surgical techniques and materials is 
therefore not only indicated to reduce postoperative adhesion formation but also to prevent 
intra-abdominal tumour recurrence. In accordance with this goal and given the fact that non-
surgical Fastsorb textile meets important criteria for surgical purposes we again point out that 
this non-abrasive textile seems a suitable substitute for surgical gauze. Intra-peritoneal 
contamination with starch from starch-powdered gloves should also be avoided to prevent 
local tumour recurrence. Since good powder-free alternatives are available there is no longer 
any justification for the use of powdered gloves during intra-abdominal surgery. 
Pathways of adhesion formation and intra~abdominal tumour recurrence 
Since peroperative peritoneal trauma cannot entirely be prevented in practice, the need for 
supplementary prophylactic measures remains urgent. Better understanding of the 
underlying pathogenesis of postoperative intra-abdominal adhesion formation and peritoneal 
tumour cell adhesion and growth will undoubtedly help in the development of balanced and 
more effective therapeutic strategies. Cellular and soluble constituents of the peritoneal 
cavity are believed to both reflect the events arising during wound healing in the peritoneal 
cavity and have the potential to modulate the outcome of tissue response to injury.18· 37-52 As 
cited before, preceding experiments showed that within a few hours after infliction of peritoneal 
trauma tumour cell adhesion and growth promoting factors could be captivated in a peritoneal 
lavage fluid and passively transferred to naive recipients. Further analysis of the fragments in 
the captured lavage fluid brought forward the presence of a cellular and soluble fraction. When 
these fractions were individually injected into pristine abdominal cavities, without any form of 
additional surgical trauma, both induced significantly more peritoneal tumour recurrence. 
However, the effect of the soluble factors was inferior to that of the cellular fraction. More 
detailed unravelling of the cellular fraction demonstrated that peritoneal trauma induces 
oscillation in intra-abdominal cells. Apart from an augmented absolute cell amount, the ration 
changes from primarily monocytes to mainly neutrophil granulocytes (PMN). This observation 
was made during the acute phase after surgery and most likely represents the PMN influx in 
response to chemoattractant factors. The coincidence of posttraumatic intra-abdominal PMN 
influx with adhesion formation and tumour cell adhesion and growth is no solid prove for the 
role of PMN in these pathogenetic processes. Therefore, studies were performed to 
investigate whether we were able to prohibit posttraumatic intra-abdominal PMN influx. Intra-
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peritoneal injection of anti-neutrophil serum (ANS) indeed foiled this PMN influx in rats. 
Moreover a well-balanced prevention of posttraumatic intra-abdominal PMN influx by ANS 
reduces adhesion formation and local tumour recurrence significantly. Accordingly, intra-
abdom·lnal influx of PMN after surgical peritoneal trauma plays a crucial role in postoperative 
adhesion formation and in the process of adhesion and growth of spilled tumour cells. This 
knowledge opens up the way to develop of novel therapeutic strategies acting subtle, in 
order to prevent unwanted side effects, upon the (dis)balance of the peritoneal healing 
process. 
The adhesion formation and tumour recurrence promoting effect of PMN's may be based on 
several characteristics of these cells. First, through PMN-cytokine production an upregulation 
of cell adhesion molecules may be induced,53· 54 hereby facilitating adhesion of tumour cells. 
In addition, cytokine activated mesothelial cells produce chemoattractants like IL-8, required 
for PMN recruitment. 55· 56 In this way, the mesothelium and inflammatory cells in the 
abdominal cavity may perpetuate a cytokine loop, resulting in extreme activation of the 
inflammatory process. Secondly, mesothelial damage may be aggravated by the 
degranulation of organelles, but most likely through the production of reactive oxygen 
species (ROS). 57 Obviously, affecting one or more of these PMN involving steps in the 
cascade of derailed peritoneal healing may lead to the evolvement of new adhesion and 
tumour recurrence preventive formulas. 
Adjuvant measures to prevent adhesion formation and tumour recurrence 
Developing novel prophylactic measures through unravelling the pathophysiologic 
mechanisms of the peritoneal healing cascade is a time consuming process. In the mean 
time the need to treat today's patients as good as possible remains and on that account we 
analysed the effect of a known adhesion reducing fluid (Sepracoat™),58"61 with also known 
trammels, on tumour recurrence in vivo and tumour cell adhesion in vitro. Hyaluronic acid is a 
principal ligand for CD44 which is an ubiquitous, multistructural and multifunctional surface 
adhesion molecule regulating cell-cell and cell-matrix interactions.62 CD44 and its variants are 
present on many cancer cell types and have found to be involved in local tumour progression 
and metastasis.63 ' 64 Therefore, hyaluronic acid containing solutions theoretically may affect 
local adhesion and growth of free inrta-abdominal tumour cells. The results of our experiments 
demonstrate that Sepracoat™ had a small but significant inhibitory effect on the adhesion of 
tumour cells to mesothelial cell monolayers in vitro. However, we were unable to repeat these 
effects in our in vivo rat models; the peroperative inoculation of Sepracoat™ did not reduce nor 
promote postoperative tumour recurrence. 
To overcome a number of major disadvantages of issued absorbable barriers and viscous 
barrier solutions60· 61 · 65-74 a glucose polymer solution already successfully and safely used in 
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peritoneal dialysis was recently developed into a fluid that is absorbed only slowly, allowing 
prolonged "hydroflotation" of the peritoneal cavity.75• 76 With this "water" barrier technique two 
damaged peritoneal suliaces are mechanically separated during the period of mesothelial 
regeneration, thereby in theory enabling the prevention of adhesion formation. In our hands 
icodextrin® was found to be a well tolerated, safe and easy to use solution that effectively 
reduces extent and severity of postoperative adhesion formation in rats without promoting or 
inhibiting intra-abdominal tumour recurrence. Apparently it is not possible to keep free 
floating tumour cells from an injured peritoneal surtace by a liquid barrier in which tumour 
cells suspend and stay alive. Physically, icodextrin® does not form a barrier between tumour 
cells and damaged peritoneal suliaces as it does between two injured peritoneal suliaces 
during the peritoneal healing process. lcodextrin® seems a very promising development in 
the avenue of future resaerch because next to working as an adhesion reducing adjuvant by 
itself, it could also function as a long lasting carrier for other adhesion and tumour inhibiting 
substances. Whether this treatment modality will proof to be effective in human remains to be 
investigated but experimental studies look promising. 
Considerations for clinical applications. 
Any form of peritoneal trauma is likely to cause postoperative adhes'1on formation and 
enhance intra-abdominal tumour recurrence. The operating skill of the surgeon therefore is a 
relevant factor in adhesion and tumour prognosis. Avoiding of unnecessary desiccation, 
handling, clamping or suturing (ischaemia) of tissue and leaving behind as little foreign 
material as possible during operative intervention are generally accepted measures for 
peliorming surgery in a non-traumatising fashion. 1-5 In addition, we advice surgeons to 
prohibit unnecessary peroperative intra-abdominal use of surgical gauzes and if frequent or 
profound use is inevitable to choose a non-abrasive textile as a substitute. Furthermore during 
surgery in non-contaminated abdominal cavities peritoneal lavage should not be peliormed. 
And moreover since good powder-free alternatives are available powdered gloves should not 
be used during intra-abdominal surgery. Minimal invasive surgery may also diminish the 
extent of peroperative peritoneal injury. 
Still intra-abdominal surgery will always bring about peroperative peritoneal trauma in some 
quantity at some point during operation. Adjuvant measures associated with surgical 
intervention seem a logical step not only to prevent postoperative adhesions but also to avert 
loco-regional tumour recurrence. At the present time, despite the great variety of agents 
employed, none of them seems to be overwhelmingly suitable for effective and save general 
use in the humans. Although it is difficult to manoeuvre, presently the clinically most 
successful and save anti-adhesive measure seems to be hyaluronic acid 
/carboxymethylcellulose. Since it effectively reduces the severity of postoperative adhesions 
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in humans and, as this thesis elaborates by animal studies, did not influence tumour 
recurrence it seems recommendable to use Sepreafilm ™ at least during abdomina! 
interventions which will be followed by planned relaparotomy or second look operations. 
Experiments described in this thesis showed that an easy to handle new glucose polymer 
solution, icodextrin®, could markedly reduce the extent and severity of postoperative 
adhesion formation in rats, (unfortunately) without affecting intra-abdominal tumour 
recurrence. It is too early to know whether these results can be repeated in humans but 
further research, in the form of clinical trials, has to be executed to estimate the clinical value 
of this barrier solution. 
In this thesis, one major step in the pathway of adhesion formation and peritoneal tumour 
recurrence has been brought into perspective. Post-traumatic intra-abdominal PMN influx 
proved to play a major role in the processes of postoperative adhesion formation and intra-
abdomina! tumour recurrence. Efforts to dim the inflammatory reaction by mastering the 
mediators of this process has already been suggested as adhesion and tumour recurrence 
abating alternatives and these experimental results contribute to this idea. In the 
development of such substrates one always has to keep in mind that the peritoneal healing 
processes rely on the same biological me-chanisms as adhesion formation and tumour 
recurrence, thus manipulation of steps in the derailed cascade has to be done selectively 
and in moderation to prevent unwanted side effects. 
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Chapter XII 
Summary and Conclusions 
Postoperative adhesion formation as well as loco-regional tumour recurrence remain serious 
complications of potentially curative surgical intra-abdominal interventions. For neither 
problem clinically relevant curative treatment modalities are available yet. Although 
understanding of the pathogenesis of adhesions and local tumour recurrence has improved 
recently, the molecular mechanisms involved still need to be delineated. Adhesion formation 
and adhesion-free reepithelialisation are alternative pathways of the cascade of the 
peritoneal defence after peritoneal trauma and we assume the same cascade plays a role in 
the process of tumour recurrence. The studies described in this thesis were aimed at 
unravelling the correlation between surgical peritoneal trauma and the process of 
postoperative adhesion formation and intra-abdominal tumour recurrence. 
The only consensus concerning the prevention of postoperative adhesions is the avoidance 
of peroperative damage to the peritoneum through the use of meticulous surgical techniques. 
Subsequently, we also tried to identify whether, besides generally accepted traumatic 
elements and actions, agents like surgical gauze, lavage solutions and glove powder, not yet 
generally considered as traumatic for the peritoneum and commonly used in surgical 
practice, were traumatic and could consequently cause adhesion formation and local tumour 
recurrence. Better understanding of the underlying pathogenesis of both processes is a 
prerequisite to rational prophylaxis and therapy of both surgical complications. 
Further experiments laid down in this thesis aimed at studying which surgery related factors 
affected adhesion formation, tumour cell adhesion and/or growth and consequently tumour 
recurrence. One aspect of the peritoneal response to surgical trauma was highlighted with 
the intention to discover whether this part of the cascade could be used for specific 
therapeutical alternatives. The last experiments appointed in this thesis aimed at evaluating 
the capacity of a new glucose polymer solution, icodextrin®, in reducing adhesion formation 
and the capacity of Sepracoat™ and icodextrin® to modify adhesion and growth of free intra-
abdominal tumour cells. 
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Chapter 1 describes postoperative adhesions as a long term and unpredictable 
problem causing impressive morbidity and even mortality, with great impact in surgical 
workload and hospital resources, resulting in considerable health care expenditures. An 
overview is given of the pathophysiology of the local peritoneal defence cascade following 
peritoneal trauma, sometimes leading to adhesion formation, and of the literature on 
adhesion preventive measures interfering with one or several steps in this dynamic process 
of peritoneal healing. Peritoneal dissemination is a common cause of post-surgical tumour 
recurrence after potentially curative resection of gastro-intestinal adenocarcinomas. The 
theoretical similarities in the pathogenesis of the process of intra-peritoneal tumour 
recurrence and the process of adhesion formation are discussed. 
In Chapter 2, the aims of this dissertation are presented. 
Chapter 3 describes the development of a reproducible rat model allowing 
semiquantitative and qualitative scoring of adhesions. Experiments using this model 
demonstrated that the infliction of minimal peritoneal trauma resulted in a significantly lower 
adhesion percentage than the infliction of moderate or severe peritoneal trauma. Adhesions 
formed after severe and moderate trauma of the peritoneum were dense and thick and could 
be classified as ZUhlke type 2-3, while adhesions formed after minimal trauma of the 
peritoneum were filmy and could be classified as ZUhlke type 1-2. Rubbing of the peritoneum 
with surgical gauze after infliction of minimal peritoneal trauma did induce significantly extra 
adhesion formation. After infliction of minimal peritoneal trauma, rubbing with surgical gauze 
did produce significantly more adhesions than rubbing with non-surgical textile. Moreover, 
rubbing the peritoneum with non-surgical textile after infliction of minimal peritoneal trauma 
did not cause additional adhesion formation at ail. 
Chapter 4 presents the results of studies evaluating the influence of peroperative 
lavage of the abdominal cavity with RPMI medium, NaCI 0.9%, polyvinylpyrrolidone iodine 
1% (PVP-1), Vias pan and chlorhexidine 0.02% on postoperative adhesion formation. They 
show that peritoneal lavage of areas with ischaemic injury was associated with significantly 
increased adhesion formation. Aggressive (chlorhexidine 0.02%) as well as non-aggressive 
(RPMI, NaCI 0.9%, PVP-1 and Viaspan) solutions engendered adhesions. Peritoneal lavage 
with aggressive solutions promoted adhesion formation significantly more than lavage with 
non-aggressive solutions. 
Chapter 5 portrays the development of a reproducible rat tumour adhesion and growth 
model, analogous to the rat adhesion model, allowing semiquantitative scoring of tumour 
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load. This model was employed to test the metastatic efficiency and the tumour cell 
entrapment hypothesis. The displayed results clearly point out that a similar correlation exists 
between local tumour recurrence and peritoneal trauma as between adhesion formation and 
peritoneal trauma. Tumour load at directly and not directly traumatised remote peritoneal sites 
was significantly higher after severe trauma than following moderate or minimal trauma of the 
peritoneum. In addition, a significant correlation between the degree of peritoneal trauma and 
the growth of "ectopic" tumours, situated under the renal capsule, was observed during 
experiments using a previously developed sub-renal capsule assay. Moreover, within a few 
hours after infliction of peritoneal trauma tumour cell adhesion and growth promoting effects 
could be captivated in a lavage fluid and be passively transferred to na·ive recipients. In these 
experiments severe peritoneal trauma was inflicted by rubbing the peritoneal surface with 
surgical Medipres gauze. 
The experiments laid down in Chapter 6 investigate whether the well-known 
adhesion provoking effect of glove powder could be reproduced in our rat adhesion model 
and whether glove powder also promotes intra-abdominal tumour recurrence in our rat 
tumour cell adhesion and growth model. Local application of glove powder or pure starch on 
minimally and severely traumatised peritoneum gave rise to a significantly higher percentage 
of adhesion formation than infliction of peritonea! trauma alone. Peritoneal application of 
glove powder or pure starch induced significantly more intra-abdominal tumour load than 
when no powder was applied. 
The studies in Chapter 7 focussed on further analysing the surgery related factors in 
the abdominal cavity that could be captivated in a lavage fluid and enhance tumour recurrence 
in naive recipients. Lavage fluids collected after trauma could be separated in a cellular and 
supernatant component, the latter containing soluble factors. Intra-peritoneal injection of naive 
recipients with both components resulted in statistically significant more tumour recurrence than 
injection with RPM!. The cellular component of the post-surgical inflammatory process was the 
most potent stimulator of tumour recurrence. Cytokines and growth factors also enhanced 
tumour load but played an inferior role. In vitro tumour cell adhesion to the mesothelium was not 
affected by soluble factors in the lavage ftuid. Analysis of the cellular part of the lavage ftuid, 
gathered after minimal or severe peritoneal trauma, demonstrated a significant influx of 
neutrophils (PMN) after infliction of severe peritoneal trauma. No differences in intra-abdominal 
cytokine concentrations were detected in mildly or severely traumatised rats. However, elevated 
concentrations of IGF-1 were detected in the abdomens of severely traumatised animals. 
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In Chapter 8 the question is addressed whether the observed coincidence of post-
traumatic intra-abdominal PMN influx and the processes of adhesion formation and local tumour 
recurrence are causally related. Experimental results again exposed that infliction of 
peritoneal trauma provokes a significant intra-abdominal PMN influx during a period of at 
least 96 hours post-trauma. This influx could be prevented by treatment with anti-neutrophil 
serum (ANS, 3 and 1 dose). Averting the post-traumatic intra-abdominal PMN influx by 
injection of 3 doses of ANS significantly reduced adhesion formation. Yet, treatment with 3 
doses of ANS did not decrease local tumour recurrence, on the contrary it significantly 
increased tumour recurrence. This was probably the consequence of immunosuppression, 
induced by 3 doses of ANS decreasing the blood lymphocyte, monocyte and PMN counts, 
which does not have an effect on adhesion formation but conceivably does promote tumour 
growth. Therapy with 1 dose of ANS did annul the post-traumatic PMN influx more selectively 
than 3 doses since it only affected blood PMN counts and did not influence blood lymphocyte 
and monocyte count. More selective prevention of post-traumatic PMN influx significantly 
lowered tumour cell adhesion and growth. 
Chapter 9 elaborates on the issue of Sepracoat™ and postoperative intra-abdominal 
adhesion and growth of free intra-peritoneal tumour cells. Sepracoat™ had a small but 
significant inhibitory effect on the adhesion of CC531 tumour cells to mesothelial cell 
monolayers in vitro. However, we were unable to repeat these results in our in vivo rat models, 
the peroperative inoculation of Sepracoat™ did not reduce postoperative tumour load at directly 
or indirectly traumatised peritoneal surfaces. If anything, SepracoatTM seemed to enhance 
tumour cell adhesion to traumatised peritoneal sites, however these differences were not 
statistically significant. 
Chapter 10 deals with the way a new glucose polymer solution, icodextrin®, sways 
the processes of postoperative adhesion formation and local tumour recurrence. 
Peroperative intra-abdominal administration of icodextrin® after infliction of surgical peritoneal 
trauma significantly decreased the extent and severity of found adhesions. Treatment with 
icodextrin® did not prevent nor promote intra-peritoneal tumour eel! adhesion and growth of 
free intra-abdominal tumour cells. 
Chapter 11 includes the general discussion of this thesis. The results of the 
presented studies and the putative explanations for the findings are debated and possible 
considerations for clinical implications are postulated. 
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Conclusions 
The degree of peroperative peritoneal trauma correlates with the extent of 
postoperative adhesion formation. (Chapter 3) 
The degree of peroperative peritoneal trauma correlates with the extent of intra-
abdominal tumour cell adhesion and growth. (Chapter 5) 
Standard surgical gauze is traumatic to the peritoneum and promotes adhesion 
formation and local tumour cell adhesion and growth. (Chapter 3 and 5) 
The non-abrasive textile Fastsorb meets important criteria for surgical swabs, is hardly 
traumatic to the peritoneum and consequently induces less adhesions and tumour cell 
adhesion and growth than standard surgical gauze. (Chapter 3 and 5) 
Lavage solutions are traumatic to the peritoneum and promote adhesion formation. 
(Chapter 4) 
Glove powder is traumatic to the peritoneum and promotes adhesion formation and 
tumour cell adhesion and growth. (Chapter 6) 
Inflammatory cells (mainly PMN), present in the abdominal cavity after surgical 
peritoneal trauma, promote tumour cell adhesion and growth. (Chapter 7) 
Cytokines and growth factors, present in the abdominal cavity after surgical peritoneal 
trauma, promote tumour cell adhesion and growth. (Chapter 7) 
Post-traumatic intra-abdominal neutrophil (PMN) influx is an important factor in the 
derailment of the dynamic cascade of peritoneal defence and preventing this influx 
reduces postoperative adhesion formation and tumour cell adhesion and growth. 
(Chapter 8) 
The hyaluronic acid solution Sepracoat™ reduces tumour cell adhesion to 
mesothelium in culture but has no effect on intra-abdominal tumour cell adhesion and 
growth. (Chapter 9) 
A new glucose polymer, icodextrin®, reduces postoperative adhesion formation very 
effectively but does not affect intra-abdominal tumour cell adhesion and growth. 
(Chapter 10) 
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Chapter XIII 
Nederlandse Samenvatting 
In dit proefschrift wordt nader ingegaan op het verschijnsel van postoperatieve 
adhesievorming en het lokaal in de buik (intra-abdominaal} terugkomen (recidiveren) van 
verwijderde kwaadaardige maagdarm tumoren. Adhesies zijn verklevingen tussen twee 
buikvlies oppervlakken welke normaliter niet met elkaar verbonden zijn. Adhesievorming 
ontstaat na bijna iedere buikoperatie en veroorzaakt meestal geen klachten. Tach kunnen 
adhesies leiden tot een aantal ernstige complicatles zoals darmobstructies, welke vaak acuut 
opnieuw operatief ingrijpen vereisen, onvruchtbaarheid bij vrouwen en chronische 
buikpijnklachten. Deze complicaties hebben niet aileen klinische- maar oak grate financi8!e 
gevolgen. 
Postoperatieve adhesievorming is een dynamisch proces, een cascade van opeenvolgende 
gebeurtenissen, wat optreedt na beschadiging (trauma) van het buikvlies (peritoneum). 
Alhoewel we deze cascade nag niet volledig begrijpen, is wei bekend dat het een 
ontregeling betreft van het normale verdedigingsmechanisme dat zorgt voor wondheling van 
beschadigde peritoneale oppervlakken. Een groat aantal therapeutische mogelijkheden, dat 
aangrijpt op verschillende niveaus in de cascade van adhesievorming, heeft zijn klinische 
relevantie tot nu toe nag niet bewezen. Er bestaat dus nag geen algemeen geaccepteerde 
behande!ing ter voorkoming van adhesies en hun complicaties. 
Operatieve behandeling van tumoren in het maagdarmkanaal wordt vaak gecompliceerd 
door het terugkomen van kanker in de buik (loco-regionale tumor recidivering). De "tumor cell 
entrapment hypothese" zou het patroon van falen van de chirurgische therapie, leidend tot 
deze locale recidieven, kunnen verk!aren. Bij deze hypothese zouden tijdens de operatie 
tumorcellen in de buikholte lekken uit de door de chirurg doorgesneden lymfebanen van het 
uitgenomen weefsel. De vrijgekomen tumorcellen zouden vervolgens op het peritoneum 
aanhechten en uitgroeien. De aanhechting (adhesie) van tumorcellen zou gemakkelijker 
plaatsvinden op beschadigde peritoneale oppervlakken. Theoretisch zou het proces van 
aanhechting van gespilde tumorcellen kunnen worden gestimuleerd door dezelfde cascade 
als het hierboven beschreven proces van adhesievorming van tijdens de operatie 
(peroperatief) beschadigde peritoneale oppervlakken. De studies beschreven in d"1t 
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proefschrift hebben het doel de mogelijke correlatie tussen chirurgisch peritoneaal trauma en 
de processen van adhesievorming en tumor recidivering te analyseren. 
De enige effectieve therapeutische mogelijkheid ter voorkoming c.q. vermindering van 
postoperatieve adhesievorming is het zoveel mogelijk voorkomen van peroperatief 
peritoneaal trauma. Het Iaten uitdrogen van het peritoneum, onnodig plaatsen van klemmen 
en hechtingen en het achterlaten van vreemd lichaamsmateriaal wordt algemeen beschouwd 
als traumatisch voor het peritoneum. Dit dient dus zoveel mogelijk te worden vermeden 
tijdens buikoperaties. Voor dit proefschrift zijn experimenten opgezet die onderzoeken of 
vee! bij operatie gebruikte en niet algemeen als traumatisch voor het peritoneum geachte 
materialen zoals chirurgische gazen, spoelvloeistoffen en handschoenenpoeder wellicht ook 
adhesievorming en tumorcel adhesie en groei kunnen bevorderen. 
In dit proefschrift wordt verder bestudeerd welke factoren in de buik geproduceerd worden na 
beschadiging van het peritoneum, en welke van deze factoren een belangrijke rol spelen bij 
het ontstaan van postoperative adhesies en tumor recidivering. Op een facet van deze 
peritoneale respons op trauma wordt dieper ingegaan. Het is de bedoeling om te ontdekken 
of door ingrijpen op dit niveau van de helingscascade, adhesievorming en tumor recidivering 
kunnnen worden voorkomen. Dit ingrijpen dient dan wei te gebeuren zonder het peritoneale 
genezingsproces te be"lnvloeden omdat anders ernstige bijwerkingen zouden kunnen 
optreden. 
De in dit proefschrift a!s laatste beschreven experimenten evalueren de preventieve 
capaciteit van een nieuwe glucose polymeer op!ossing, icodextrin® ten aanzien van 
adhesievorming. Voorts worden de mogelijkheden bestudeerd om met Seprecoat™ en 
icodextrin® de adhesie en groei van vrije in de buikholte aanwezige tumorcellen te 
voorkomen. 
Hoofdstuk 1 geeft een samenvatting van literatuur gegevens over de incidentie, de 
klinische- en financi81e consequenties, de eathiologie, de pathophysiologie, de behandeling 
en de preventie van postoperatieve adhesievorming en locoregionale tumor recidivering. 
In Hoofdstuk 2 worden de doelstellingen van dit proefschrift gepresenteerd. 
Hoofdstuk 3 beschrijft de ontwikkeling van een reproduceerbaar proefdier model 
waarin semi-kwantitatieve en kwalitatieve beoordeling van adhesievorming mogelijk is. Met 
behulp van dit model kon worden aangetoond dat er een relatie bestaat tussen de intensiteit 
van peritoneaal trauma en de mate van adhesievorming; aanbrengen van ernstig trauma 
resulteerde in een significant hager adhesie percentage dan aanrichten van minimaal 
trauma. Adhesies die ontstaan na ernstig trauma waren dikker en steviger dan adhesies die 
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ontstaan na minimaal trauma. In hetzelfde proefdier model werd vervolgens oak aangetoond 
dat intra-abdominaal gebruik van ruw chirurgisch gaas schadelijker is voor het peritoneum en 
tot significant meer adhesievorming leidt dan gebruik van een zachter gaas afkomstig uit de 
elektronica industrie. Het bleek zelfs dat minimaal peritoneaal trauma dat werd veroorzaakt 
door schuren met het zachtere gaas, helemaal niet leidde tot additionele adhesievorming. 
Hoofdstuk 4 laat de resultaten zien van experimenten die het effect van 
verschillende spoelvloeistoffen op het peritoneum onderzoeken. Peroperatief spoelen van de 
buikholte met RPMI, NaCI 0.9%, polyvinylpyrrolidone iodine 1% (PVP-1), Viaspan en 
chloorhexidine 0.02% beschadigt het peritoneum zodanig dat het postoperatieve 
adhesievorming bevordert. Peritoneale spoeling van minimaal getraumatiseerde buikholtes 
met agressieve oplossingen bracht significant meer, dikkere en steviger adhesies teweeg 
dan lavage van minimaal getraumatiseerde buikholtes met minder agressieve oplossingen. 
Hoofdstuk 5 beschrijft de ontwikkeling van een tweede reproduceerbaar proefdier 
model, analoog aan het ratten adhesiemodel. In dlt model is een seml-kwantitatieve 
beoordeling van intra-abdominale tumor deposities mogelijk. Hiermee werd de correlatie 
tussen de intensiteit van peritoneaal trauma en de mate van tumor recidivering 
gedemonstreerd; op de plaatsen waar het peritoneum het meest werd beschadigd, werd een 
significant grotere tumor depositie aangetroffen dan op peritoneale oppervlakken die minder 
ernstig werden beschadigd. Nag opmerkelijker was dater oak op de niet direct beschadigde 
peritoneale oppervlakken meer tumor depositie werd gevonden in ernstig getraumatiseerde 
buikholtes dan in minimaal getraumatiseerde buikholtes. 
Met behulp van een eerder ontwikkeld reproduceerbaar proefdier model, waarin 
kwantitatieve beoordeling van de groei van buiten de buikholte gelegen tumoren mogelijk is, 
kon worden aangetoond dat de mate van groei van deze tumoren correleert met de 
intensiteit van aangebracht peritoneaal trauma. Het lijkt dan oak dat factoren die 
geproduceerd worden na een chirurgisch trauma van het peritoneum niet aileen locaal (in de 
buik), maar oak op afstand een tumor stimulerend effect hebben. Resultaten uit volgende 
experimenten toonden aan dat deze in de buikholte vrijkomende factoren konden worden 
gevangen in een vloeistof waarmee men de buik na het aanbrengen van peritoneaal trauma 
spoelde. Wanneer deze vloeistof nu samen met tumorcellen in buiken van niet geopereerde 
naTeve proefdieren werd ingespoten, stimuleerde dit tumorcel adhesie en groei op de niet 
beschadigde peritoneale oppervlakken. De mate van tumor depositie in deze niet 
geopereerde proefdieren hing zelfs samen met de intensiteit waarmee het peritoneum van 
het "donordier" werd beschadigd. 
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In studies vastgelegd in Hoofdstuk 6 is onderzocht of het "bekende" adhesie 
provocerende effect van handschoenpoeder kon worden gereproduceerd in ons proefdier 
adhesiemodel en of handschoenpoeder ook recidivering van intra-abdominale tumoren 
veroorzaakt. Locale applicatie van handschoenpoeder of puur zetmeel op minimaal- en 
ernstig getraumatiseerd peritoneum deed een significant hager percentage adhesies 
ontstaan dan aanbrengen van peritoneaal trauma aileen. Het aanbrengen van 
handschoenpoeder of puur zetmeel op het peritoneum induceerde ook een significant 
hogere tumor recidivering in de buikholte dan wanneer geen poeder was achtergelaten. 
Experimenten beschreven in Hoofdstuk 7 zijn gericht op verdere analyse van 
chirugie-gerelateerde factoren die na peritoneaal trauma in de buikholte geproduceerd 
worden. Het bleek dat niet aileen de spoel-oplossing in zijn geheel maar ook zijn gescheiden 
componenten tumor recidivering kon bevorderen. Oplosbare factoren en ontstekings 
(inflammatoire) celten konden ieder individueel, wanneer zij samen met tumorcellen in de 
buikholtes van niet geopereerde ontvangers werden ingespoten, significant meer intra-
abdominale tumor deposities veroorzaken dan wanneer aileen tumorcellen werden 
ge'lnjecteerd. De cellulaire component stimuleerde de tumorcel adhesie en groei significant 
meer dan de vloeistof die aileen oplosbare factoren bevat. Analyse van de cellulaire 
component liet zien dat peritoneaal trauma een significante influx van neutrofielen 
granulocyten (PMN) in de buikholte veroorzaakt. In het oplosbare deel van de spoel-
oplossing waren acute fase pro-inflammatoire cytokines, chemokines en groeifactoren 
waarneembaar. 
In Hoofdstuk 8 wordt de vraag gesteld of de geobserveerde co'lncidentie van post-
traumatische influx van neutrofielen in de buikholte en post-traumatische adhesievorming en 
tumor recidivering ook betekent dat neutrofile granulocyten een hoofdrol spelen in het proces 
van adhesievorming en van adhesie en groei van tumorcellen. Experimentele resultaten 
lieten opnieuw zien dat peritoneale schade, gedurende minstens 96 uur na het trauma, een 
hoog aantal intra-abdominale neutrofielen bewerkstelligt. Deze post-traumatische PMN influx 
kon worden voorkomen door het intra-abdominaal toedienen van selectieve antilichamen 
tegen PMN (ANS). Verhindering van post-traumatische PMN influx door inspuiten van 3 
doses ANS verminderde postoperatieve adhesievorming significant. Daarentegen 
reduceerde een behandeling met 3 doses ANS de tumor recidivering niet. Het bleek zelfs dat 
de behandeling met 3 doses ANS de tumor recidivering significant induceerde. Dit was 
waarschijnlijk de consequentie van immuunsuppressie omdat injectie van 3 doses ANS 
gepaard ging met een significante daling van het aantal lymfocyten, monocyten en 
neutrofielen in het bloed. Behandeting met een dosis ANS voorkwam de post traumatische 
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PMN influx meer selectief. Hierdoor daalden aileen de neutrofielen in het bloed nag Iicht. 
Deze meer se!ectieve preventie van post-traumatische PMN influx ging gepaard met een 
significante vermindering van post-traumatische tumorcel adhesie en groei. 
In Hoofdstuk 9 wordt de adhesiepreventieve gel Sepracoat™ getest op haar 
vermogen om tumorcel adhesie en groei na operatief ingrijpen te beperken. Sepracoat™ had 
een minimaal maar significant remmend effect op de aanhechting van tumorcellen op 
mesotheelcellen (buikvliescel!en) in kweek. Echter, dit effect van Sepracoat™ kon niet 
worden gestaafd met resultaten verkregen uit in vivo studies; wanneer Sepracoat™ 
peroperatief in de buikholte werd aangebracht had dit geen invloed op postoperatieve tumor 
depositie op direct en indirect getraumatiseerd peritoneum. 
In Hoofdstuk 10 worden de resultaten gepresenteerd van experimenten die het 
effect van een nieuwe glucose polymeer op!ossing op adhesievorming en tumor recidivering 
evalueren. Na aanbrengen van ernstig peritoneaal trauma reduceerde het in de buikholte 
achterlaten van icodextrin® de omvang en de ernst van postoperatieve adhesies significant. 
Behandeling van ernstig getraumatiseerde buikholtes met icodextrin® had noch een 
remmend noch een stimulerend effect op tumorcel adhesie en groei van vrij in de buikholte 
aanwezige tumorcellen. 
Met de algemene discussie in Hoofdstuk 11 wordt dit proefschrift besloten. Het 
geeft een overzicht van de resultaten van de in deze dissertatie gepresenteerde studies, 
bediscussieert deze resultaten tegen het Iicht van andere in de literatuur beschreven data 
over dit onderwerp, bespreekt de mogelijke klinische gevolgen en toepasbaarheid van de 
resultaten en geeft suggesties voor verder onderzoek. Het is belangrijk dat, zolang nag geen 
klinisch toepasbare preventieve mogelijkheden zonder bijwerkingen bestaan voor 
postoperatieve adhesievorming en tumor recidivering, het experimenteel onderzoek wordt 
voortgezet en de resultaten hiervan getest worden in prospectief gerandomiseerde klinische 
trials. 
Conclusies 
De intensiteit van peroperatief aangericht peritoneaal trauma correleert met de mate en 
ernst van postoperatieve adhesievorming. 
De intensiteit van peroperatief aangericht peritoneaal trauma correleert met de mate van 
intra-abdominale tumorcel adhesie en groei en dus met de mate van locale tumor 
recidive ring. 
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Standaard chirurgisch buikgaas is traumatisch voor het peritoneum en stimuleert 
postoperatieve adhesievorming en intra-abdominale tumor recidivering. 
Zacht textiel afkomstig uit de elektronica industria voldoet aan belangrijke eisen voor 
chirurgisch buikgaas, is nauwelijks traumatisch voor het peritoneum en induceert dus 
minder adhesievorming en tumor recidivering dan standaard chirurgisch gaas. 
Spoelvloeistoffen zijn traumatisch voor het peritoneum en stimuleren postoperatieve 
adhesievorming en intra-abdominale tumor recidivering. 
Handschoenpoeder is traumatisch voor het peritoneum en stimuleert postoperatieve 
adhesievorming en intra-abdominale tumor recidivering. 
Neutrofiele granulocyten, geproduceerd in de buikholte na peritoneaal trauma, stimuleren 
tumorcel adhesie en groei. 
Cytokines en groei factoren geproduceerd in de buikholte na peritoneaal trauma, 
stimuleren tumorcel adhesie en groei. 
Post-traumatische intra-abdominale neutrofiele granulocyten influx speelt een belangrijke 
rol bij de ontsporing van de dynamische peritoneale verdedigings cascade en het 
verijdelen van deze influx reduceert postoperatieve adhesievorming en tumorcel adhesie 
en groei. 
De hyaluronzuur oplossing Sepracoat™ reduceert tumorcel adhesie op mesotheelcellen 
in kweek, maar heeft geen invloed op intra-abdominale tumorcel adhesie en groei. 
Een nieuwe glucose polymeer oplossing, icodextrin®, reduceert postoperatieve 
adhesievorming maar heeft geen invloed op intra-abdominale tumorcel adhesie en groei. 
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LIST OF ABBREVIATIONS 
ANOVA 
ANS 
bFGF 
BSA 
CAPD 
CD 
ECM 
EDTA 
EGF 
ELISA 
FCS 
HA 
HE 
I CAM 
lg 
IGF 
ll 
LDH 
MCP 
NSAID's 
PAA 
PAl 
PBS 
PDGF 
PMN 
PG 
PVP 
ROS 
RPM I 
SD 
TGF 
TNF 
t-PA 
rt-PA 
u-PA 
analysis of variance 
anti-neutrophil serum 
basic fibroblast growth factor 
bovine serum albumin 
continuous ambulatory peritoneal dialysis 
cluster of differentiation 
extra cellular matrix 
ethylenediaminetetraacetic 
epidermal growth factor 
enzyme linked immune sorbent assay 
foetal calf serum 
hyaluronic acid 
hematoxilin eosin 
inter cellular adhesion molecule 
immunoglobulin 
insulin-like growth factor 
interleukin 
lactate dehydrogenase 
monocyte chemotactic protein 
nonsteroidal anti-inflammatory drugs 
plasminogen activator activity 
plasminogen activator inhibitor 
phophate buffered saline 
platelet derived growth factor 
polymorph neuclear leucocytes 
prostaglandins 
polyvinylpyrolidine iodine 
reactive oxygen species 
Rosewall Park Memorial Institute medium 
standard deviation 
transforming growth factor 
tumour necrosis factor 
tissue-type plasminogen activator 
recombinant tissue-type plasminogen activator 
urokinase-type plasminogen activator 
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